+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 58494

Chapter 58494 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Gupta, K.; Mandlik, D.; Patel, P.; Desai, T.; Patel, K.D., 2016:
PET-CT with MR Fusion: Single Comprehensive Preoperative Metastatic Workup in Head and Neck Malignancy: A Case Report

Zijlstra, Jée.M., 2016:
PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?

Randall, E.K., 2016:
PET-Computed Tomography in Veterinary Medicine

Bishop, G., 2015:
PET-Directed Therapy for Hodgkin's Lymphoma

Villarejo-Galende, A.; Sarandeses, P.; Penas-Prado, M.; Hernández-Laín, A.; Ramos, A.; Hernández-Martínez, A.Cristina.; Carro, E.; Ricoy, Jé.Ramón.; Hernández-Gallego, Jús., 2016:
PET-Florbetapir findings in primary cerebral amyloidoma

Yaddanapudi, K.; Brunken, R.; Tan, C.D.; Rodriguez, E.Rene.; Bolen, M.A., 2016:
PET-MR Imaging in Evaluation of Cardiac and Paracardiac Masses With Histopathologic Correlation

Vandenberghe, S.; Marsden, P.K., 2016:
PET-MRI: a review of challenges and solutions in the development of integrated multimodality imaging

Tudisca, C.; Nasoodi, A.; Fraioli, F., 2016:
PET-MRI: clinical application of the new hybrid technology

Sickinger, M.T.; von Tresckow, B.; Kobe, C.; Borchmann, P.; Engert, A.; Skoetz, N., 2016:
PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis

Laffon, E.; Marthan, R., 2015:
PET-adapted salvage therapy for Hodgkin's lymphoma

Tirelli, U.; Spina, M., 2015:
PET-adapted salvage therapy in Hodgkin's lymphoma

Moskowitz, A.J.; Schöder, H.; Yahalom, J.; McCall, S.J.; Fox, S.Y.; Gerecitano, J.; Grewal, R.; Hamlin, P.A.; Horwitz, S.; Kobos, R.; Kumar, A.; Matasar, M.; Noy, A.; Palomba, M.Lia.; Perales, M-Angel.; Portlock, C.S.; Sauter, C.; Shukla, N.; Steinherz, P.; Straus, D.; Trippett, T.; Younes, A.; Zelenetz, A.; Moskowitz, C.H., 2015:
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study

Lee, S.Yee.; Kingham, T.Peter.; LaGratta, M.D.; Jessurun, J.; Cherqui, D.; Jarnagin, W.R.; Kluger, M.D., 2016:
PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions

Zanzonico, P.; Carrasquillo, J.A.; Pandit-Taskar, N.; O'Donoghue, J.A.; Humm, J.L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A.M.; Kemeny, N.E.; Fong, Y.; Wong, D.; Scheinberg, D.; Ritter, G.; Jungbluth, A.; Old, L.J.; Larson, S.M., 2016:
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer

Even, A.J.G.; van der Stoep, J.; Zegers, C.M.L.; Reymen, B.; Troost, E.G.C.; Lambin, P.; van Elmpt, W., 2016:
PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes

Dimitrakopoulou-Strauss, A., 2016:
PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome

Chirla, R.; Marcu, L.G., 2016:
PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer

Speirs, C.K.; Grigsby, P.W.; Huang, J.; Thorstad, W.L.; Parikh, P.J.; Robinson, C.G.; Bradley, J.D., 2015:
PET-based radiation therapy planning

Dorius, T.H.; Bennion, N.R.; Armitage, J.O., 2016:
PET-directed therapy in Hodgkin lymphoma: Ready for prime time?

Strelnikov, K.; Marx, M.; Lagleyre, S.; Fraysse, B.; Deguine, O.; Barone, P., 2015:
PET-imaging of brain plasticity after cochlear implantation

Valenta, I.; Antoniou, A.; Marashdeh, W.; Leucker, T.; Kasper, E.; Jones, S.R.; Dannals, R.F.; Solnes, L.; Pomper, M.G.; Schindler, T.H., 2016:
PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients

Pemmaraju, N.; Jain, P.; Medeiros, L.Jeffrey.; Jorgenson, J.L.; Jain, N.; Willis, J.; Kontoyiannis, D.P.; Estrov, Z.; Wierda, W.G., 2016:
PET-positive lymphadenopathy in CLL-Not always Richter transformation

Jennings, M.; Marcu, L.G.; Bezak, E., 2015:
PET-specific parameters and radiotracers in theoretical tumour modelling

Novelli, S.; Briones, J.; Flotats, A.; Sierra, J., 2015:
PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis

Huda, P.; Binderup, T.; Pedersen, M.Cramer.; Midtgaard, Søren.Roi.; Elema, D.Ringkjøbing.; Kjær, A.; Jensen, M.; Arleth, L., 2016:
PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice

Kairemo, K.; Rasulova, N.; Kiljunen, T.; Partanen, K.; Kangasmäki, A.; Joensuu, T., 2016:
PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients

Kim, R.; Prithviraj, G.; Kothari, N.; Springett, G.; Malafa, M.; Hodul, P.; Kim, J.; Yue, B.; Morse, B.; Mahipal, A., 2016:
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer

Ghaderi, K.F.; Yoo, D.C.; Hart, J., 2016:
PET/CT Helps Downgrade an Aggressive-Appearing Rib Mass to a Probable Benign Lesion in a 9-Year-Old Girl

Tang, H-Jun., 2015:
PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma

Lei, L.; Wang, X.; Chen, Z., 2016:
PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer

Bhosale, P.; Iyer, R.; Jhingran, A.; Podoloff, D., 2010:
PET/CT Imaging in Gynecologic Malignancies Other than Ovarian and Cervical Cancer

Luehmann, H.P.; Detering, L.; Fors, B.P.; Pressly, E.D.; Woodard, P.K.; Randolph, G.J.; Gropler, R.J.; Hawker, C.J.; Liu, Y., 2017:
PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles

Zamagni, E.; Nanni, C.; Mancuso, K.; Tacchetti, P.; Pezzi, A.; Pantani, L.; Zannetti, B.; Rambaldi, I.; Brioli, A.; Rocchi, S.; Terragna, C.; Martello, M.; Marzocchi, G.; Borsi, E.; Rizzello, I.; Fanti, S.; Cavo, M., 2016:
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma

Blodgett, T.M.; Ryan, A.; Akbarpouranbadr, A.; McCook, B.M., 2007:
PET/CT Protocols and Artifacts in the Head and Neck

Wong, T.Z.; Fras, I.Michael., 2007:
PET/CT Protocols and Practical Issues for the Evaluation of Patients with Head and Neck Cancer

Yoon, J.Won.; Kim, S.; Kim, S.Wun.; Kim, Y.Tae.; Kang, W.Jun.; Nam, E.Ji., 2016:
PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation

Gofrit, O.Nathan.; Frank, S.; Meirovitz, A.; Nechushtan, H.; Orevi, M., 2016:
PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer

Abdülrezzak, Ümmühan.; Kula, M.; Tutuş, A.; Buyukkaya, F.; Karaca, H., 2016:
PET/CT and Bremsstrahlung Imaging After 90Y DOTANOC Therapy for Rectal Net With Liver Metastases

Anagnostopoulos, C.D.; Georgakopoulos, A.; Pianou, N.; Tsirebolos, G.; Nekolla, S.G.; Danias, P.G.; Rizos, I-Antonios., 2015:
PET/CT and CMR imaging in a patient with chest pain and unobstructed coronary vessels

Bigalke, B.; Phinikaridou, A.; Andia, M.E.; Cooper, M.S.; Schuster, A.; Wurster, T.; Onthank, D.; Münch, Götz.; Blower, P.; Gawaz, M.; Nagel, E.; Botnar, R.M., 2015:
PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc)

Besson, F.L.; Blanc-Durand, P.; Meyer, Céline.; Grimon, G.; Durand, E., 2016:
PET/CT and MRI Imaging of a Eumycetoma of the Right Thigh

Rischke, H.Christian.; Eiberger, A-Kristin.; Volegova-Neher, N.; Henne, K.; Krauss, T.; Grosu, A-L.; Jilg, C.A., 2016:
PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases

Kusmirek, J.; Robbins, J.; Allen, H.; Barroilhet, L.; Anderson, B.; Sadowski, E.A., 2016:
PET/CT and MRI in the imaging assessment of cervical cancer

Pessanha, Lís.Bastos.; de Oliveira, Aé.Ribeiro.Nogueira.; Guerra, L.Felipe.Alves.; Martins, D.Lima.Nava.; Rondina, R.Garcia.; Mello, M.Bozzi.Nonato., 2016:
PET/CT and brown fat in the evaluation of treatment response in Hodgkin lymphoma

Casneuf, V.; Delrue, L.; Kelles, M.; Berrevoet, F.; Duyck, P.; D.H.mptinne, B.; Van Damme, N.; Monsaert, E.; Peeters, M., 2016:
PET/CT can direct diagnostic and therapeutic decisions in pancreatic lesions

Gilardi, L.; de Marinis, F.; Grana, C.M., 2015:
PET/CT characterization of non-small-cell lung cancer heterogeneity

Janssen, I.; Chen, C.C.; Millo, C.M.; Ling, A.; Taieb, D.; Lin, F.I.; Adams, K.T.; Wolf, K.I.; Herscovitch, P.; Fojo, A.T.; Buchmann, I.; Kebebew, E.; Pacak, K., 2016:
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma

Mazurek, T.; Kobylecka, Młgorzata.; Zielenkiewicz, M.; Kurek, A.; Kochman, J.; Filipiak, K.J.; Mazurek, K.; Huczek, Z.; Królicki, L.; Opolski, G., 2016:
PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?

Tomura, N.; Mizuno, Y.; Saginoya, T., 2016:
PET/CT findings for tumors in the base of the skull: comparison of 18 F-FDG with 11 C-methionine

Hirshoren, N.; Olayos, E.; Callahan, J.; Lau, E., 2016:
PET/CT findings within the contralateral tonsil following unilateral tonsillectomy

Jha, P.; Bijan, B., 2016:
PET/CT for Pancreatic Malignancy: Potential and Pitfalls

Erak, M.Dj.; Mitrić, M.; Djuran, B.; Tesanović, D.; Vasiljev, S., 2016:
PET/CT fusion in radiotherapy planning for lung cancer--Case reports

Chen, R.Y.; Dodd, L.E.; Lee, M.; Paripati, P.; Hammoud, D.A.; Mountz, J.M.; Jeon, D.; Zia, N.; Zahiri, H.; Coleman, M.Teresa.; Carroll, M.W.; Lee, J.Doo.; Jeong, Y.Joo.; Herscovitch, P.; Lahouar, S.; Tartakovsky, M.; Rosenthal, A.; Somaiyya, S.; Lee, S.; Goldfeder, L.C.; Cai, Y.; Via, L.E.; Park, S-Kyu.; Cho, S-Nae.; Barry, C.E., 2015:
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis

Yaita, K.; Akiyoshi, H.; Nakae, I.; Kawasaki, Y.; Nakama, K.; Sakai, Y.; Masunaga, K.; Watanabe, H., 2017:
Disseminated Mycobacterium intracellulare infection with multiple abscesses on extremities in a woman with chronic corticosteroid therapy

Wiwanitkit, V., 2015:
PET/CT imaging for metastatic choroidal melanoma

Konert, T.; Vogel, W.; MacManus, M.P.; Nestle, U.; Belderbos, Jé.; Grégoire, V.; Thorwarth, D.; Fidarova, E.; Paez, D.; Chiti, A.; Hanna, G.G., 2015:
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014

Wang, G-M.; Liu, D-F.; Xu, Y-P.; Meng, T.; Zhu, F., 2017:
PET/CT imaging in diagnosing lymph node metastasis of esophageal carcinoma and its comparison with pathological findings

Hochhegger, B.; Alves, G.Rafael.Tronco.; Irion, K.Loureiro.; Fritscher, C.Cezar.; Fritscher, L.Genehr.; Concatto, Nália.Henz.; Marchiori, E., 2016:
PET/CT imaging in lung cancer: indications and findings

Epelbaum, R.; Bar-Shalom, R.; Keidar, Z.; Gaitini, D.; Haddad, R.; Israel, O., 2016:
PET/CT imaging in patients with suspected recurrence of pancreatic cancer

Ankrah, A.O.; van der Werf, T.S.; de Vries, E.F.J.; Dierckx, R.A.J.O.; Sathekge, M.M.; Glaudemans, A.W.J.M., 2016:
PET/CT imaging of Mycobacterium tuberculosis infection

Turkbey, B.; Lindenberg, M.L.; Adler, S.; Kurdziel, K.A.; McKinney, Y.L.; Weaver, J.; Vocke, C.D.; Anver, M.; Bratslavsky, G.; Eclarinal, P.; Kwarteng, G.; Lin, F.I.; Yaqub-Ogun, N.; Merino, M.J.; Linehan, W.Marston.; Choyke, P.L.; Metwalli, A.R., 2016:
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study

Coleman, M.Teresa.; Chen, R.Y.; Lee, M.; Lin, P.Ling.; Dodd, L.E.; Maiello, P.; Via, L.E.; Kim, Y.; Marriner, G.; Dartois, V.; Scanga, C.; Janssen, C.; Wang, J.; Klein, E.; Cho, S.Nae.; Barry, C.E.; Flynn, J.L., 2015:
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis

Sawatzke, A.B.; Norris, A.W.; Spyropoulos, F.; Walsh, S.A.; Acevedo, M.R.; Hu, S.; Yao, J.; Wang, C.; Sunderland, J.J.; Boles Ponto, L.L., 2015:
PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissues

Delgado, A.; Mesa, J.; Guayambuco, S.; Rodriguez, T.; Fernández, I.; Rodeño, E., 2018:
PET/CT imaging with 18F-FDG in Castleman disease

Kairemo, K., 2016:
PET/CT in External Beam Radiation Therapy Dose Planning

Hany, T.F., 2008:
PET/CT in Gastrointestinal Cancer: Methodological Aspects

Amit, A.; Schink, J.; Reiss, A.; Lowenstein, L., 2010:
PET/CT in Gynecologic Cancer: Present Applications and Future Prospects-A Clinician's Perspective

Wassef, H.R.; Hanna, N.; Colletti, P., 2016:
PET/CT in Head-neck Malignancies: The Implications for Personalized Clinical Practice

Anonymous, 2016:
PET/CT in Neuroendocrine Tumors

Prasad, V.; Ambrosini, V.; Alavi, A.; Fanti, S.; Baum, R.P., 2008:
PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism

Yu, J.Q.; Doss, M.; Codreanu, I.; Zhuang, H., 2012:
PET/CT in Patients with Sarcoidosis or IgG4 Disease

Beriwal, S., 2009:
PET/CT in Radiation Therapy Planning for Breast Cancer

Infante, J.R.; Garcia, L.; Rayo, J.I.; Serrano, J.; Dominguez, M.L.; Moreno, M., 2016:
PET/CT in a Patient Diagnosed With Dandy-Walker Syndrome

Rehak, Z.; Vasina, J.; Ptacek, J.; Kazda, T.; Fojtik, Z.; Nemec, P., 2016:
PET/CT in giant cell arteritis: High 18F-FDG uptake in the temporal, occipital and vertebral arteries

Capitanio, S.; Nordin, A.Jalil.; Noraini, A.Rahim.; Rossetti, C., 2016:
PET/CT in nononcological lung diseases: current applications and future perspectives

Padma, S.; Sundaram, P.Shanmuga.; Tewari, A., 2016:
PET/CT in paediatric malignancies - An update

Mintz, A., 2015:
PET/CT in prostate cancer: an unmet clinical need

Sharp, S.E.; Gelfand, M.J.; Shulkin, B.L., 2008:
PET/CT in the Evaluation of Neuroblastoma

Barbosa, F.de.Galiza., 2016:
PET/CT in the evaluation of pulmonary solitary nodule

Yuan, H.; Tong, D.K.H.; Vardhanabhuti, V.; Law, S.Y.K.; Chiu, K.W.H.; Khong, P-Lan., 2016:
PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma

Fischer, B.Malene.; Siegel, B.A.; Weber, W.A.; von Bremen, K.; Beyer, T.; Kalemis, A., 2016:
PET/CT is a cost-effective tool against cancer: synergy supersedes singularity

Demir, M.; Meteroğlu, F.; Kaya, H.; Taylan, Mşuk.; Yenibertiz, D.; Yılmaz, Süreyya.; Şenyiğit, A., 2016:
PET/CT positive in a case with eosinophilic granuloma

Lindner, K.; Palmes, D.; Senninger, N.; Hummel, R., 2015:
PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer

Picelli, A.; Borghero, A.; Lupi, A.; Bertagnoni, G., 2016:
PET/CT scan in traumatic brain injury: a new frontier for the prognosis from cerebellum activity?

Piga, M.; Pesella, F.; Corraine, M.Luisa.; Floris, A.; Cauli, A.; Mathieu, A., 2016:
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels

Kreppel, M.; Kreppel, B.; Zöller, J.E., 2016:
PET/CT surveillance versus neck dissection in advanced head and neck cancer

Hochhegger, B., 2016:
PET/CT used in the evaluation of pulmonary nodules suspicious for lung cancer in regions where infectious lung disease is endemic: to be or not to be?

Aljabery, F.; Lindblom, G.; Skoog, S.; Shabo, I.; Olsson, H.; Rosell, J.; Jahnson, S., 2016:
PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer

Fanti, S.; Minozzi, S.; Castellucci, P.; Balduzzi, S.; Herrmann, K.; Krause, B.Joachim.; Oyen, W.; Chiti, A., 2016:
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data

Chiaravalloti, A.; D.B.agio, D.; Tavolozza, M.; Calabria, F.; Schillaci, O., 2016:
PET/CT with (18)F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?

Bondue, B.; Sherer, Félicie.; Van Simaeys, G.; Doumont, G.; Egrise, D.; Yakoub, Y.; Huaux, Fçois.; Parmentier, M.; Rorive, S.; Sauvage, Sébastien.; Lacroix, S.; Vosters, O.; D.V.yst, P.; Goldman, S., 2015:
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis

Lapa, P.; Silva, R.; Saraiva, T.; Figueiredo, A.; Ferreira, R.; Costa, G.; Lima, Jão.Pedroso., 2016:
PET/CT with 18F-Fluorocholine in Patients with Prostatic Cancer in Biochemical Recurrence

Teixeira, S.C.; Koolen, B.B.; Elkhuizen, P.H.M.; Vrancken Peeters, M-J.T.F.D.; Stokkel, M.P.M.; Rodenhuis, S.; van der Noort, V.; Rutgers, E.J.T.; Valdés Olmos, R.A., 2016:
PET/CT with 18 F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease

Travaini, L.L.; Zampino, M.G.; Colandrea, M.; Ferrari, M.E.; Gilardi, L.; Leonardi, M.C.; Santoro, L.; Orecchia, R.; Grana, C.M., 2016:
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Chowdhury, F.U., 2016:
PET/CT "Virtual" Special Issue

Schwenzer, N.F.; Pfannenberg, A.Christina., 2016:
PET/CT, MR, and PET/MR in Lymphoma and Melanoma

Song, Y.Sung.; Paeng, J.Chul.; Kim, H-Cheol.; Chung, J.Wook.; Cheon, G.Jeong.; Chung, J-Key.; Lee, D.Soo.; Kang, K.Wook., 2015:
PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy

Loevner, L.A.; Kim, A.K.; Mikityansky, I., 2008:
PET/CT-MR Imaging in Head and Neck Cancer Including Pitfalls and Physiologic Variations

Makris, N.E.; Boellaard, R.; van Lingen, A.; Lammertsma, A.A.; van Dongen, G.A.M.S.; Verheul, H.M.; Menke, C.W.; Huisman, M.C., 2015:
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab

Guo, W.; Hao, B.; Chen, H-Jun.; Zhao, L.; Luo, Z-Ming.; Wu, H.; Sun, L., 2016:
PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique

Kornerup, J.S.; Brodin, N.P.; Björk-Eriksson, T.; Birk Christensen, C.; Kiil-Berthelsen, A.; Aznar, M.C.; Hollensen, C.; Markova, E.; Munck, A.R.senschöld, P., 2015:
PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy

Subramaniam, R.M., 2016:
PET/CT: Adding Value to Patient Outcomes and Health Care Delivery

Subramaniam, R.M., 2016:
PET/CT: Defining Value to Patients and Health Systems

Foerter, J.; Sundell, J.; Vroman, P., 2016:
PET/CT: First-Line Examination to Assess Disease Extent of Disseminated Coccidioidomycosis

Wang, X., 2016:
PET/CT: appropriate application in lymphoma

Sharma, P.; Kumar, R.; Alavi, A., 2016:
PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy

Rohren, E.M., 2016:
PET/Computed Tomography and Patient Outcomes in Melanoma

Bonichon, Fçoise.; Godbert, Y.; Gangi, A.; Buy, X.; Palussière, J., 2016:
PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy)

Suresh Malapure, S.; Das, K.Jyoti.; Kumar, R., 2016:
PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?

Ortega López, N., 2016:
PET/Computed Tomography in Evaluation of Transarterial Chemoembolization

Shamim, S.Ahmed.; Kumar, A.; Kumar, R., 2016:
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes

Bouchelouche, K.; Choyke, P.L., 2016:
PET/Computed Tomography in Renal, Bladder, and Testicular Cancer

Malibari, N.; Hickeson, M.; Lisbona, R., 2016:
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers

Ceci, F.; Castellucci, P.; Graziani, T.; Schiavina, R.; Fanti, S., 2016:
PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer

Kumar, R., 2016:
PET/Computed Tomography-based Intervention

Sałyga, A.; Guzikowska-Ruszkowska, I.; Czepczyński, Rł.; Ruchała, M., 2016:
PET/MR - a rapidly growing technique of imaging in oncology and neurology

Yoon, S.Ho.; Goo, J.Mo.; Lee, S.Min.; Park, C.Min.; Cheon, G.Jeong., 2016:
PET/MR Imaging for Chest Diseases: Review of Initial Studies on Pulmonary Nodules and Lung Cancers

Paspulati, R.Mohan.; Gupta, A., 2016:
PET/MR Imaging in Cancers of the Gastrointestinal Tract

Rischpler, C.; Nekolla, S.G., 2016:
PET/MR Imaging in Heart Disease

Andersen, K.Francis.; Jensen, K.Erik.; Loft, A., 2016:
PET/MR Imaging in Musculoskeletal Disorders

Ripa, R.Sejersten.; Pedersen, S.Folke.; Kjær, A., 2016:
PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation

Zaidi, H., 2016:
PET/MR Imaging: Advances in Instrumentation and Quantitative Procedures

Torigian, D.A.; Kjær, A.; Zaidi, H.; Alavi, A., 2016:
PET/MR Imaging: Clinical Applications

Sekine, T.; Barbosa, F.de.Galiza.; Sah, B-Ram.; Mader, Cäcilia.E.; Delso, G.; Burger, I.A.; Stolzmann, P.; Ter Voert, E.E.; von Schulthess, G.K.; Veit-Haibach, P.; Huellner, M.W., 2016:
PET/MR Outperforms PET/CT in Suspected Occult Tumors

Pellino, G.; Nicolai, E.; Catalano, O.A.; Campione, S.; D'Armiento, F.P.; Salvatore, M.; Cuocolo, A.; Selvaggi, F., 2015:
PET/MR Versus PET/CT Imaging: Impact on the Clinical Management of Small-Bowel Crohn's Disease

Bignell, H., 2016:
PET/MR and SPECT/MR multimodal imaging constructs: Direct radiolabelling of silica shell iron oxide nanorods for use in liver imaging and potential for hyperthermia therapy

Ladefoged, C.; Benoit, D.; Law, I.; Holm, S.; Hojgaard, L.; Hansen, A.Espe.; Andersen, F.Littrup., 2016:
PET/MR attenuation correction in brain imaging using a continuous bone signal derived from UTE

Aasheim, L.Birger.; Karlberg, A.; Goa, Pål.Erik.; Håberg, A.; Sørhaug, S.; Fagerli, U-Merete.; Eikenes, L., 2016:
PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction

Ladefoged, C.Nøhr.; Hansen, A.Espe.; Andersen, K.Francis.; Loft, A.; Højgaard, L.; Kjær, A.; Andersen, F., 2014:
PET/MR imaging of sarcomas: effect of PET quantification by classification of tissue

Naeger, D.M.; Behr, S.C., 2015:
PET/MR imaging: current and future applications for cardiovascular disease

Tabouret-Viaud, C.; Botsikas, D.; Delattre, Bénédicte.M.A.; Mainta, I.; Amzalag, Gël.; Rager, O.; Vinh-Hung, V.; Miralbell, R.; Ratib, O., 2016:
PET/MR in Breast Cancer

Queiroz, M.A.; Huellner, M.W., 2016:
PET/MR in cancers of the head and neck

Barthel, H.; Schroeter, M.L.; Hoffmann, K-Titus.; Sabri, O., 2016:
PET/MR in dementia and other neurodegenerative diseases

Weissler, B.; Gebhardt, P.; Lerche, C.W.; Soultanidis, G.; Wehner, J.; Heberling, D.; Schulz, V., 2014:
PET/MR synchronization by detection of switching gradients

Schwaiger, M.; Kunze, K.; Rischpler, C.; Nekolla, S.G., 2016:
PET/MR: Yet another Tesla?

Benoit, D.; Ladefoged, C.; Rezaei, A.; Keller, S.; Andersen, F.; Hojgaard, L.; Hansen, A.Espe.; Holm, S.; Nuyts, J., 2016:
PET/MR: improvement of the UTE μ-maps using modified MLAA

Bagade, S.; Fowler, K.J.; Schwarz, J.K.; Grigsby, P.W.; Dehdashti, F., 2016:
PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer

Flechsig, P.; Mehndiratta, A.; Haberkorn, U.; Kratochwil, C.; Giesel, F.L., 2016:
PET/MRI and PET/CT in Lung Lesions and Thoracic Malignancies

Queiroz, M.A.; Kubik-Huch, R.A.; Hauser, N.; Freiwald-Chilla, B.; von Schulthess, G.; Froehlich, J.M.; Veit-Haibach, P., 2016:
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison

Kuwert, T.; Ritt, P., 2016:
PET/MRI and PET/CT: is there room for both at the top of the food chain?

Fernández, S.; Donaire, A.; Serès, E.; Setoain, X.; Bargalló, N.; Falcón, C.; Sanmartí, F.; Maestro, I.; Rumià, J.; Pintor, L.; Boget, T.; Aparicio, J.; Carreño, M., 2015:
PET/MRI and PET/MRI/SISCOM coregistration in the presurgical evaluation of refractory focal epilepsy

Buonincontri, G.; Methner, C.; Krieg, T.; Hawkes, R.C.; Carpenter, T.Adrian.; Sawiak, S.J., 2014:
PET/MRI assessment of the infarcted mouse heart

Rischpler, C.; Langwieser, N.; Souvatzoglou, M.; Batrice, A.; van Marwick, S.; Snajberk, J.; Ibrahim, T.; Laugwitz, K-Ludwig.; Nekolla, S.G.; Schwaiger, M., 2016:
PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake

Fraum, T.J.; Fowler, K.J.; McConathy, J.; Parent, E.E.; Dehdashti, F.; Grigsby, P.W.; Siegel, B.A., 2016:
PET/MRI for the body imager: abdominal and pelvic oncologic applications

Heacock, L.; Weissbrot, J.; Raad, R.; Campbell, N.; Friedman, K.P.; Ponzo, F.; Chandarana, H., 2015:
PET/MRI for the evaluation of patients with lymphoma: initial observations

Barp, A.; Cecchin, D.; Cagnin, A., 2016:
PET/MRI imaging unmasks leptomeningeal carcinomatosis in unexplained diplopia

Bashir, U.; Mallia, A.; Stirling, J.; Joemon, J.; MacKewn, J.; Charles-Edwards, G.; Goh, V.; Cook, G.J., 2016:
PET/MRI in Oncological Imaging: State of the Art

Fan, L.; Sher, A.; Kohan, A.; Vercher-Conejero, J.; Rajiah, P., 2015:
PET/MRI in lung cancer

Chen, B-Bin.; Tien, Y-Wen.; Chang, M-Chu.; Cheng, M-Fang.; Chang, Y-Ting.; Wu, C-Horng.; Chen, X-Jia.; Kuo, T-Chun.; Yang, S-Hung.; Shih, I-Lun.; Lai, H-Shiee.; Shih, T.Ting-Fang., 2016:
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis

Gavra, M.; Syed, R.; Fraioli, F.; Afaq, A.; Bomanji, J., 2016:
PET/MRI in the Upper Abdomen

Wehner, J.; Weissler, B.; Dueppenbecker, P.; Gebhardt, P.; Schug, D.; Ruetten, W.; Kiessling, F.; Schulz, V., 2014:
PET/MRI insert using digital SiPMs: Investigation of MR-compatibility

Fowler, K.J.; Maughan, N.M.; Laforest, R.; Saad, N.E.; Sharma, A.; Olsen, J.; Speirs, C.K.; Parikh, P.J., 2016:
PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response

Nie, X.; Laforest, R.; Elvington, A.; Randolph, G.J.; Zheng, J.; Voller, T.; Abendschein, D.R.; Lapi, S.E.; Woodard, P.K., 2016:
PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model

Yang, Z.Lu.; Zhang, L.Jiang., 2016:
PET/MRI of central nervous system: current status and future perspective

Kogan, F.; Fan, A.P.; McWalter, E.J.; Oei, E.H.G.; Quon, A.; Gold, G.E., 2016:
PET/MRI of metabolic activity in osteoarthritis: A feasibility study

Rischpler, C.; Nekolla, S.G.; Kunze, K.P.; Schwaiger, M., 2016:
PET/MRI of the heart

Xin, J.; Ma, Q.; Guo, Q.; Sun, H.; Zhang, S.; Liu, C.; Zhai, W., 2016:
PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer

Ho, A.M.; Kalantari, B.N., 2016:
PET/MRI: A New Frontier in Breast Cancer Imaging

Carreras-Delgado, J.L.; Pérez-Dueñas, V.; Riola-Parada, C.; García-Cañamaque, L., 2018:
PET/MRI: A luxury or a necessity?

Fraum, T.J.; Fowler, K.J.; McConathy, J., 2015:
PET/MRI: Emerging Clinical Applications in Oncology

Jung, J.Ho.; Choi, Y.; Im, K.Chun., 2016:
PET/MRI: Technical Challenges and Recent Advances

Bryden, F.; Savoie, H.; Rosca, E.V.; Boyle, R.W., 2015:
PET/PDT theranostics: synthesis and biological evaluation of a peptide-targeted gallium porphyrin

Lu, F-Mei.; Yuan, Z., 2015:
PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases

Deau, B.; Franchi, P.; Briere, J.; Ohnona, J.; Tamburini, J.; Thieblemont, C.; Brice, P., 2015:
PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP

Pawlowski, J., 2015:
PETA fuels animal lab improvements

Trull, F.L., 2015:
PETA undermines science and scientists

O'Brien, M.; Kaplan-Levy, R.N.; Quon, T.; Sappl, P.G.; Smyth, D.R., 2016:
PETAL LOSS, a trihelix transcription factor that represses growth in Arabidopsis thaliana, binds the energy-sensing SnRK1 kinase AKIN10

Wan, M.Young.Simon.; Endozo, R.; Michopoulou, S.; Shortman, R.; Rodriguez-Justo, M.; Menezes, L.; Yusuf, S.; Richards, T.; Wild, D.; Waser, B.; Reubi, J.Claude.; Groves, A., 2016:
PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand

Boyce, B.Ann.; Lund, J.; O'Neil, K., 2016:
PETE Doctoral Institutions: Programs, Faculty, and Doctoral Students

Takahashi, H.; Schmollinger, S.; Lee, J-Hyeok.; Schroda, M.; Rappaport, F.; Wollman, F-André.; Vallon, O., 2016:
PETO Interacts with Other Effectors of Cyclic Electron Flow in Chlamydomonas

Thomas, B.A.; Cuplov, V.; Bousse, A.; Mendes, A.; Thielemans, K.; Hutton, B.F.; Erlandsson, K., 2016:
PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography

Ramchandani, N.; Maguire, L.L.; Stern, K.; Quintos, J.B.; Lee, M.; Sullivan-Bolyai, S., 2017:
PETS-D (parents education through simulation-diabetes): Parents' qualitative results

Sullivan-Bolyai, S.; Crawford, S.; Bova, C.; Lee, M.; Quintos, J.B.; Johnson, K.; Cullen, K.; Hamm, T.; Bisordi, J.; Ramchandani, N.; Fletcher, J.; Quinn, D.; Jaffarian, C.; Lipman, T.; Melkus, G., 2017:
PETS-D: Impact on Diabetes Management Outcomes

Berthon, B.; Häggström, I.; Apte, A.; Beattie, B.J.; Kirov, A.S.; Humm, J.L.; Marshall, C.; Spezi, E.; Larsson, A.; Schmidtlein, C.Ross., 2016:
PETSTEP: Generation of synthetic PET lesions for fast evaluation of segmentation methods

Xia, B.; Zhang, H.; Li, Q.; Li, T., 2016:
PETs: A Stable and Accurate Predictor of Protein-Protein Interacting Sites Based on Extremely-Randomized Trees

Anonymous, 2016:
PEW scores: what are they good for?

Sargent, G.; van Zutphen, T.; Shatseva, T.; Zhang, L.; Di Giovanni, V.; Bandsma, R.; Kim, P.Kijun., 2017:
PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation

Zaki, M.S.; Heller, R.; Thoenes, M.; Nürnberg, G.; Stern-Schneider, G.; Nürnberg, P.; Karnati, S.; Swan, D.; Fateen, E.; Nagel-Wolfrum, K.; Mostafa, M.I.; Thiele, H.; Wolfrum, U.; Baumgart-Vogt, E.; Bolz, H.J., 2016:
PEX6 is Expressed in Photoreceptor Cilia and Mutated in Deafblindness with Enamel Dysplasia and Microcephaly

Nanetti, L.; Pensato, V.; Leoni, V.; Rizzetto, M.; Caccia, C.; Taroni, F.; Mariotti, C.; Gellera, C., 2015:
PEX7 Mutations Cause Congenital Cataract Retinopathy and Late-Onset Ataxia and Cognitive Impairment: Report of Two Siblings and Review of the Literature

Chatrath, S.; Gupta, V.Kumar.; Dixit, A.; Garg, L.C., 2016:
PE_PGRS30 of Mycobacterium tuberculosis mediates suppression of proinflammatory immune response in macrophages through its PGRS and PE domains

Palucci, I.; Camassa, S.; Cascioferro, A.; Sali, M.; Anoosheh, S.; Zumbo, A.; Minerva, M.; Iantomasi, R.; D.M.io, F.; D.S.nte, G.; Ria, F.; Sanguinetti, M.; Palù, G.; Brennan, M.J.; Manganelli, R.; Delogu, G., 2016:
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2

Chen, D.; Mao, C.; Zhou, Y.; Su, Y.; Liu, S.; Qi, W-Qing., 2016:
PF-04691502, a dual PI3K/mTOR inhibitor has potent pre-clinical activity by inducing apoptosis and G1 cell cycle arrest in aggressive B-cell non-Hodgkin lymphomas

Thompson, W.Clayton.; Zhou, Y.; Talukdar, S.; Musante, C.J., 2016:
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates

Zou, H.Y.; Li, Q.; Engstrom, L.D.; West, M.; Appleman, V.; Wong, K.A.; McTigue, M.; Deng, Y-Li.; Liu, W.; Brooun, A.; Timofeevski, S.; McDonnell, S.R.P.; Jiang, P.; Falk, M.D.; Lappin, P.B.; Affolter, T.; Nichols, T.; Hu, W.; Lam, J.; Johnson, T.W.; Smeal, T.; Charest, A.; Fantin, V.R., 2015:
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Zou, H.Y.; Friboulet, L.; Kodack, D.P.; Engstrom, L.D.; Li, Q.; West, M.; Tang, R.W.; Wang, H.; Tsaparikos, K.; Wang, J.; Timofeevski, S.; Katayama, R.; Dinh, D.M.; Lam, H.; Lam, J.L.; Yamazaki, S.; Hu, W.; Patel, B.; Bezwada, D.; Frias, R.L.; Lifshits, E.; Mahmood, S.; Gainor, J.F.; Affolter, T.; Lappin, P.B.; Gukasyan, H.; Lee, N.; Deng, S.; Jain, R.K.; Johnson, T.W.; Shaw, A.T.; Fantin, V.R.; Smeal, T., 2015:
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

Zheng, W.; Warner, R.; Ruggeri, R.; Su, C.; Cortes, C.; Skoura, A.; Ward, J.; Ahn, K.; Kalgutkar, A.; Sun, D.; Maurer, T.S.; Bonin, P.D.; Okerberg, C.; Bobrowski, W.; Kawabe, T.; Zhang, Y.; Coskran, T.; Bell, S.; Kapoor, B.; Johnson, K.; Buckbinder, L., 2015:
PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis

Park, J.Su.; Kang, D.Hoon.; Lee, D.Hyun.; Bae, S.Han., 2016:
PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1

Jiang, W-Yi.; Seo, G.Seog.; Kim, Y-Chul.; Sohn, D.Hwan.; Lee, S.Hee., 2016:
PF2405, standardized fraction of Scutellaria baicalensis, ameliorates colitis in vitro and in vivo

Bettadapura, R.; Rasheed, M.; Vollrath, A.; Bajaj, C., 2016:
PF2fit: Polar Fast Fourier Matched Alignment of Atomistic Structures with 3D Electron Microscopy Maps

Pucci, F.; Rickelt, S.; Newton, A.P.; Garris, C.; Nunes, E.; Evavold, C.; Pfirschke, C.; Engblom, C.; Mino-Kenudson, M.; Hynes, R.O.; Weissleder, R.; Pittet, M.J., 2016:
PF4 Promotes Platelet Production and Lung Cancer Growth

Din, T.Ahmad.Damitri.Al.Astani.Tengku.; Seeni, A.; Yusoff, M.Saiful.Bahri.; Shamsuddin, S.; Jaafar, H., 2016:
PF4-Induced apoptosis in breast cancer in vivo study: The role of the caspases family

Laverdure, F.; Louvain-Quintard, V.; Kortchinsky, T.; Rezaiguïa-Delclaux, Sïda.; Imbert, A.; Stéphan, Fçois., 2016:
PF4-heparin antibodies during ECMO: incidence, course, and outcomes

Mabeta, P., 2016:
PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

Leyton-Puig, D.; Kedziora, K.M.; Isogai, T.; van den Broek, B.; Jalink, K.; Innocenti, M., 2016:
PFA fixation enables artifact-free super-resolution imaging of the actin cytoskeleton and associated proteins

Morales, Y.; Bosque, G.; Vehí, J.; Picó, Jús.; Llaneras, F., 2017:
PFA toolbox: a MATLAB tool for Metabolic Flux Analysis

Salehzadeh, F.; Vahedi, M.; Hosseini-Asl, S.; Jahangiri, S.; Habibzadeh, S.; Hosseini-Khotbesara, M., 2015:
PFAPA and 12 Common MEFV Gene Mutations Our Clinical Experience

Cantarini, L.; Vitale, A.; Bersani, G.; Nieves, L.Martin.; Cattalini, M.; Lopalco, G.; Caso, F.; Costa, L.; Iannone, F.; Lapadula, G.; Galeazzi, M.; Ceribelli, A.; Brunetta, E.; Selmi, C.; Rigante, D., 2015:
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists

Hernández Vidal, M.J.; Trasancos Escura, C.; Meseguer Noguera, R.; Del M Gil Ortega, M., 2015:
PFAPA syndrome: Diagnosis in adulthood

Vanoni, F.; Theodoropoulou, K.; Hofer, Mël., 2016:
PFAPA syndrome: a review on treatment and outcome

Klang, M.G., 2016:
PFAT5 and the Evolution of Lipid Admixture Stability

Njunge, J.M.; Mandal, P.; Przyborski, J.M.; Boshoff, A.; Pesce, E-Rachele.; Blatch, G.L., 2016:
PFB0595w is a Plasmodium falciparum J protein that co-localizes with PfHsp70-1 and can stimulate its in vitro ATP hydrolysis activity

Gao, C.; Zhang, L.; Luo, D.; Liu, D.; Gong, H., 2016:
PFC Activity Pattern During Verbal WM Task in Healthy Male and Female Subjects: A NIRS Study

Kuritz, N.; Murat, M.; Balaish, M.; Ein-Eli, Y.; Natan, A., 2016:
PFC and Triglyme for Li-Air Batteries: A Molecular Dynamics Study

Anonymous, 1994:
PFC will not make savings promised

Wang, P.; Zhao, J.; Yang, X.; Guan, S.; Feng, H.; Han, D.; Lu, J.; Ou, B.; Jin, R.; Sun, J.; Zong, Y.; Feng, B.; Ma, J.; Lu, A.; Zheng, M., 2016:
PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization

Dunn, K., 1981:
PFDs for the Handicapped: A Question of Responsibility

Blythe, T.W.; Sederman, A.J.; Stitt, E.Hugh.; York, A.P.E.; Gladden, L.F., 2016:
PFG NMR and Bayesian analysis to characterise non-Newtonian fluids

Dalmasso, M.; Jordan, K., 2015:
PFGE as a tool to track Listeria monocytogenes in food processing facilities: case studies

Jaros, P.; Dufour, M.; Gilpin, B.; Freeman, M.M.; Ribot, E.M., 2015:
PFGE for Shiga toxin-producing Escherichia coli O157:H7 (STEC O157) and non-O157 STEC

Bakhshi, B.; Kalantar, M.; Rastegar-Lari, A.; Fallah, F., 2016:
PFGE genotyping and molecular characterization of iCampylobacter spp. isolated from chicken meat

L.B.urgeois, P.; Passerini, D.; Coddeville, Mèle.; Guellerin, Méva.; Daveran-Mingot, M-Line.; Ritzenthaler, P., 2015:
PFGE protocols to distinguish subspecies of Lactococcus lactis

Michelon, D.; Félix, B.; Vingadassalon, N.; Mariet, J-François.; Larsson, J.T.; Møller-Nielsen, E.; Roussel, S., 2015:
PFGE standard operating procedures for Listeria monocytogenes: harmonizing the typing of food and clinical strains in Europe

Basra, M.K.A.; Zammit, A-Marie.; Kamudoni, P.; Eghlileb, A.M.; Finlay, A.Y.; Salek, M.Sam., 2016:
PFI-14©: A Rasch Analysis Refinement of the Psoriasis Family Index

Zhu, W.; Ye, L.; Zhang, J.; Yu, P.; Wang, H.; Ye, Z.; Tian, J., 2016:
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer

Qu, J.; Lu, D.; Guo, H.; Miao, W.; Wu, G.; Zhou, M., 2016:
PFKFB3 modulates glycolytic metabolism and alleviates endoplasmic reticulum stress in human osteoarthritis cartilage

Ge, X.; Cao, Z.; Gu, Y.; Wang, F.; Li, J.; Han, M.; Xia, W.; Yu, Z.; Lyu, P., 2016:
PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production

Qin, P.; Chen, T.; Lu, Q.; Hu, F.; Yang, H., 2016:
PFKFB3 regulates 11'-deoxyverticillin A (C42)-induced autophagy and apoptosis in HeLa cells

Jiang, H.; Shi, H.; Sun, M.; Wang, Y.; Meng, Q.; Guo, P.; Cao, Y.; Chen, J.; Gao, X.; Li, E.; Liu, J., 2017:
PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense

Lv, Y.; Zhang, B.; Zhai, C.; Qiu, J.; Zhang, Y.; Yao, W.; Zhang, C., 2016:
PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation/reperfusion and is regulated by Cdh1

Yang, J.; Li, J.; Le, Y.; Zhou, C.; Zhang, S.; Gong, Z., 2016:
PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer

Auranen, M.; Palmio, J.; Ylikallio, E.; Huovinen, S.; Paetau, A.; Sandell, S.; Haapasalo, H.; Viitaniemi, K.; Piirilä, Päivi.; Tyynismaa, H.; Udd, B., 2016:
PFKM gene defect and glycogen storage disease GSDVII with misleading enzyme histochemistry

Cui, X-Bin.; Zhang, S-Mao.; Xu, Y-Xun.; Dang, H-Wei.; Liu, C-Xia.; Wang, L-Hai.; Yang, L.; Hu, J-Ming.; Liang, W-Hua.; Jiang, J-Fang.; Li, N.; Li, Y.; Chen, Y-Zhao.; Li, F., 2017 :
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Hu, S-Jun.; Chang, S-Min.; Ma, Z.; Du, S-Chao.; Xiong, L-Ping.; Wang, X., 2016:
PFNA-II protrusion over the greater trochanter in the Asian population used in proximal femoral fractures

Gillow, S.J.; Lee, V.H., 2016:
PFO Closure for Cryptogenic Stroke

Bozinovski, J., 2016:
PFO is generally benign in OPCAB: Until it Isn't

Butera, G.; Piazza, L.; Heles, M., 2016:
PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure

Zafar, Q.; Ahmad, Z.; Sulaiman, K., 2015:
PFO-DBT:MEH-PPV:PC₇₁BM ternary blend assisted platform as a photodetector

Pizzino, F.; Khandheria, B.; Carerj, S.; Oreto, G.; Cusmà-Piccione, M.; Todaro, M.Chiara.; Oreto, L.; Vizzari, G.; D.B.lla, G.; Zito, C., 2016:
PFO: Button me up, but wait … Comprehensive evaluation of the patient

Love, B.A.; Diener, H-Christoph., 2016:
PFO: "Please Figure Out," or Now "Potentially Figured Out?"

Galloway, T.S.; Fletcher, T.; Thomas, O.J.; Lee, B.P.; Pilling, L.C.; Harries, L.W., 2015:
PFOA and PFOS are associated with reduced expression of the parathyroid hormone 2 receptor (PTH2R) gene in women

Betts, K.S., 2015:
PFOA and high cholesterol: basis for the finding of a probable link

Li, W.; He, Q-zhi.; Wu, C-qiu.; Pan, X-yuan.; Wang, J.; Tan, Y.; Shan, X-yun.; Zeng, H-cai., 2016:
PFOS Disturbs BDNF-ERK-CREB Signalling in Association with Increased MicroRNA-22 in SH-SY5Y Cells

Hagenaars, A.; Stinckens, E.; Vergauwen, L.; Bervoets, L.; Knapen, D., 2015:
PFOS affects posterior swim bladder chamber inflation and swimming performance of zebrafish larvae

Xu, J.; Shimpi, P.; Armstrong, L.; Salter, D.; Slitt, A.L., 2016:
PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway

Jantzen, C.E.; Annunziato, K.A.; Bugel, S.M.; Cooper, K.R., 2016:
PFOS, PFNA, and PFOA sub-lethal exposure to embryonic zebrafish have different toxicity profiles in terms of morphometrics, behavior and gene expression

Morard, Rël.; Darling, K.F.; Mahé, Fédéric.; Audic, Séphane.; Ujiié, Y.; Weiner, A.K.M.; André, A.; Seears, H.A.; Wade, C.M.; Quillévéré, Fédéric.; Douady, C.J.; Escarguel, G.; de Garidel-Thoron, T.; Siccha, M.; Kucera, M.; de Vargas, C., 2016:
PFR²: a curated database of planktonic foraminifera 18S ribosomal DNA as a resource for studies of plankton ecology, biogeography and evolution

Yang, L.; Zhu, J.; Huang, H.; Yang, Q.; Cai, J.; Wang, Q.; Zhu, J.; Shao, M.; Xiao, J.; Cao, J.; Gu, X.; Zhang, S.; Wang, Y., 2016:
PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion

Zhang, W.; Liu, R.; Tang, C.; Xi, Q.; Lu, S.; Chen, W.; Zhu, L.; Cheng, J.; Chen, Y.; Wang, W.; Zhong, J.; Deng, Y., 2016:
PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer

Sengupta, J.; Sharma, S.K.; Sahu, D., 2003:
PG Canine Retraction Spring

Heath, J.E.; Seers, C.A.; Veith, P.D.; Butler, C.A.; Nor Muhammad, N.A.; Chen, Y-Yen.; Slakeski, N.; Peng, B.; Zhang, L.; Dashper, S.G.; Cross, K.J.; Cleal, S.M.; Moore, C.; Reynolds, E.C., 2016:
PG1058 Is a Novel Multidomain Protein Component of the Bacterial Type IX Secretion System

Djouhri, L., 2016:
PG110, A Humanized Anti-NGF Antibody, Reverses Established Pain Hypersensitivity in Persistent Inflammatory Pain, but not Peripheral Neuropathic Pain, Rat Models

Winterhoff, B.; Freyer, L.; Hammond, E.; Giri, S.; Mondal, S.; Roy, D.; Teoman, A.; Mullany, S.A.; Hoffmann, R.; von Bismarck, A.; Chien, J.; Block, M.S.; Millward, M.; Bampton, D.; Dredge, K.; Shridhar, V., 2015:
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples

Toosi, S.; Naderi-Meshkin, H.; Kalalinia, F.; Peivandi, M.Taghi.; HosseinKhani, H.; Bahrami, A.Reza.; Heirani-Tabasi, A.; Mirahmadi, M.; Behravan, J., 2017:
PGA-incorporated collagen: Toward a biodegradable composite scaffold for bone-tissue engineering

Wen, B.; Xu, S.; Zhou, R.; Zhang, B.; Wang, X.; Liu, X.; Xu, X.; Liu, S., 2016:
PGA: an R/Bioconductor package for identification of novel peptides using a customized database derived from RNA-Seq

Zhang, S.; Zhao, Y.; Lei, B.; Li, C.; Mao, X., 2016:
PGAM1 is Involved in Spermatogenic Dysfunction and Affects Cell Proliferation, Apoptosis, and Migration

He, G-Wei.; Günther, C.; Kremer, A.E.; Thonn, V.; Amann, K.; Poremba, C.; Neurath, M.F.; Wirtz, S.; Becker, C., 2016:
PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury

Ramachandran, A.; Jaeschke, H., 2016:
PGAM5: a new player in immune-mediated liver injury

Zhang, C.; Lin, L.; Li, G.; Ma, J.; Han, X.; Fei, R., 2016:
PGBL inhibits the RAW 264.7 cells to express inflammatory factor

Oliveros-Etter, M.; Li, Z.; Nee, K.; Hosohama, L.; Hargan-Calvopina, J.; Lee, S.A.; Joti, P.; Yu, J.; Clark, A.T., 2016:
PGC Reversion to Pluripotency Involves Erasure of DNA Methylation from Imprinting Control Centers followed by Locus-Specific Re-methylation

He, C-Yun.; Sun, L-Ping.; Xu, Q.; Liu, J-Wei.; Jiang, J-Yi.; Dong, N-Nan.; Yuan, Y., 2015:
PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis

Zhang, S.; Liu, X.; Liu, J.; Guo, H.; Xu, H.; Zhang, G., 2016:
PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation

Singh, S.P.; Schragenheim, J.; Cao, J.; Falck, J.R.; Abraham, N.G.; Bellner, L., 2017:
PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid

Oropeza, D.; Jouvet, N.; Bouyakdan, K.; Perron, G.; Ringuette, L-Jeanne.; Philipson, L.H.; Kiss, R.S.; Poitout, V.; Alquier, T.; Estall, J.L., 2015:
PGC-1 coactivators in β-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids

Kwon, H.; Shin, S.; Roh, M.S.; Choi, H.J.; Kwak, J.; Yang, Y.S.; Park, J., 2016:
PGC-1 expression level in human colorectal cancer: A predictor of lymph node metastasis

Silvennoinen, M.; Ahtiainen, J.P.; Hulmi, J.J.; Pekkala, S.; Taipale, R.S.; Nindl, B.C.; Laine, T.; Häkkinen, K.; Selänne, H.; Kyröläinen, H.; Kainulainen, H., 2015:
PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise

Yang, Z.; Chen, X.; Chen, Y.; Zhao, Q., 2015:
PGC-1 mediates the regulation of metformin in muscle irisin expression and function

Diop, S.Balla.; Bisharat-Kernizan, J.; Birse, R.Tyge.; Oldham, S.; Ocorr, K.; Bodmer, R., 2015:
PGC-1/Spargel Counteracts High-Fat-Diet-Induced Obesity and Cardiac Lipotoxicity Downstream of TOR and Brummer ATGL Lipase

Mehlem, A.; Palombo, I.; Wang, X.; Hagberg, C.E.; Eriksson, U.; Falkevall, A., 2017:
PGC-1α Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B

Iacovelli, J.; Rowe, G.C.; Khadka, A.; Diaz-Aguilar, D.; Spencer, C.; Arany, Z.; Saint-Geniez, M., 2016:
PGC-1α Induces Human RPE Oxidative Metabolism and Antioxidant Capacity

Cui, X.; Feng, H.; Xu, X.; Li, H.; Zhang, H., 2016:
PGC-1α Mediated Peripheral Nerve Protection of Tongxinluo in STZ-Induced Diabetic Rats

Xiong, S.; Patrushev, N.; Forouzandeh, F.; Hilenski, L.; Alexander, R.Wayne., 2016:
PGC-1α Modulates Telomere Function and DNA Damage in Protecting against Aging-Related Chronic Diseases

Su, X.; Chu, Y.; Kordower, J.H.; Li, B.; Cao, H.; Huang, L.; Nishida, M.; Song, L.; Wang, D.; Federoff, H.J., 2016:
PGC-1α Promoter Methylation in Parkinson's Disease

Qi, Y.; Yin, X.; Wang, S.; Jiang, H.; Wang, X.; Ren, M.; Su, X-Ping.; Lei, S.; Feng, H., 2015:
PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model

Ciron, C.; Zheng, L.; Bobela, W.; Knott, G.W.; Leone, T.C.; Kelly, D.P.; Schneider, B.L., 2016:
PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein

Li, J.; Geng, X-Yong.; Cong, X-Liang., 2017:
PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells

Dabrowska, A.; Venero, J.Luis.; Iwasawa, R.; Hankir, M-Khair.; Rahman, S.; Boobis, A.; Hajji, N., 2016:
PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity

Gill, J.F.; Delezie, J.; Santos, G.; Handschin, C., 2016:
PGC-1α expression in murine AgRP neurons regulates food intake and energy balance

Hollinger, K.; Selsby, J.T., 2016:
PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress

Yu, W.; Cao, D.; Zhou, H.; Hu, Y.; Guo, T., 2016:
PGC-1α is responsible for survival of multiple myeloma cells under hyperglycemia and chemotherapy

Zhao, Q.; Zhang, J.; Wang, H., 2016:
PGC-1α limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen species

Vainshtein, A.; Desjardins, E.Ma.; Armani, A.; Sandri, M.; Hood, D.A., 2015:
PGC-1α modulates denervation-induced mitophagy in skeletal muscle

Dinulovic, I.; Furrer, R.; D.F.lvio, S.; Ferry, A.; Beer, M.; Handschin, C., 2016:
PGC-1α modulates necrosis, inflammatory response, and fibrotic tissue formation in injured skeletal muscle

Wang, J.; Wang, F.; Zhang, P.; Liu, H.; He, J.; Zhang, C.; Fan, M.; Chen, X., 2016:
PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading

Kang, C.; Goodman, C.A.; Hornberger, T.A.; Ji, L.Li., 2016:
PGC-1α overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization

Zhao, M.; Yuan, Y.; Bai, M.; Ding, G.; Jia, Z.; Huang, S.; Zhang, A., 2017:
PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria

Zhao, Q.; Zhang, J.; Wang, H., 2015:
PGC-1α overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice

Kang, C.; Ji, L.Li., 2016:
PGC-1α overexpression via local transfection attenuates mitophagy pathway in muscle disuse atrophy

Li, J.; Zhang, Y.; Liu, Y.; Shen, T.; Zhang, H.; Xing, Y.; Zhu, D., 2015:
PGC-1α plays a major role in the anti-apoptotic effect of 15-HETE in pulmonary artery endothelial cells

Halling, J.F.; Ringholm, S.; Nielsen, M.M.; Overby, P.; Pilegaard, H., 2016:
PGC-1α promotes exercise-induced autophagy in mouse skeletal muscle

Fu, X-feng.; Yao, K.; Du, X.; Li, Y.; Yang, X-yu.; Yu, M.; Li, M-zhang.; Cui, Q-hua., 2016:
PGC-1α regulates the cell cycle through ATP and ROS in CH1 cells

Lu, H.; Zhu, L.; Lian, L.; Chen, M.; Shi, D.; Wang, K., 2016:
PGC-1α regulates the expression and activity of IRF-1

Wu, H.; Deng, X.; Shi, Y.; Su, Y.; Wei, J.; Duan, H., 2017:
PGC-1α, glucose metabolism and type 2 diabetes mellitus

Miranda, D.; Jara, C.; Ibañez, J.; Ahumada, V.; Acuña-Castillo, C.; Martin, A.; Córdova, A.; Montoya, M., 2016:
PGC-1α-Dependent Mitochondrial Adaptation Is Necessary to Sustain IL-2-Induced Activities in Human NK Cells

Senoo, N.; Miyoshi, N.; Goto-Inoue, N.; Minami, K.; Yoshimura, R.; Morita, A.; Sawada, N.; Matsuda, J.; Ogawa, Y.; Setou, M.; Kamei, Y.; Miura, S., 2016:
PGC-1α-mediated changes in phospholipid profiles of exercise-trained skeletal muscle

Zhang, X.; Ren, X.; Zhang, Q.; Li, Z.; Ma, S.; Bao, J.; Li, Z.; Bai, X.; Zheng, L.; Zhang, Z.; Shang, S.; Zhang, C.; Wang, C.; Cao, L.; Wang, Q.; Ji, J., 2015:
PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β

Brown, J.L.; Rosa-Caldwell, M.E.; Lee, D.E.; Brown, L.A.; Perry, R.A.; Shimkus, K.L.; Blackwell, T.A.; Fluckey, J.D.; Carson, J.A.; Dridi, S.; Washington, T.A.; Greene, N.P., 2016:
PGC-1α4 gene expression is suppressed by the IL-6-MEK-ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury

Victorino, V.Jacob.; Barroso, W.A.; Assunção, A.K.M.; Cury, V.; Jeremias, I.C.; Petroni, R.; Chausse, B.; Ariga, S.K.; Herrera, A.C.S.A.; Panis, C.; Lima, T.M.; Souza, H.P., 2015:
PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways

Chen, H.; Liu, Y.; Li, D.; Song, J.; Xia, M., 2016:
PGC-1β suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation

Bhin, J.; Jeong, H-Su.; Kim, J.Soo.; Shin, J.Oh.; Hong, K.Sung.; Jung, H-Sung.; Kim, C.; Hwang, D.; Kim, K-Seong., 2016:
PGC-Enriched miRNAs Control Germ Cell Development

Henagan, T.M.; Stewart, L.K.; Forney, L.A.; Sparks, L.M.; Johannsen, N.; Church, T.S., 2015:
PGC1α -1 Nucleosome Position and Splice Variant Expression and Cardiovascular Disease Risk in Overweight and Obese Individuals

Anonymous, 2016:
PGC1α Represses Melanoma Cell Invasion and Metastasis

Zhang, S.; Xu, X.; Zhu, S.; Liu, J., 2016:
PGCCs generating erythrocytes to form VM structure contributes to tumor blood supply

Tulay, P.; Gültomruk, M.; Fındıklı, N.; Bahçeci, M., 2016:
PGD management scheme for older females with balanced translocations: Do older females have less chance of balanced embryo transfer?

Kainuma, S.; Tokuda, H.; Kuroyanagi, G.; Yamamoto, N.; Ohguchi, R.; Fujita, K.; Matsushima-Nishiwaki, R.; Kozawa, O.; Otsuka, T., 2016:
PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK

Tan, T.King.; Tan, K.Yun.; Hari, R.; Mohamed Yusoff, A.; Wong, G.Jah.; Siow, C.Chuen.; Mutha, N.V.R.; Rayko, M.; Komissarov, A.; Dobrynin, P.; Krasheninnikova, K.; Tamazian, G.; Paterson, I.C.; Warren, W.C.; Johnson, W.E.; O'Brien, S.J.; Choo, S.Woh., 2016:
PGD: a pangolin genome hub for the research community

Murata, K.; Sawaji, Y.; Alimasi, W.; Suzuki, H.; Endo, K.; Tanaka, H.; Yorifuji, M.; Kosaka, T.; Shishido, T.; Yamamoto, K., 2015:
PGE1 Attenuates IL-1β-induced NGF Expression in Human Intervertebral Disc Cells

Wu, J-Dan.; Tao, S.; Jin, X.; Jiang, L-Lan.; Shen, Y.; Luo, Y.; Zhang, P.; Lee, K-Onn.; Ye, L.; Ma, J-Hua., 2016:
PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes

Shi, Q.; Yin, Z.; Zhao, B.; Sun, F.; Yu, H.; Yin, X.; Zhang, L.; Wang, S., 2016:
PGE2 Elevates IL-23 Production in Human Dendritic Cells via a cAMP Dependent Pathway

Yang, G.; Dong, W-Hao.; Hu, C-Long.; Mei, Y-Ai., 2016:
PGE2 Modulates GABAA Receptors via an EP1 Receptor-Mediated Signaling Pathway

Hangai, S.; Ao, T.; Kimura, Y.; Matsuki, K.; Kawamura, T.; Negishi, H.; Nishio, J.; Kodama, T.; Taniguchi, T.; Yanai, H., 2016:
PGE2 induced in and released by dying cells functions as an inhibitory DAMP

Hassouneh, R.; Nasrallah, R.; Zimpelmann, J.; Gutsol, A.; Eckert, D.; Ghossein, J.; Burns, K.D.; Hébert, R.L., 2017:
PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes

Wu, H.; Wu, T.; Hua, W.; Dong, X.; Gao, Y.; Zhao, X.; Chen, W.; Cao, W.; Yang, Q.; Qi, J.; Zhou, J.; Wang, J., 2015:
PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice

Tse, K-Hei.; Chow, K.B.S.; Wise, H., 2016:
PGE2 released by primary sensory neurons modulates Toll-like receptor 4 activities through an EP4 receptor-dependent process

Nasrallah, R.; Hassouneh, R.; Hébert, R.L., 2016:
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes

Leclerc, J.L.; Lampert, A.S.; Diller, M.A.; Doré, S., 2017:
PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice

Tian, X.; Ji, C.; Luo, Y.; Yang, Y.; Kuang, S.; Mai, S.; Ma, J.; Yang, J., 2018:
PGE2-EP3 signaling pathway contributes to protective effects of misoprostol on cerebral injury in APP/PS1 mice

Trabanelli, S.; Lecciso, M.; Salvestrini, V.; Cavo, M.; Očadlíková, D.; Lemoli, R.M.; Curti, A., 2015:
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response

Draijer, C.; Boorsma, C.E.; Reker-Smit, C.; Post, E.; Poelstra, K.; Melgert, B.N., 2017:
PGE2-treated macrophages inhibit development of allergic lung inflammation in mice

Lin, M-Chieh.; Chen, S-Yin.; Tsai, H-Min.; He, P-Lin.; Lin, Y-Chun.; Herschman, H.; Li, H-Jung., 2016:
PGE2 /EP4 Signaling Controls the Transfer of the Mammary Stem Cell State by Lipid Rafts in Extracellular Vesicles

Maingret, V.; Barthet, Gël.; Deforges, Séverine.; Jiang, N.; Mulle, C.; Amédée, T., 2016:
PGE2-EP3 signaling pathway impairs hippocampal presynaptic long-term plasticity in a mouse model of Alzheimer's disease

Xu, C.; Liu, W.; You, X.; Leimert, K.; Popowycz, K.; Fang, X.; Wood, S.L.; Slater, D.M.; Sun, Q.; Gu, H.; Olson, D.M.; Ni, X., 2016:
PGF2α modulates the output of chemokines and pro-inflammatory cytokines in myometrial cells from term pregnant women through divergent signaling pathways

Gomez, E.; Martin, D.; Carrocera, S.; Muñoz, M., 2016:
PGF₂α levels in Day 8 blood plasma are increased by the presence of one or more embryos in the uterus

Mahadevan, S.; Velayutham, P., 2016:
PGI Endocrine training: Recollection from another Arjuna

Simons, B.; Ferrini, M.E.; Carvalho, S.; Bassett, D.J.P.; Jaffar, Z.; Roberts, K., 2016:
PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen

Zieker, D.; Koenigsrainer, I.; Traub, F.; Nieselt, K.; Stirnkorb, C.; Kupka, S.; Fend, F.; Hartmann, J.T.; Northoff, H.; Bruecher, B.L.; Koenigsrainer, A., 2016:
PGK1 a prospect marker for peritoneal dissemination in gastric cancer

Li, X.; Zheng, Y.; Lu, Z., 2016:
PGK1 is a new member of the protein kinome

Zhao, Y.; Yan, X.; Li, X.; Zheng, Y.; Li, S.; Chang, X., 2016:
PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis

Aoki, S.T.; Kershner, A.M.; Bingman, C.A.; Wickens, M.; Kimble, J., 2016:
PGL germ granule assembly protein is a base-specific, single-stranded RNase

Yang, Y.; Xu, J.; Huang, L.; Leng, Y.; Dai, L.; Rao, Y.; Chen, L.; Wang, Y.; Tu, Z.; Hu, J.; Ren, D.; Zhang, G.; Zhu, L.; Guo, L.; Qian, Q.; Zeng, D., 2015:
PGL, encoding chlorophyllide a oxygenase 1, impacts leaf senescence and indirectly affects grain yield and quality in rice

Rončević, T.; Gajski, G.; Ilić, N.; Goić-Barišić, I.; Tonkić, M.; Zoranić, L.; Simunić, J.; Benincasa, M.; Mijaković, M.; Tossi, A.; Juretić, D., 2016:
PGLa-H tandem-repeat peptides active against multidrug resistant clinical bacterial isolates

Zeevaert, R.; Scalais, E.; Muino Mosquera, L.; D.M.irleir, L.; D.B.aufort, C.; Witsch, M.; Jaeken, J.; D.S.hepper, J., 2016:
PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure

Sun, Y.; Hu, H.; Yu, B.; Xu, F-Jian., 2016:
PGMA-Based Cationic Nanoparticles with Polyhydric Iodine Units for Advanced Gene Vectors

Li, R-Quan.; Wu, Y.; Zhi, Y.; Yang, X.; Li, Y.; Xu, F-Jian.; Du, J., 2016:
PGMA-Based Star-Like Polycations with Plentiful Hydroxyl Groups Act as Highly Efficient miRNA Delivery Nanovectors for Effective Applications in Heart Diseases

Xu, C.; Yu, B.; Hu, H.; Nizam, M.Naeem.; Yuan, W.; Ma, J.; Xu, F-Jian., 2016:
PGMA-based gene carriers with lipid molecules

Zhang, Z.; Chong, Y.; Chen, X.; Jin, C.; Yang, L.; Liu, T., 2016:
PGNAA system preliminary design and measurement of In-Hospital Neutron Irradiator for boron concentration measurement

Chennappa, G.; Naik, M.K.; Adkar-Purushothama, C.R.; Amaresh, Y.S.; Sreenivasa, M.Y., 2016:
PGP potential, abiotic stress tolerance and antifungal activity of Azotobacter strains isolated from paddy soils

Arend, D.; Junker, A.; Scholz, U.; Schüler, D.; Wylie, J.; Lange, M., 2016 :
PGP repository: a plant phenomics and genomics data publication infrastructure

Hou, J.; Liu, W.; Wang, B.; Wang, Q.; Luo, Y.; Franks, A.E., 2016:
PGPR enhanced phytoremediation of petroleum contaminated soil and rhizosphere microbial community response

Vaishnav, A.; Kumari, S.; Jain, S.; Varma, A.; Tuteja, N.; Choudhary, D.Kumar., 2016:
PGPR-mediated expression of salt tolerance gene in soybean through volatiles under sodium nitroprusside

Gómez-Sagasti, Mía.T.; Marino, D., 2015:
PGPRs and nitrogen-fixing legumes: a perfect team for efficient Cd phytoremediation?

Suorsa, M.; Rossi, F.; Tadini, L.; Labs, M.; Colombo, M.; Jahns, P.; Kater, M.M.; Leister, D.; Finazzi, G.; Aro, E-Mari.; Barbato, R.; Pesaresi, P., 2016:
PGR5-PGRL1-Dependent Cyclic Electron Transport Modulates Linear Electron Transport Rate in Arabidopsis thaliana

Chaux, Fédéric.; Johnson, X.; Auroy, P.; Beyly-Adriano, A.; Te, I.; Cuiné, Séphan.; Peltier, G., 2016:
PGRL1 and LHCSR3 Compensate for Each Other in Controlling Photosynthesis and Avoiding Photosystem I Photoinhibition during High Light Acclimation of Chlamydomonas Cells

Hampton, K.K.; Stewart, R.; Napier, D.; Claudio, P.Paolo.; Craven, R.J., 2015:
PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival

Luciano, A.M.; Peluso, J.J., 2016:
PGRMC1 and the faithful progression through mitosis and meiosis

Lin, S-Ting.; May, E.Wong.Soon.; Chang, J-Fan.; Hu, R-Yu.; Wang, L.Hui-Ching.; Chan, H-Lin., 2015:
PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

Terzaghi, L.; Tessaro, I.; Raucci, F.; Merico, V.; Mazzini, G.; Garagna, S.; Zuccotti, M.; Franciosi, F.; Lodde, V., 2017:
PGRMC1 participates in late events of bovine granulosa cells mitosis and oocyte meiosis

Cahill, M.A.; Jazayeri, J.A.; Kovacevic, Z.; Richardson, D.R., 2016:
PGRMC1 regulation by phosphorylation: potential new insights in controlling biological activity

Gerhardt, K., 2016:
PGRMC1: A Fertility Stabilizer

Xu, H-Min.; Tan, L.; Wan, Y.; Tan, M-Shan.; Zhang, W.; Zheng, Z-Jie.; Kong, L-Li.; Wang, Z-Xuan.; Jiang, T.; Tan, L.; Yu, J-Tai., 2016:
PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis

Tian, R.; Li, Y.; Yao, X., 2016:
PGRN Suppresses Inflammation and Promotes Autophagy in Keratinocytes Through the Wnt/β-Catenin Signaling Pathway

Liu, J.; Li, H.; Zhou, B.; Xu, L.; Kang, X.; Yang, W.; Wu, S.; Sun, H., 2016:
PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance

Dong, T.; Yang, D.; Li, R.; Zhang, L.; Zhao, H.; Shen, Y.; Zhang, X.; Kong, B.; Wang, L., 2016:
PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts

Gordon, A.S.; Fulton, R.S.; Qin, X.; Mardis, E.R.; Nickerson, D.A.; Scherer, S., 2016:
PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation

Iatsenko, I.; Kondo, S.; Mengin-Lecreulx, D.; Lemaitre, B., 2017:
PGRP-SD, an Extracellular Pattern-Recognition Receptor, Enhances Peptidoglycan-Mediated Activation of the Drosophila Imd Pathway

Spannagl, M.; Nussbaumer, T.; Bader, K.C.; Martis, M.M.; Seidel, M.; Kugler, K.G.; Gundlach, H.; Mayer, K.F.X., 2016:
PGSB PlantsDB: updates to the database framework for comparative plant genome research

Spannagl, M.; Bader, K.; Pfeifer, M.; Nussbaumer, T.; Mayer, K.F.X., 2016:
PGSB/MIPS Plant Genome Information Resources and Concepts for the Analysis of Complex Grass Genomes

Drobnjak, I.; Zhang, H.; Ianuş, A.; Kaden, E.; Alexander, D.C., 2016:
PGSE, OGSE, and sensitivity to axon diameter in diffusion MRI: Insight from a simulation study

Nagaraj, S.H.; Waddell, N.; Madugundu, A.K.; Wood, S.; Jones, A.; Mandyam, R.A.; Nones, K.; Pearson, J.V.; Grimmond, S.M., 2016:
PGTools: A Software Suite for Proteogenomic Data Analysis and Visualization

Pan, Y.; Cheng, R.; Li, Z.; Zhao, Y.; He, J., 2015:
PGWD: integrating personal genome for warfarin dosing

Yee, J., 2016:
PGX: Pharmacogenomics During Generation X

Liu, Y.; Khan, S.M.; Wang, J.; Rynge, M.; Zhang, Y.; Zeng, S.; Chen, S.; Maldonado Dos Santos, J.V.; Valliyodan, B.; Calyam, P.P.; Merchant, N.; Nguyen, H.T.; Xu, D.; Joshi, T., 2016:
PGen: large-scale genomic variations analysis workflow and browser in SoyKB

Zhao, X.; Ning, Q.; Chai, H.; Ai, M.; Ma, Z., 2016:
PGlcS: Prediction of protein O-GlcNAcylation sites with multiple features and analysis

Zhao, X.; Ning, Q.; Ai, M.; Chai, H.; Yin, M., 2015:
PGluS: prediction of protein S-glutathionylation sites with multiple features and analysis

Askenazi, M.; Ruggles, K.V.; Fenyö, D., 2015:
PGx: Putting Peptides to BED

Lee, D.M.; Rodrigues, F.F.; Yu, C.Guo.; Swan, M.; Harris, T.J.C., 2016:
PH Domain-Arf G Protein Interactions Localize the Arf-GEF Steppke for Cleavage Furrow Regulation in Drosophila

Cichocka, M.; Kozub, J.; Urbanik, A., 2015:
PH Measurements of the Brain Using Phosphorus Magnetic Resonance Spectroscopy ((31)PMRS) in Healthy Men - Comparison of Two Analysis Methods

Zhao, D.; Li, B.; Han, J.; Yang, Y.; Zhang, X.; Wu, G., 2016:
PH responsive polypeptide based polymeric micelles for anticancer drug delivery

Bar-Shavit, R.; Grisaru-Granovsky, S.; Uziely, B., 2016:
PH-domains as central modulators driving tumor growth

Zhou, Y.; Shaw, C.; Chen, T., 2016:
PH-sauvagine from the skin secretion of Phyllomedusa hypochondrialis: A novel CRF-like peptide with smooth muscle contraction activity

Zare-Akbari, Z.; Farhadnejad, H.; Furughi-Nia, B.; Abedin, S.; Yadollahi, M.; Khorsand-Ghayeni, M., 2016:
PH-sensitive bionanocomposite hydrogel beads based on carboxymethyl cellulose/ZnO nanoparticle as drug carrier

Liu, F.; Li, M.; Liu, C.; Liu, Y.; Zhang, N., 2015:
PH-sensitive self-assembled carboxymethyl chitosan-modified DNA/polyethylenimine complexes for efficient gene delivery

Bispinghoff, M.; Grützmacher, Hörg., 2016:
PH3 as a Phosphorus Source for Phosphinidene-Carbene Adducts and Phosphinidene-Transition Metal Complexes

Korkakaki, E.; Mulders, M.; Veeken, A.; Rozendal, R.; van Loosdrecht, M.C.M.; Kleerebezem, R., 2016:
PHA production from the organic fraction of municipal solid waste (OFMSW): Overcoming the inhibitory matrix

Pandit, A.; Jain, V.; Kumar, N.; Mukhopadhyay, A., 2015:
PHA-4/FOXA-regulated microRNA feed forward loops during Caenorhabditis elegans dietary restriction

Baba, S.M.; Azad, N.A.; Shah, Z.A.; Afroze, D.; Pandith, A.A.; Jan, A.; Aziz, S.A.; Dar, F.A., 2016:
PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide

Caudill, M.T.; Spear, E.L.; Varian-Ramos, C.W.; Cristol, D.A., 2015:
PHA-stimulated immune-responsiveness in mercury-dosed zebra finches does not match results from environmentally exposed songbirds

Müller, C.Joy.; Valdés, A.Elisa.; Wang, G.; Ramachandran, P.; Beste, L.; Uddenberg, D.; Carlsbecker, A., 2016:
PHABULOSA Mediates an Auxin Signaling Loop to Regulate Vascular Patterning in Arabidopsis

Sebastian, J.; Ryu, K.Hui.; Zhou, J.; Tarkowská, Dše.; Tarkowski, P.; Cho, Y-Hee.; Yoo, S-Dong.; Kim, E-Sol.; Lee, J-Young., 2015:
PHABULOSA controls the quiescent center-independent root meristem activities in Arabidopsis thaliana

Eggertson, L., 2015:
PHAC chided for lack of antimicrobial resistance strategy

Garzon, M.C.; Epstein, L.G.; Heyer, G.L.; Frommelt, P.C.; Orbach, D.B.; Baylis, A.L.; Blei, F.; Burrows, P.E.; Chamlin, S.L.; Chun, R.H.; Hess, C.P.; Joachim, S.; Johnson, K.; Kim, W.; Liang, M.G.; Maheshwari, M.; McCoy, G.N.; Metry, D.W.; Monrad, P.A.; Pope, E.; Powell, J.; Shwayder, T.A.; Siegel, D.H.; Tollefson, M.M.; Vadivelu, S.; Lew, S.M.; Frieden, I.J.; Drolet, B.A., 2016:
PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations

Mamlouk, M.D.; Yu, J-Paul.J.; Asch, S.; Mathes, E.F., 2016:
PHACE syndrome and congenitally absent thyroid gland at MR imaging

Foster, K.A.; Ares, W.J.; Tempel, Z.J.; McCormick, A.A.; Panigrahy, A.; Grunwaldt, L.J.; Greene, S., 2017:
PHACE syndrome is associated with intracranial cavernous malformations

Thomson, J.; Greig, A.; Lloyd, C.; Morrison, D.; Flohr, C., 2016:
PHACE syndrome misdiagnosed as a port-wine stain

Nayak, L.; Nayak, B.; Sinha, G.; Khokhar, S., 2017:
PHACE syndrome with lip haemangioma, microphthalmos and persistent fetal vasculature

Winter, P.R.; Itinteang, T.; Leadbitter, P.; Tan, S.T., 2016:
PHACE syndrome--clinical features, aetiology and management

Winter, P.R.; Itinteang, T.; Leadbitter, P.; FitzJohn, T.; Tan, S.T., 2016:
PHACE(S) Syndrome With Absent Intracranial Internal Carotid Artery and Anomalous Circle of Willis

Heyer, G.L., 2016:
PHACE(S) syndrome

Favia, G.; Limongelli, L.; Tempesta, A.; Favia, M.; Maiorano, E., 2015:
PHACES syndrome: Diode laser photocoagulation of intraoral hemangiomas in six young patients

Liu, A.; Dong, M.; Ota, K.; Long, J., 2015:
PHACK: An Efficient Scheme for Selective Forwarding Attack Detection in WSNs

Pérez-Hernández, N.; Vargas-Alarcón, G.; Posadas-Sánchez, R.; Martínez-Rodríguez, N.; Tovilla-Zárate, C.Alfonso.; Rodríguez-Cortés, Aán.Asael.; Pérez-Méndez, O.; Blachman-Braun, R.; Rodríguez-Pérez, Jé.Manuel., 2017:
PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population

Kiando, S.Romuald.; Tucker, N.R.; Castro-Vega, L-Jaime.; Katz, A.; D'Escamard, V.; Tréard, C.; Fraher, D.; Albuisson, J.; Kadian-Dodov, D.; Ye, Z.; Austin, E.; Yang, M-Lee.; Hunker, K.; Barlassina, C.; Cusi, D.; Galan, P.; Empana, J-Philippe.; Jouven, X.; Gimenez-Roqueplo, A-Paule.; Bruneval, P.; Hyun Kim, E.Soo.; Olin, J.W.; Gornik, H.L.; Azizi, M.; Plouin, P-François.; Ellinor, P.T.; Kullo, I.J.; Milan, D.J.; Ganesh, S.K.; Boutouyrie, P.; Kovacic, J.C.; Jeunemaitre, X.; Bouatia-Naji, N., 2016:
PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance

Zhao, Q.; Wei, H.; Liu, D.; Shi, B.; Li, L.; Yan, M.; Zhang, X.; Wang, F.; Ouyang, Y., 2016:
PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population

Turner, A.W.; McPherson, R., 2015:
PHACTR1: Functional Clues Linking a Genome-Wide Association Study Locus to Coronary Artery Disease

Cao, F.; Liu, M.; Zhang, Q-Z.; Hao, R., 2017:
PHACTR4 regulates proliferation, migration and invasion of human hepatocellular carcinoma by inhibiting IL-6/Stat3 pathway

Lévèque, T.; Faure, B.; Esnault, F.X.; Delaroche, C.; Massonnet, D.; Grosjean, O.; Buffe, F.; Torresi, P.; Bomer, T.; Pichon, A.; Béraud, P.; Lelay, J.P.; Thomin, S.; Laurent, P., 2015:
PHARAO laser source flight model: design and performances

Cheng, C-Wen.; Martin, G.S.; Wu, P-Yen.; Wang, M.D., 2014:
PHARM - Association Rule Mining for Predictive Health

Aston, G., 2016:
PHARMACISTS to the fore

Kaye, S.; Johnson, S.; Arnold, R.D.; Nie, B.; Davis, J.T.; Gulland, F.; Abou-Madi, N.; Fletcher, D.J., 2016:
PHARMACOKINETIC STUDY OF ORAL ε-AMINOCAPROIC ACID IN THE NORTHERN ELEPHANT SEAL (MIROUNGA ANGUSTIROSTRIS)

Klipa, T.V.; Eremenko, A.A.; Shepelyuk, A.N.; Antonov, I.O., 2015:
PHARMACOLOGICAL NEUROPROTECTION IN CARDIOSURGERY (Part 1): DRUGS FOR GENERAL ANESTHESIA

Bil, M.; Huybrechts, R., 2016:
PHARMACOLOGICAL REGULATION OF DIGESTION IN THE ANAUTOGENOUS FLESH FLY, Sarcophaga crassipalpis, BY SIMPLE INJECTION OF 6-HYDROXYDOPAMINE

Fidalgo-Neto, A.Augusto.; Alberto, A.Viana.Pinto.; Bonavita, Aé.Gustavo.Calvano.; Bezerra, Rômulo.José.Soares.; Berçot, F.Faria.; Lopes, R.Matos.; Alves, L.Anastacio., 2015:
PHARMAVIRTUA: educational software for teaching and learning basic pharmacology

Backes, D.; Vergouwen, M.D.I.; Tiel Groenestege, A.T.; Bor, A.Stijntje.E.; Velthuis, B.K.; Greving, J.P.; Algra, A.; Wermer, M.J.H.; van Walderveen, M.A.A.; terBrugge, K.G.; Agid, R.; Rinkel, G.J.E., 2015:
PHASES Score for Prediction of Intracranial Aneurysm Growth

Rinkel, G.J.E.; Algra, A.; Greving, J.P.; Vergouwen, M.D.I.; Etminan, N., 2016:
PHASES and the natural history of unruptured aneurysms: science or pseudoscience?

Dew, K.; Turner, A.M.; Desai, L.; Martin, N.; Laurenzi, A.; Kirchhoff, K., 2015:
PHAST: A Collaborative Machine Translation and Post-Editing Tool for Public Health

Arndt, D.; Grant, J.R.; Marcu, A.; Sajed, T.; Pon, A.; Liang, Y.; Wishart, D.S., 2017:
PHASTER: a better, faster version of the PHAST phage search tool

Brinton, L.T.; Bauknight, D.K.; Dasa, S.Sai.Krishna.; Kelly, K.A., 2017:
PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing

Zhu, Z.; Li, C.; Zeng, Y.; Ding, J.; Qu, Z.; Gu, J.; Ge, L.; Tang, F.; Huang, X.; Zhou, C.; Wang, P.; Zheng, D.; Jin, Y., 2016:
PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs

Chowdhury, D.; Kumar, D.; Sarma, P.; Tangutur, A.Devi.; Bhadra, M.Pal., 2016:
PHB in Cardiovascular and Other Diseases: Present Knowledge and Implications

Wu, Y-Long.; Wang, H.; Qiu, Y-Kun.; Liow, S.Shy.; Li, Z.; Loh, X.Jun., 2016:
PHB-Based Gels as Delivery Agents of Chemotherapeutics for the Effective Shrinkage of Tumors

Su, Z.; Li, P.; Wu, B.; Ma, H.; Wang, Y.; Liu, G.; Zeng, H.; Li, Z.; Wei, X., 2015:
PHBVHHx scaffolds loaded with umbilical cord-derived mesenchymal stem cells or hepatocyte-like cells differentiated from these cells for liver tissue engineering

Deschoemaeker, S.; D.C.nza, G.; Lilla, S.; Martín-Pérez, R.; Mennerich, D.; Boon, L.; Hendrikx, S.; Maddocks, O.D.K.; Marx, C.; Radhakrishnan, P.; Prenen, H.; Schneider, M.; Myllyharju, J.; Kietzmann, T.; Vousden, K.H.; Zanivan, S.; Mazzone, M., 2016:
PHD1 regulates p53-mediated colorectal cancer chemoresistance

Guentsch, A.; Beneke, A.; Swain, L.; Farhat, K.; Nagarajan, S.; Wielockx, B.; Raithatha, K.; Dudek, J.; Rehling, P.; Zieseniss, A.; Jatho, A.; Chong, M.; Santos, C.X.C.; Shah, A.M.; Katschinski, Dörthe.M., 2016:
PHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages

Xie, L.; Pi, X.; Townley-Tilson, W.H.Davin.; Li, N.; Wehrens, X.H.T.; Entman, M.L.; Taffet, G.E.; Mishra, A.; Peng, J.; Schisler, J.C.; Meissner, G.; Patterson, C., 2015:
PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban

Meneses, A.M.; Wielockx, B., 2016:
PHD2: from hypoxia regulation to disease progression

German, N.J.; Yoon, H.; Yusuf, R.Z.; Murphy, J.Patrick.; Finley, L.W.S.; Laurent, Gëlle.; Haas, W.; Satterstrom, F.Kyle.; Guarnerio, J.; Zaganjor, E.; Santos, D.; Pandolfi, P.Paolo.; Beck, A.H.; Gygi, S.P.; Scadden, D.T.; Kaelin, W.G.; Haigis, M.C., 2016:
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2

Chen, Y.; Zhang, H-Sheng.; Fong, G-Hua.; Xi, Q-Lei.; Wu, G-Hao.; Bai, C-Guang.; Ling, Z-Qiang.; Fan, L.; Xu, Y-Ming.; Qin, Y-Qing.; Yuan, T-Long.; Sun, H.; Fang, J., 2015:
PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function

Mouriz, A.; López-González, L.; Jarillo, J.A.; Piñeiro, M., 2016:
PHDs govern plant development

Yuan, Q.; Bleiziffer, O.; Boos, A.M.; Sun, J.; Brandl, A.; Beier, J.P.; Arkudas, A.; Schmitz, M.; Kneser, U.; Horch, R.E., 2015:
PHDs inhibitor DMOG promotes the vascularization process in the AV loop by HIF-1a up-regulation and the preliminary discussion on its kinetics in rat

Fenton, K.; Mackie, A., 2016:
PHE guidance does warn about PSA testing

Duffin, C.; Griffin, M., 2015:
PHE seeks to boost numbers of 'antibiotic guardians' to 100,000

Cavallaro, G.; Craparo, E.Fabiola.; Sardo, C.; Lamberti, G.; Barba, A.Angela.; Dalmoro, A., 2016:
PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions

Gérardin, M.; Couec, M-Laure.; Grall-Bronnec, M.; Feuillet, F.; Wainstein, L.; Rousselet, M.; Pinot, M-Lyne.; Perrouin, F.; Bonnot, O.; Drouineau, M-Hélène.; Jolliet, P.; Victorri-Vigneau, C., 2016:
PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population

Türkmen, D.; Denizli, A., 2015:
PHEMA based composite cryogels with loaded hydrophobic beads for lysozyme purification

Bakhshpour, M.; Derazshamshir, A.; Bereli, N.; Elkak, A.; Denizli, A., 2016:
PHEMA/PEI]-Cu(II) based immobilized metal affinity chromatography cryogels: Application on the separation of IgG from human plasma

Torices, Rén.; Muñoz-Pajares, A.Jesús., 2015:
PHENIX: An R package to estimate a size-controlled phenotypic integration index

Verma, S.S.; Frase, A.T.; Verma, A.; Pendergrass, S.A.; Mahony, S.; Haas, D.W.; Ritchie, M.D., 2016:
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG)

Kahanda, I.; Funk, C.; Verspoor, K.; Ben-Hur, A., 2016:
PHENOstruct: Prediction of human phenotype ontology terms using heterogeneous data sources

Brechalov, A.V.; Valieva, M.E.; Georgieva, S.G.; Soshnikova, N.V., 2016:
PHF10 isoforms are phosphorylated in the PBAF mammalian chromatin remodeling complex

Muscat, P.; Mercado, K.; Payne, K.; Chahal, H.; Jones, G., 2016:
PHF11 expression and cellular distribution is regulated by the Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid in HaCaT keratinocytes

Chung, H-Ryun.; Xu, C.; Fuchs, A.; Mund, A.; Lange, M.; Staege, H.; Schubert, T.; Bian, C.; Dunkel, I.; Eberharter, A.; Regnard, C.; Klinker, H.; Meierhofer, D.; Cozzuto, L.; Winterpacht, A.; Di Croce, L.; Min, J.; Will, H.; Kinkley, S., 2016:
PHF13 is a molecular reader and transcriptional co-regulator of H3K4me2/3

Klein, B.J.; Wang, X.; Cui, G.; Yuan, C.; Botuyan, M.Victoria.; Lin, K.; Lu, Y.; Wang, X.; Zhao, Y.; Bruns, C.J.; Mer, G.; Shi, X.; Kutateladze, T.G., 2016:
PHF20 Readers Link Methylation of Histone H3K4 and p53 with H4K16 Acetylation

Bertonha, F.Bernardi.; Barros Filho, M.de.Camargo.; Kuasne, H.; Dos Reis, P.Pintor.; da Costa Prando, E.; Muñoz, J.José.Augusto.Moyano.; Roffé, Mín.; Hajj, G.Noeli.Maroso.; Kowalski, L.Paulo.; Rainho, C.Aparecida.; Rogatto, S.Regina., 2015:
PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas

Wang, Z.; Hu, J.; Li, G.; Qu, L.; He, Q.; Lou, Y.; Song, Q.; Ma, D.; Chen, Y., 2015:
PHF23 (plant homeodomain finger protein 23) negatively regulates cell autophagy by promoting ubiquitination and degradation of E3 ligase LRSAM1

Todd, M.A.M.; Ivanochko, D.; Picketts, D.J., 2015:
PHF6 Degrees of Separation: The Multifaceted Roles of a Chromatin Adaptor Protein

de Rooij, J.D.E.; van den Heuvel-Eibrink, M.M.; van de Rijdt, N.K.A.M.; Verboon, L.J.; de Haas, V.; Trka, J.; Baruchel, A.; Reinhardt, D.; Pieters, R.; Fornerod, M.; Zwaan, C.Michel., 2016:
PHF6 mutations in paediatric acute myeloid leukaemia

Samanta, D.; Park, Y.; Andrabi, S.A.; Shelton, L.M.; Gilkes, D.M.; Semenza, G.L., 2017:
PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis

Shin, Y.; Hyeon, J.; Lee, B.; Ha, S.Yun.; Hong, M.Eui.; Do, I.Gu.; Kim, K-Mee., 2015:
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors

Cantiello, F.; Russo, G.Ivan.; Cicione, A.; Ferro, M.; Cimino, S.; Favilla, V.; Perdonà, S.; D.C.belli, O.; Magno, C.; Morgia, G.; Damiano, R., 2015:
PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance

Fuchsova, R.; Topolcan, O.; Windrichova, J.; Hora, M.; Dolejsova, O.; Pecen, L.; Kasik, P.; Novak, J.; Casova, M.; Smejkal, J., 2016:
PHI in the Early Detection of Prostate Cancer

Urban, M.; Cuzick, A.; Rutherford, K.; Irvine, A.; Pedro, H.; Pant, R.; Sadanadan, V.; Khamari, L.; Billal, S.; Mohanty, S.; Hammond-Kosack, K.E., 2016 :
PHI-base: a new interface and further additions for the multi-species pathogen-host interactions database

Matthiessen, D., 2016:
PHILIPPE HUNEMAN (ed.), Functions: Selection and Mechanisms, Dordrecht: Springer, 2013, Synthese Library, Studies in Epistemology, Logic, Methodology, and Philosophy of Science, 243 pp., $159,00 (hard cover)

Sarma, A.; O'Donoghue, M.L., 2016:
PHILO -- ensuring trial results are not lost in translation

Hatfull, G.F.; Racaniello, V., 2014:
PHIRE and TWiV: Experiences in Bringing Virology to New Audiences

Puchalska, M.; Sihver, L., 2016:
PHITS simulations of absorbed dose out-of-field and neutron energy spectra for ELEKTA SL25 medical linear accelerator

Lartaud, M.; Perin, C.; Courtois, B.; Thomas, E.; Henry, S.; Bettembourg, M.; Divol, F.; Lanau, N.; Artus, F.; Bureau, C.; Verdeil, J-Luc.; Sarah, G.; Guiderdoni, E.; Dievart, A., 2015:
PHIV-RootCell: a supervised image analysis tool for rice root anatomical parameter quantification

Choi, R.; Park, H-Doo.; Kang, B.; Choi, S.Yoon.; Ki, C-Seok.; Lee, S-Youn.; Kim, J-Won.; Song, J.; Choe, Y.Ho., 2016:
PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations

Wang, X.; Li, G.; Koul, S.; Ohki, R.; Maurer, M.; Borczuk, A.; Halmos, B., 2015:
PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling

Han, C.Yeob.; Lim, S.Woo.; Koo, J.Hyun.; Kim, W.; Kim, S.Geon., 2017:
PHLDA3 overexpression in hepatocytes by endoplasmic reticulum stress via IRE1-Xbp1s pathway expedites liver injury

Smith, A.J.; Wen, Y-An.; Stevens, P.D.; Liu, J.; Wang, C.; Gao, T., 2016:
PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells

Hribal, M.Letizia.; Mancuso, E.; Spiga, R.; Mannino, G.Chiara.; Fiorentino, T.Vanessa.; Andreozzi, F.; Sesti, G., 2015:
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases

Huang, H.; Pan, X.; Jin, H.; Li, Y.; Zhang, L.; Yang, C.; Liu, P.; Liu, Y.; Chen, L.; Li, J.; Zhu, J.; Zeng, X.; Fu, K.; Chen, G.; Gao, J.; Huang, C., 2016:
PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure

Mathur, A.; Rizvi, F.; Kakkar, P., 2016:
PHLPP2 down regulation influences nuclear Nrf2 stability via Akt-1/Gsk3β/Fyn kinase axis in acetaminophen induced oxidative renal toxicity: Protection accorded by morin

Grzechnik, A.T.; Newton, A.C., 2017:
PHLPPing through history: a decade in the life of PHLPP phosphatases

Xu, H.; Kim, S.; Sorek, H.; Lee, Y.; Jeong, D.; Kim, J.; Oh, E.Joong.; Yun, E.Ju.; Wemmer, D.E.; Kim, K.Heon.; Kim, S.Rin.; Jin, Y-Su., 2016:
PHO13 deletion-induced transcriptional activation prevents sedoheptulose accumulation during xylose metabolism in engineered Saccharomyces cerevisiae

Yadav, K.Kumar.; Singh, N.; Rajasekharan, R., 2016:
PHO4 transcription factor regulates triacylglycerol metabolism under low-phosphate conditions in Saccharomyces cerevisiae

Kizawa, K.; Aono, T.; Ohtomo, R., 2016:
PHO8 gene coding alkaline phosphatase of Saccharomyces cerevisiae is involved in polyphosphate metabolism

Deng, Y.; Altschuler, S.J.; Wu, L.F., 2017:
PHOCOS: inferring multi-feature phenotypic crosstalk networks

Craddock, C.P.; Adams, N.; Bryant, F.M.; Kurup, S.; Eastmond, P.J., 2015:
PHOSPHATIDIC ACID PHOSPHOHYDROLASE Regulates Phosphatidylcholine Biosynthesis in Arabidopsis by Phosphatidic Acid-Mediated Activation of CTP:PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE Activity

Andrews, I.P.; Kwon, O., 2012:
PHOSPHINE-CATALYZED [3 + 2] ANNULATION: SYNTHESIS OF ETHYL 5-(itert -BUTYL)-2-PHENYL-1-TOSYL-3-PYRROLINE-3-CARBOXYLATE

Javeri, H.; Vélez-Mejía, C.; Cadena, J., 2018:
Disseminated Mycobacterium simiae infection in a non-immunosuppressed patient in the USA

Martínez-Morales, Mía.Cecilia.; Deswarte, C.; Castañeda-Casimiro, J.; Bustamante, J.; Blancas-Galicia, L.; Scheffler-Mendoza, S., 2017:
Disseminated infection by M. tuberculosis complex in patient with IFN-γ receptor 1 complete deficiency

Gasch, O.; Meije, Y.; Espasa, M.; Font, B.; Jiménez, S.; Fernández-Hidalgo, N., 2018:
Disseminated Infection Due to Mycobacterium chimaera After Aortic Valve Replacement

Kicia, M.; Wesolowska, M.; Kopacz, Z.; Kvác, M.; Sak, B.; Sokulska, M.; Cebulski, K.; Hendrich, A.B.; Pozowski, A., 2018:
Disseminated infection of Encephalitozoon cuniculi associated with osteolysis of hip periprosthetic tissue

Peel, T., 2018:
Disseminated infection of Encephalitozoon cuniculi associated with osteolysis of hip periprosthetic tissue - Association versus Causation

Yeager, J.; Krenzer, B., 2018:
Disseminated infection to immune activation

Greaney, M.F., 2016:
PHOTOCATALYSIS. Copper catalysis in a blue light

Maillard, M.C.; Arlinghaus, L.; Glashofer, M.; Lee, K.S.; Jacobson, K.A., 1991:
Photolabile A1-Adenosine Receptor Agonists As "caged" Electrophysiological Probes

Naggie, S.; Kim, A.Y., 2015:
PHOTON-2: hope for patients with HIV and HCV co-infection?

Leverenz, R.L.; Sutter, M.; Wilson, Aélé.; Gupta, S.; Thurotte, A.; Bourcier de Carbon, Céline.; Petzold, C.J.; Ralston, C.; Perreau, Fçois.; Kirilovsky, D.; Kerfeld, C.A., 2015:
PHOTOSYNTHESIS. A 12 Å carotenoid translocation in a photoswitch associated with cyanobacterial photoprotection

Cook, S.S.; Whittock, L.; Wright, S.W.; Hallegraeff, G.M., 2011:
Photosynthetic pigment and genetic differences between two southern ocean Morphotypes of Emiliania Huxleyi (Haptophyta) 1

Fristedt, R.; Herdean, A.; Blaby-Haas, C.E.; Mamedov, F.; Merchant, S.S.; Last, R.L.; Lundin, Börn., 2015:
PHOTOSYSTEM II PROTEIN33, a protein conserved in the plastid lineage, is associated with the chloroplast thylakoid membrane and provides stability to photosystem II supercomplexes in Arabidopsis

Xue, H.; Tokutsu, R.; Bergner, S.Verena.; Scholz, M.; Minagawa, J.; Hippler, M., 2016:
PHOTOSYSTEM II SUBUNIT R is required for efficient binding of LIGHT-HARVESTING COMPLEX STRESS-RELATED PROTEIN3 to photosystem II-light-harvesting supercomplexes in Chlamydomonas reinhardtii

D.L.scio, S.; Saba, E.; Belperio, D.; Raimondi, A.; Lucchetti, H.; Fornasari, D.; Benfante, R., 2016:
PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line

Yang, L.; Ke, X-Xue.; Xuan, F.; Tan, J.; Hou, J.; Wang, M.; Cui, H.; Zhang, Y., 2016:
PHOX2B Is Associated with Neuroblastoma Cell Differentiation

Naftali, O.; Maman, S.; Meshel, T.; Sagi-Assif, O.; Ginat, R.; Witz, I.P., 2016:
PHOX2B is a suppressor of neuroblastoma metastasis

Chiffelle, R.L., 2018:
PHOs: An ideal vehicle to create ACOs

Liu, Z-Wei.; Yu, Y.; Hu, M.; Liu, H-Ming.; Zhou, L.; Xiao, S-Yuan., 2016:
PHQ-9 and PHQ-2 for Screening Depression in Chinese Rural Elderly

Wu, M.Zhi.; Post, V.E.A.; Salmon, S.Ursula.; Morway, E.D.; Prommer, H., 2016:
PHT3D-UZF: A Reactive Transport Model for Variably-Saturated Porous Media

Choi, H-Gu.; Kraft, G.T.; Kim, H-Seop.; Guiry, M.D.; Saunders, G.W., 2008:
PHYLOGENETIC RELATIONSHIPS AMONG LINEAGES OF THE CERAMIACEAE (CERAMIALES, RHODOPHYTA) BASED ON NUCLEAR SMALL SUBUNIT rDNA SEQUENCE DATA(1)

Handy, S.M.; Bachvaroff, T.R.; Timme, R.E.; Wayne Coats, D.; Kim, S.; Delwiche, C.F., 2009:
PHYLOGENY OF FOUR DINOPHYSIACEAN GENERA (DINOPHYCEAE, DINOPHYSIALES) BASED ON rDNA SEQUENCES FROM SINGLE CELLS AND ENVIRONMENTAL SAMPLES(1)

Kim, J.Im.; Shin, W., 2008:
PHYLOGENY OF THE EUGLENALES INFERRED FROM PLASTID LSU rDNA SEQUENCES(1)

Nascimento, M.; Sousa, A.; Ramirez, Mário.; Francisco, A.P.; Carriço, Jão.A.; Vaz, Cátia., 2016:
PHYLOViZ 2.0: providing scalable data integration and visualization for multiple phylogenetic inference methods

Ribeiro-Gonçalves, B.; Francisco, A.P.; Vaz, Cátia.; Ramirez, Mário.; Carriço, Jão.André., 2017:
PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees

Faircloth, B.C., 2017:
PHYLUCE is a software package for the analysis of conserved genomic loci

Ding, H.; Yang, W.; Tang, H.; Feng, P-Mian.; Huang, J.; Chen, W.; Lin, H., 2016:
PHYPred: a tool for identifying bacteriophage enzymes and hydrolases

Rupprecht, J-Francois.; Prost, J., 2016:
PHYSICAL BIOLOGY. A fresh eye on nonequilibrium systems

Stone, R., 2016:
PHYSICAL SCIENCE. Researchers rise to challenge of replacing helium-3

Banerjee, S.; Gupta, P.Sarthi.Sen.; Nayek, A.; Das, S.; Sur, V.Pratap.; Seth, P.; Islam, R.Nawaz.Ul.; Bandyopadhyay, A.K., 2015:
PHYSICO2: an UNIX based standalone procedure for computation of physicochemical, window-dependent and substitution based evolutionary properties of protein sequences along with automated block preparation tool, version 2

Skylaris, C-Kriton., 2016:
PHYSICS. A benchmark for materials simulation

Beenakker, C., 2016:
PHYSICS. Bringing order to the expanding fermion zoo

Burkov, A., 2015:
PHYSICS. Chiral anomaly without relativity

Karimi, E.; Boyd, R.W., 2016:
PHYSICS. Classical entanglement?

Cho, A., 2015:
PHYSICS. Controversial test finds no sign of a holographic universe

Zaanen, J., 2016:
PHYSICS. Electrons go with the flow in exotic material systems

Furukawa, Y., 2015:
PHYSICS. Frustrating a quantum magnet

Cartlidge, E., 2016:
PHYSICS. Long-delayed nuclear center looks set for construction

Süsstrunk, R.; Huber, S.D., 2015:
PHYSICS. Observation of phononic helical edge states in a mechanical topological insulator

Suderow, H.J., 2015:
PHYSICS. Opening the gate on superconductivity

Hollen, S.M.; Gupta, J.A., 2016:
PHYSICS. Painting magnetism on a canvas of graphene

Kale, M.J.; Christopher, P., 2015:
PHYSICS. Plasmons at the interface

Celi, A.; Tarruell, L., 2015:
PHYSICS. Probing the edge with cold atoms

Cleland, A.N., 2015:
PHYSICS. Pumping up the quantum

Struzhkin, V., 2016:
PHYSICS. Squeezing into superconductivity

Mason, N., 2016:
PHYSICS. Superconductivity on the edge

Polkovnikov, A.; Sels, D., 2016:
PHYSICS. Thermalization in small quantum systems

Bovensiepen, U.; Ligges, M., 2016:
PHYSICS. Timing photoemission--Final state matters

Ueda, K., 2015:
PHYSICS. To catch and smash charge on the hop

Wehner, S., 2016:
PHYSICS. To see the world in a grain of spins

Khajetoorians, A.Ako.; Heinrich, A.J., 2016:
PHYSICS. Toward single-atom memory

Cho, A., 2016:
PHYSICS. Triumph for gravitational wave hunt

Aleksandraviciene, R.; Zaicenkoviene, K.; Stasiule, L.; Stasiulis, A., 2015:
PHYSIOLOGICAL RESPONSES AND ENERGETICS OF COMPETITIVE GROUP EXERCISE IN FEMALE AEROBIC GYMNASTS WITH DIFFERENT LEVELs OF PERFORMANCE

Volkova, L.A.; Urmantseva, V.V.; Popova, E.V.; Nosov, A.M., 2016:
PHYSIOLOGICAL, CYTOLOGICAL AND BIOCHEMICAL STABILITY OF Medicago sativa L. CELL CULTURE AFTER 27 YEARS OF CRYOGENIC STORAGE

Roth, Z., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Cellular and molecular mechanisms of heat stress related to bovine ovarian function

Cohick, W.S., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Effects of insulin on mammary gland differentiation during pregnancy and lactation

Faubert, J.; Battista, M-C.; Baillargeon, J-P., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review

Baumgard, L.H., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin revisited

Caires, K.C., 2015:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Reproductive success in ruminants: a complex interaction among endocrine, metabolic, and environmental factors

Rhoads, R.P.; Baumgard, L.H.; El-Kadi, S.W.; Zhao, L.D., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Roles for insulin-supported skeletal muscle growth

Bromfield, J.J.; Santos, J.E.P.; Block, J.; Williams, R.S.; Sheldon, I.M., 2016:
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Uterine infection: linking infection and innate immunity with infertility in the high-producing dairy cow

Pennisi, E., 2016:
PHYSIOLOGY. A fish back from the dead

Kumar, N.N.; Velic, A.; Soliz, J.; Shi, Y.; Li, K.; Wang, S.; Weaver, J.L.; Sen, J.; Abbott, S.B.G.; Lazarenko, R.M.; Ludwig, M-Gabrielle.; Perez-Reyes, E.; Mohebbi, N.; Bettoni, C.; Gassmann, M.; Suply, T.; Seuwen, K.; Guyenet, P.G.; Wagner, C.A.; Bayliss, D.A., 2015:
PHYSIOLOGY. Regulation of breathing by CO₂ requires the proton-activated receptor GPR4 in retrotrapezoid nucleus neurons

Zhang, Y.; Liu, Z.; Chen, Y.; He, J-Xian.; Bi, Y., 2016:
PHYTOCHROME-INTERACTING FACTOR 5 (PIF5) positively regulates dark-induced senescence and chlorophyll degradation in Arabidopsis

Moreira, M.; Guevara, J.Nieto.; Caceres, D., 2015:
PHiD-CV effectiveness against invasive pneumococcal disease caused by serotype 19A

Siggins, M.K.; Gill, S.K.; Langford, P.R.; Li, Y.; Ladhani, S.N.; Tregoning, J.S., 2016:
PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice

Bagaitkar, J.; Barbu, E.A.; Perez-Zapata, L.J.; Austin, A.; Huang, G.; Pallat, S.; Dinauer, M.C., 2016:
PI(3)P-p40phox binding regulates NADPH oxidase activation in mouse macrophages and magnitude of inflammatory responses in vivo

Mironova, Y.A.; Lenk, G.M.; Lin, J-Ping.; Lee, S.Joon.; Twiss, J.L.; Vaccari, I.; Bolino, A.; Havton, L.A.; Min, S.H.; Abrams, C.S.; Shrager, P.; Meisler, M.H.; Giger, R.J., 2017:
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms

Hong, N.Hyung.; Qi, A.; Weaver, A.M., 2015:
PI(3,5)P2 controls endosomal branched actin dynamics by regulating cortactin-actin interactions

Jiang, K.; Liu, Y.; Fan, J.; Zhang, J.; Li, X-An.; Evers, B.Mark.; Zhu, H.; Jia, J., 2016:
PI(4)P Promotes Phosphorylation and Conformational Change of Smoothened through Interaction with Its C-terminal Tail

Venditti, R.; Masone, M.Chiara.; Wilson, C.; D.M.tteis, M.Antonietta., 2015:
PI(4)P homeostasis: Who controls the controllers?

Gulshan, K.; Brubaker, G.; Conger, H.; Wang, S.; Zhang, R.; Hazen, S.L.; Smith, J.D., 2016:
PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly

Suh, B-Chang.; Yeon, J-Hee.; Park, C-Gyu., 2016:
PI(4,5)P2 and L-type Ca(2+) Channels Partner Up to Fine-Tune Ca(2+) Dynamics in β Cells

Vicinanza, M.; Korolchuk, V.I.; Ashkenazi, A.; Puri, C.; Menzies, F.M.; Clarke, J.H.; Rubinsztein, D.C., 2015:
PI(5)P regulates autophagosome biogenesis

Maurya, A.Kumar.; Vinayak, M., 2016:
PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T- Cell Lymphoma Exposed to Hydrogen Peroxide

Maurya, A.Kumar.; Vinayak, M., 2016:
PI-103 attenuates PI3K-AKT signaling and induces apoptosis in murineT-cell lymphoma

Singh, A.R.; Joshi, S.; Zulcic, M.; Alcaraz, M.; Garlich, J.R.; Morales, G.A.; Cho, Y.J.; Bao, L.; Levy, M.L.; Newbury, R.; Malicki, D.; Messer, K.; Crawford, J.; Durden, D.L., 2016:
PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

Liao, B-Yi.; Wang, Z.; Hu, J.; Liu, W-Feng.; Shen, Z-Zhuo.; Zhang, X.; Yu, L.; Fan, J.; Zhou, J., 2015:
PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection

Piazzi, M.; Blalock, W.L.; Bavelloni, A.; Faenza, I.; Raffini, M.; Tagliavini, F.; Manzoli, L.; Cocco, L., 2015:
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress

Weinreb, J.C.; Barentsz, J.O.; Choyke, P.L.; Cornud, F.; Haider, M.A.; Macura, K.J.; Margolis, D.; Schnall, M.D.; Shtern, F.; Tempany, C.M.; Thoeny, H.C.; Verma, S., 2016:
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2

Purysko, A.S.; Rosenkrantz, A.B.; Barentsz, J.O.; Weinreb, J.C.; Macura, K.J., 2016:
PI-RADS Version 2: A Pictorial Update

Woo, S.; Kim, S.Youn.; Lee, J.; Kim, S.Hyup.; Cho, J.Yeon., 2016:
PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer

Park, S.Yoon.; Shin, S-Jin.; Jung, D.Chul.; Cho, N.Hoon.; Choi, Y.Deuk.; Rha, K.Ho.; Hong, S.Joon.; Oh, Y.Taik., 2016:
PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer

Barrett, T.; Turkbey, B.; Choyke, P.L., 2016:
PI-RADS version 2: what you need to know

Richenberg, J.L., 2016:
PI-RADS: past, present and future

Gray, J.W., 2016:
PI3 Kinase Pathway Mutations in Human Cancers

Sander, S.; Chu, V.Trung.; Yasuda, T.; Franklin, A.; Graf, R.; Calado, D.Pedro.; Li, S.; Imami, K.; Selbach, M.; D.V.rgilio, M.; Bullinger, L.; Rajewsky, K., 2016:
PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark Zones

Lindblad, O.; Kazi, J.U.; Rönnstrand, L.; Sun, J., 2016:
PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner

Draaisma, K.; Wijnenga, M.M.J.; Weenink, B.; Gao, Y.; Smid, M.; Robe, P.; van den Bent, M.J.; French, P.J., 2016:
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients

Nawaz, Z.; Patil, V.; Paul, Y.; Hegde, A.S.; Arivazhagan, A.; Santosh, V.; Somasundaram, K., 2017:
PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA

Kolic, J.; Manning Fox, J.E.; Chepurny, O.G.; Spigelman, A.F.; Ferdaoussi, M.; Schwede, F.; Holz, G.G.; MacDonald, P.E., 2016:
PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets

Deuker, M.M.; Marsh Durban, V.; Phillips, W.A.; McMahon, M., 2015:
PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma

Masuda, Y.; Yazawa, J.; Makino, Y.; Takada, K., 2016:
PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells

Nobs, S.Philip.; Schneider, C.; Dietrich, M.Gil.; Brocker, T.; Rolink, A.; Hirsch, E.; Kopf, M., 2016:
PI3-Kinase-γ Has a Distinct and Essential Role in Lung-Specific Dendritic Cell Development

Gessain, Gégoire.; Disson, O.; Lecuit, M., 2016:
PI3-kinase activation is critical for host barrier permissiveness to Listeria monocytogenes

Slouzkey, I.; Maroun, M., 2016:
PI3-kinase cascade has a differential role in acquisition and extinction of conditioned fear memory in juvenile and adult rats

Winnay, J.N.; Solheim, M.H.; Dirice, E.; Sakaguchi, M.; Noh, H-Lim.; Kang, H.Joon.; Takahashi, H.; Chudasama, K.K.; Kim, J.K.; Molven, A.; Kahn, C.Ronald.; Njølstad, Pål.R., 2016:
PI3-kinase mutation linked to insulin and growth factor resistance in vivo

Lauvau, Gégoire., 2015:
PI3-kinase, the key for bugs to get in?

Geng, X.; Xie, L.; Xing, H., 2017:
PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo

Anonymous, 2016:
PI3K Inhibitor Improves PFS in BELLE-2 Trial

Niessner, H.; Schmitz, J.; Tabatabai, G.; Schmid, A.M.; Calaminus, C.; Sinnberg, T.; Weide, B.; Eigentler, T.K.; Garbe, C.; Schittek, B.; Quintanilla-Fend, L.; Bender, B.; Mai, M.; Praetorius, C.; Beissert, S.; Schackert, G.; Muders, M.H.; Meinhardt, M.; Baretton, G.B.; Dummer, R.; Flaherty, K.; Pichler, B.J.; Kulms, D.; Westphal, D.; Meier, F., 2016:
PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo

Kana, K.; Song, H.; Laschinger, C.; Zandstra, P.W.; Radisic, M., 2016:
PI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System

Okkenhaug, K.; Burger, J.A., 2016:
PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)

Faes, S.; Dormond, O., 2016:
PI3K and AKT: Unfaithful Partners in Cancer

Saw, S.; Arora, N., 2016:
PI3K and ERK1/2 kinase inhibition potentiate protease inhibitor to attenuate allergen induced Th2 immune response in mouse

Hua, Z.; Gu, X.; Dong, Y.; Tan, F.; Liu, Z.; Thiele, C.J.; Li, Z., 2016:
PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma

Caravagna, Céline.; Soliz, J., 2015:
PI3K and MEK1/2 molecular pathways are involved in the erythropoietin-mediated regulation of the central respiratory command

Nishio, K.; Sakai, K.; Togashi, Y., 2015:
PI3K and mTOR pathway and molecular targeted agents

Alberobello, A.Teresa.; Wang, Y.; Beerkens, F.Joseph.; Conforti, F.; McCutcheon, J.N.; Rao, G.; Raffeld, M.; Liu, J.; Rahhal, R.; Zhang, Y-Wen.; Giaccone, G., 2017:
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Soler, A.; Angulo-Urarte, A.; Graupera, M., 2015:
PI3K at the crossroads of tumor angiogenesis signaling pathways

Steele, A.J., 2015 :
PI3K in CLL: are 2 isoforms better than 1?

Bosch, A.; Li, Z.; Bergamaschi, A.; Ellis, H.; Toska, E.; Prat, A.; Tao, J.J.; Spratt, D.E.; Viola-Villegas, N.T.; Castel, P.; Minuesa, G.; Morse, N.; Rodón, J.; Ibrahim, Y.; Cortes, J.; Perez-Garcia, J.; Galvan, P.; Grueso, J.; Guzman, M.; Katzenellenbogen, J.A.; Kharas, M.; Lewis, J.S.; Dickler, M.; Serra, V.; Rosen, N.; Chandarlapaty, S.; Scaltriti, M.; Baselga, Jé., 2016:
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer

Silveira, Aé.Bortolini.; Laranjeira, A.Brunelli.Albertoni.; Rodrigues, G.Olinto.Libanio.; Leal, P.César.; Cardoso, B.António.; Barata, Jão.Taborda.; Yunes, R.Augusto.; Zanchin, N.Ivo.Tonin.; Brandalise, Sílvia.Regina.; Yunes, Jé.Andrés., 2016:
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia

Shi, L.; Fei, X.; Wang, Z.; You, Y., 2016:
PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway

Massacesi, C.; D.T.maso, E.; Urban, P.; Germa, C.; Quadt, C.; Trandafir, L.; Aimone, P.; Fretault, N.; Dharan, B.; Tavorath, R.; Hirawat, S., 2016:
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Stark, A-Katrien.; Sriskantharajah, S.; Hessel, E.M.; Okkenhaug, K., 2016:
PI3K inhibitors in inflammation, autoimmunity and cancer

Zhang, Y.; Wang, H.; Guo, Q.; Li, X.; Gao, J.; Liu, Y.; Yang, C.; Niu, L.; Yang, J., 2016:
PI3K is involved in P2Y receptor-regulated cAMP /Epac/Kv channel signaling pathway in pancreatic β cells

Aasrum, M.; Tjomsland, V.; Thoresen, G.Hege.; D.A.gelis, P.M.; Christoffersen, T.; Brusevold, I.J., 2015:
PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells

Bareiss, S.K.; Dugan, E.; Brewer, K.L., 2016:
PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias

Mukohara, T., 2015:
PI3K mutations in breast cancer: prognostic and therapeutic implications

Zhao, H-Fu.; Wang, J.; Jiang, H-Ran.; Chen, Z-Ping.; To, S-Shun.Tony., 2016:
PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition

Borges, B.C.; Garcia-Galiano, D.; Rorato, R.; Elias, L.L.K.; Elias, C.F., 2016:
PI3K p110β subunit in leptin receptor expressing cells is required for the acute hypophagia induced by endotoxemia

Rojas, Jé.M.; Spada, R.; Sanz-Ortega, L.; Morillas, L.; Mejías, R.; Mulens-Arias, V.; Pérez-Yagüe, S.; Barber, D.F., 2016:
PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D-mediated activation

Lonetti, A.; Cappellini, A.; Spartà, A.Maria.; Chiarini, F.; Buontempo, F.; Evangelisti, C.; Evangelisti, C.; Orsini, E.; McCubrey, J.A.; Martelli, A.Maria., 2016:
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors

Nichol, D.; Mellinghoff, I.K., 2016:
PI3K pathway inhibition in GBM—is there a signal?

Alonso, N.; Diaz Nebreda, A.; Monczor, F.; Gutkind, J.Silvio.; Davio, C.; Fernandez, N.; Shayo, C., 2016:
PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells

Morishita, Y.; Miura, D.; Kida, S., 2016:
PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter

Yamaoka, M.; Ando, T.; Terabayashi, T.; Okamoto, M.; Takei, M.; Nishioka, T.; Kaibuchi, K.; Matsunaga, K.; Ishizaki, R.; Izumi, T.; Niki, I.; Ishizaki, T.; Kimura, T., 2016:
PI3K regulates endocytosis after insulin secretion by mediating signaling crosstalk between Arf6 and Rab27a

Kima, P.E., 2016:
PI3K signaling in Leishmania infections

Lupieri, A.; Smirnova, N.; Malet, N.; Gayral, Séphanie.; Laffargue, M., 2016:
PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms

Darcq, E.; Kieffer, B.L., 2016:
PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research

Beretta, M.; Bauer, M.; Hirsch, E., 2016:
PI3K signaling in the pathogenesis of obesity: The cause and the cure

Borges, B.C.; Elias, C.F.; Elias, L.L.K., 2016:
PI3K signaling: A molecular pathway associated with acute hypophagic response during inflammatory challenges

Hawkins, P.T.; Stephens, L.R., 2015:
PI3K signalling in inflammation

Majeed, R.; Hussain, A.; Sangwan, P.L.; Chinthakindi, P.K.; Khan, I.; Sharma, P.R.; Koul, S.; Saxena, A.K.; Hamid, A., 2016:
PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation

Bachelot, T.; Campone, M.; Tredan, O., 2016:
PI3K targeting in breast cancer: the end of the beginning?

Caino, M.Cecilia.; Ghosh, J.C.; Chae, Y.Chan.; Vaira, V.; Rivadeneira, D.B.; Faversani, A.; Rampini, P.; Kossenkov, A.V.; Aird, K.M.; Zhang, R.; Webster, M.R.; Weeraratna, A.T.; Bosari, S.; Languino, L.R.; Altieri, D.C., 2015 :
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion

Le, A.W.; Shan, L.L.; Dai, X.Y.; Xiao, T.H.; Li, X.R.; Wang, Z.H.; Zhang, J.; Chen, X.Y., 2016:
PI3K, AKT, and P-AKT levels in thin endometrium

Reddy, N.M.; Potteti, H.R.; Vegiraju, S.; Chen, H-Jou.; Tamatam, C.Mohan.; Reddy, S.P., 2016:
PI3K-AKT Signaling via Nrf2 Protects against Hyperoxia-Induced Acute Lung Injury, but Promotes Inflammation Post-Injury Independent of Nrf2 in Mice

Lin, Y.X.; Lin, K.; Liu, X.X.; Kang, D.Z.; Ye, Z.X.; Wang, X.F.; Zheng, S.F.; Yu, L.H.; Lin, Z.Y., 2016:
PI3K-AKT pathway polymerase chain reaction (PCR) array analysis of epilepsy induced by type II focal cortical dysplasia

Sun, Y.; Zhang, X.; Wang, G.; Lin, S.; Zeng, X.; Wang, Y.; Zhang, Z., 2016:
PI3K-AKT signaling pathway is involved in hypoxia/thermal-induced immunosuppression of small abalone Haliotis diversicolor

Martins, F.; de Sousa, S.Com.; Dos Santos, E.; Woo, S-Bin.; Gallottini, M., 2016:
PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis

Brotelle, T.; Bay, J-Olivier., 2016:
PI3K-AKT-mTOR pathway: Description, therapeutic development, resistance, predictive/prognostic biomarkers and therapeutic applications for cancer

Shi, Q.; Hoffman, B.; Liu, Q., 2016:
PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs

Song, Q.; Han, C.C.; Xiong, X.P.; He, F.; Gan, W.; Wei, S.H.; Liu, H.H.; Li, L.; Xu, H.Y., 2016:
PI3K-Akt-mTOR signal inhibition affects expression of genes related to endoplasmic reticulum stress

Fan, B.; Yu, Y.; Zhang, Y., 2016 :
PI3K-Akt1 expression and its significance in liver tissues with chronic fluorosis

Leibiger, B.; Moede, T.; Paschen, M.; Yunn, N-Oh.; Lim, J.Hoon.; Ryu, S.Ho.; Pereira, T.; Berggren, P-Olof.; Leibiger, I.B., 2016:
PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation

Campa, C.C.; Franco, I.; Hirsch, E., 2015:
PI3K-C2α: One enzyme for two products coupling vesicle trafficking and signal transduction

Cao, B-Yan.; Li, R.; Tian, H-Huan.; Ma, Y-Jia.; Hu, X-Gang.; Jia, N.; Wang, Y-Ying., 2016:
PI3K-GLUT4 Signal Pathway Associated with Effects of EX-B3 Electroacupuncture on Hyperglycemia and Insulin Resistance of T2DM Rats

Matsumoto, C.S.; Almeida, L.O.; Guimarães, D.M.; Martins, M.D.; Papagerakis, P.; Papagerakis, S.; Leopoldino, A.M.; Castilho, R.M.; Squarize, C.H., 2016:
PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells

Brady, S.W.; Zhang, J.; Tsai, M-Horng.; Yu, D., 2016:
PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibition

Lin, F.; de Gooijer, M.C.; Hanekamp, D.; Chandrasekaran, G.; Buil, L.C.M.; Thota, N.; Sparidans, R.W.; Beijnen, J.H.; Würdinger, T.; van Tellingen, O., 2016:
PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models

Mohlin, S.; Hamidian, A.; von Stedingk, K.; Bridges, E.; Wigerup, C.; Bexell, D.; Påhlman, S., 2016:
PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma

Dinda, M.; Dasgupta, U.; Singh, N.; Bhattacharyya, D.; Karmakar, P., 2015:
PI3K-mediated proliferation of fibroblasts by Calendula officinalis tincture: implication in wound healing

Chen, H.; Fajol, A.; Hoene, M.; Zhang, B.; Schleicher, E.D.; Lin, Y.; Calaminus, C.; Pichler, B.J.; Weigert, C.; Häring, H.U.; Lang, F.; Föller, M., 2016:
PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome

Rice, G.B.; Wadhwani, N.R., 2016:
PI3K/AKT Pathway and Brain Malformations

Nozhat, Z.; Hedayati, M., 2016:
PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas

Hossini, A.M.; Quast, A.S.; Plötz, M.; Grauel, K.; Exner, T.; Küchler, J.; Stachelscheid, H.; Eberle, Jürgen.; Rabien, A.; Makrantonaki, E.; Zouboulis, C.C., 2017:
PI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem Cells

Spangle, J.M.; Dreijerink, K.M.; Groner, A.C.; Cheng, H.; Ohlson, C.E.; Reyes, J.; Lin, C.Y.; Bradner, J.; Zhao, J.J.; Roberts, T.M.; Brown, M., 2016:
PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer

Ghorbani, A.; Jeddi-Tehrani, M.; Saidpour, A.; Safa, M.; Bayat, A.Ali.; Zand, H., 2015:
PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells

Olasz, J.; Doleschall, Zán.; Dunai, Z.; Pazsitka, Aás.; Csuka, O., 2015:
PI3K/AKT pathway activation and therapeutic consequences in breast cancer

Jansen, L.A.; Mirzaa, G.M.; Ishak, G.E.; O'Roak, B.J.; Hiatt, J.B.; Roden, W.H.; Gunter, S.A.; Christian, S.L.; Collins, S.; Adams, C.; Rivière, J-Baptiste.; St-Onge, J.; Ojemann, J.G.; Shendure, J.; Hevner, R.F.; Dobyns, W.B., 2015:
PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia

Barber, A.G.; Castillo-Martin, M.; Bonal, D.M.; Jia, A.J.; Rybicki, B.A.; Christiano, A.M.; Cordon-Cardo, C., 2016 :
PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer

Prasad, S.Babu.; Yadav, S.Singh.; Das, M.; Modi, A.; Kumari, S.; Pandey, L.Kant.; Singh, S.; Pradhan, S.; Narayan, G., 2016:
PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer

Platonova, N.; Manzo, T.; Mirandola, L.; Colombo, M.; Calzavara, E.; Vigolo, E.; Cermisoni, G.Chiara.; De Simone, D.; Garavelli, S.; Cecchinato, V.; Lazzari, E.; Neri, A.; Chiaramonte, R., 2015:
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation

Giorgi, C.; Boro, A.; Rechfeld, F.; Lopez-Garcia, L.A.; Gierisch, M.E.; Schäfer, B.W.; Niggli, F.K., 2016:
PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1

Zhang, Y.; Wang, S-Jie.; Han, Z-Hua.; Li, Y-Qin.; Xue, J-Hong.; Gao, D-Feng.; Wu, X-San.; Wang, C-Xia., 2015:
PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells

Shi, L-Xiao.; Wang, J-Hua.; Shi, X-Dong., 2016:
PI3K/AKT/mTOR Pathway and Pediatric T Acute Lymphoblastic Leukemia-Review

Sharma, N.; Nanta, R.; Sharma, J.; Gunewardena, S.; Singh, K.P.; Shankar, S.; Srivastava, R.K., 2016:
PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

Babichev, Y.; Kabaroff, L.; Datti, A.; Uehling, D.; Isaac, M.; Al-Awar, R.; Prakesch, M.; Sun, R.X.; Boutros, P.C.; Venier, R.; Dickson, B.C.; Gladdy, R.A., 2016:
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

Li, J.; Dang, Y.; Gao, J.; Li, Y.; Zou, J.; Shen, L., 2016:
PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs)

Ribback, S.; Cigliano, A.; Kroeger, N.; Pilo, M.G.; Terracciano, L.; Burchardt, M.; Bannasch, P.; Calvisi, D.F.; Dombrowski, F., 2016:
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men

Lu, Y.; Wang, C.; Xue, Z.; Li, C.; Zhang, J.; Zhao, X.; Liu, A.; Wang, Q.; Zhou, W., 2015:
PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13

Samarin, J.; Laketa, V.; Malz, M.; Roessler, S.; Stein, I.; Horwitz, E.; Singer, S.; Dimou, E.; Cigliano, A.; Bissinger, M.; Falk, C.Susanne.; Chen, X.; Dooley, S.; Pikarsky, E.; Calvisi, D.Francesco.; Schultz, C.; Schirmacher, P.; Breuhahn, K., 2016:
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells

Zhang, J.; Zhang, J-Xiang.; Zhang, Q-Liang., 2017:
PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder

Fan, S.; Zhang, B.; Luan, P.; Gu, B.; Wan, Q.; Huang, X.; Liao, W.; Liu, J., 2016:
PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy

Guerrero-Zotano, A.; Mayer, I.A.; Arteaga, C.L., 2016:
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

Yang, W-Rong.; Zhu, F-Wei.; Zhang, J-Jiao.; Wang, Y.; Zhang, J-Hua.; Lu, C.; Wang, X-Zhong., 2016:
PI3K/Akt Activated by GPR30 and Src Regulates 17β-Estradiol-Induced Cultured Immature Boar Sertoli Cells Proliferation

Guidetti, G.F.; Canobbio, I.; Torti, M., 2016:
PI3K/Akt in platelet integrin signaling and implications in thrombosis

Komeili-Movahhed, T.; Fouladdel, S.; Barzegar, E.; Atashpour, S.; Hossein Ghahremani, M.; Nasser Ostad, S.; Madjd, Z.; Azizi, E., 2015:
PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy

Yu, Z-Hai.; Cai, M.; Xiang, J.; Zhang, Z-Nian.; Zhang, J-Si.; Song, X-Ling.; Zhang, W.; Bao, J.; Li, W-Wei.; Cai, D-Fang., 2016:
PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats

Dan, H.C.; Antonia, R.J.; Baldwin, A.S., 2018:
PI3K/Akt promotes feedforward mTORC2 activation through IKKα

Zhang, J.; Yu, X-Hua.; Yan, Y-Guo.; Wang, C.; Wang, W-Jun., 2016:
PI3K/Akt signaling in osteosarcoma

Zhang, X-Ling.; Xing, R-Ge.; Chen, L.; Liu, C-Rong.; Miao, Z-Gang., 2016:
PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition

Zhuo, B.; Li, Y.; Li, Z.; Qin, H.; Sun, Q.; Zhang, F.; Shen, Y.; Shi, Y.; Wang, R., 2015:
PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma

Pi, T.; Zhou, X-Wen.; Cai, L.; Zhang, W.; Su, C-Fen.; Wu, W-Tian.; Ren, X-Ming.; Luo, H-Min., 2016:
PI3K/Akt signaling pathway is involved in the neurotrophic effect of senegenin

Liu, M-Hua.; Li, G-Hua.; Peng, L-Jun.; Qu, S-Lin.; Zhang, Y.; Peng, J.; Luo, X-Yuan.; Hu, H-Jing.; Ren, Z.; Liu, Y.; Tang, H.; Liu, L-Shan.; Tang, Z-Han.; Jiang, Z-Sheng., 2016:
PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cells

Sharma, V.Ruchi.; Gupta, G.Kumar.; Sharma, A.K.; Batra, N.; Sharma, D.K.; Joshi, A.; Sharma, A.K., 2016:
PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation

Park, J-Hoon.; Kim, K.Pil.; Ko, J-Jae.; Park, K-Soon., 2017:
PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy

Asati, V.; Mahapatra, D.Kar.; Bharti, S.Kumar., 2016:
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

Lee, J.Jx.; Loh, K.; Yap, Y-Sim., 2016:
PI3K/Akt/mTOR inhibitors in breast cancer

Chen, J.; Shao, R.; Li, F.; Monteiro, M.; Liu, J-Ping.; Xu, Z.Ping.; Gu, W., 2015:
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells

Makker, A.; Goel, M.Mati.; Mahdi, A.Ali.; Bhatia, V.; Das, V.; Agarwal, A.; Pandey, A., 2016:
PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes iPTEN & iLKB1 in human uterine leiomyomas

Qian, D.C.; Xiao, X.; Byun, J.; Suriawinata, A.A.; Her, S.C.; Amos, C.I.; Barth, R.J., 2016:
PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer

Li, X.; Wu, C.; Chen, N.; Gu, H.; Yen, A.; Cao, L.; Wang, E.; Wang, L., 2017:
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma

Xia, P.; Xu, X-Yan., 2015:
PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application

Petrulea, M.S.; Plantinga, T.S.; Smit, J.W.; Georgescu, C.E.; Netea-Maier, R.T., 2015:
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma

Zhang, X.; Wu, H.; Liu, C.; Tian, J.; Qu, L., 2016:
PI3K/Akt/p53 pathway inhibits reovirus infection

Joshi, A.; Ellenson, L.Hedrick., 2016:
PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma

Jiang, H.; Xiao, J.; Kang, B.; Zhu, X.; Xin, N.; Wang, Z., 2017:
PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide

Zaidi, A.H.; Kosovec, J.E.; Matsui, D.; Omstead, A.N.; Raj, M.; Rao, R.R.; Biederman, R.W.W.; Finley, G.G.; Landreneau, R.J.; Kelly, R.J.; Jobe, B.A., 2016:
PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model

Kolev, V.N.; Wright, Q.G.; Vidal, C.M.; Ring, J.E.; Shapiro, I.M.; Ricono, J.; Weaver, D.T.; Padval, M.V.; Pachter, J.A.; Xu, Q., 2015:
PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells

Citro, S.; Miccolo, C.; Meloni, L.; Chiocca, S., 2016:
PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression

Miyasaka, A.; Oda, K.; Ikeda, Y.; Sone, K.; Fukuda, T.; Inaba, K.; Makii, C.; Enomoto, A.; Hosoya, N.; Tanikawa, M.; Uehara, Y.; Arimoto, T.; Kuramoto, H.; Wada-Hiraike, O.; Miyagawa, K.; Yano, T.; Kawana, K.; Osuga, Y.; Fujii, T., 2015:
PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer

King, D.; Yeomanson, D.; Bryant, H.E., 2015:
PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma

Dbouk, H.A., 2015:
PI3King the right partner: unique interactions and signaling by p110β

Lopez-Guadamillas, E.; Muñoz-Martin, M.; Martinez, S.; Pastor, J.; Fernandez-Marcos, P.J.; Serrano, M., 2016:
PI3Kα inhibition reduces obesity in mice

McLean, B.A.; Zhabyeyev, P.; Patel, V.B.; Basu, R.; Parajuli, N.; DesAulniers, J.; Murray, A.G.; Kassiri, Z.; Vanhaesebroeck, B.; Oudit, G.Y., 2015:
PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heart

Torti, M., 2015:
PI3Kβ inhibition: all that glitters is not gold

Anonymous, 2016:
PI3Kγ Inhibition Potentiates Immune Checkpoint Blockade

Maffei, A.; Cifelli, G.; Carnevale, R.; Iacobucci, R.; Pallante, F.; Fardella, V.; Fardella, S.; Hirsch, E.; Lembo, G.; Carnevale, D., 2016:
PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice

Nobs, S.Philip.; Schneider, C.; Heer, A.Kaspar.; Huotari, J.; Helenius, A.; Kopf, M., 2016:
PI3Kγ Is Critical for Dendritic Cell-Mediated CD8+ T Cell Priming and Viral Clearance during Influenza Virus Infection

Lima, I.Vieira.de.Assis.; Campos, A.Cristina.; Miranda, A.Silva.; Vieira, Érica.Leandro.Marciano.; Amaral-Martins, Fávia.; Vago, J.Priscila.; Santos, R.Priscila.de.Melo.; Sousa, Lândia.Pires.; Vieira, L.Bruno.; Teixeira, M.Martins.; Fiebich, B.L.; Moraes, Márcio.Flávio.Dutra.; Teixeira, A.Lucio.; de Oliveira, A.Carlos.Pinheiro., 2015:
PI3Kγ deficiency enhances seizures severity and associated outcomes in a mouse model of convulsions induced by intrahippocampal injection of pilocarpine

Pearce, V.Q.; Bouabe, H.; MacQueen, A.R.; Carbonaro, V.; Okkenhaug, K., 2016:
PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes

Juris, L.; Montino, M.; Rube, P.; Schlotterhose, P.; Thumm, M.; Krick, R., 2015:
PI3P binding by Atg21 organises Atg8 lipidation

Cianciulli, A.; Calvello, R.; Porro, C.; Trotta, T.; Salvatore, R.; Panaro, M.Antonietta., 2016:
PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia

Mounayar, M.; Kefaloyianni, E.; Smith, B.; Solhjou, Z.; Maarouf, O.H.; Azzi, J.; Chabtini, L.; Fiorina, P.; Kraus, M.; Briddell, R.; Fodor, W.; Herrlich, A.; Abdi, R., 2016:
PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

Zeeman, A-Marie.; Lakshminarayana, S.B.; van der Werff, N.; Klooster, E.J.; Voorberg-van der Wel, A.; Kondreddi, R.R.; Bodenreider, C.; Simon, O.; Sauerwein, R.; Yeung, B.K.S.; Diagana, T.T.; Kocken, C.H.M., 2017:
PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites

Boal, Fédéric.; Puhar, A.; Xuereb, J-Marie.; Kunduzova, O.; Sansonetti, P.J.; Payrastre, B.; Tronchère, Hélène., 2016:
PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment

Uszkoreit, J.; Maerkens, A.; Perez-Riverol, Y.; Meyer, H.E.; Marcus, K.; Stephan, C.; Kohlbacher, O.; Eisenacher, M., 2016:
PIA: An Intuitive Protein Inference Engine with a Web-Based User Interface

Bruland, P.; Hänse, W.; Schedel, F.; Ständer, S.; Fritz, F., 2015:
PIACS: A System for the Automatic Detection, Categorization and Comparison of Scratch-Related Skin Lesions in Dermatology

Moreno-Ayala, R.; Schnabel, Dí.; Salas-Vidal, E.; Lomelí, H., 2015:
PIAS-like protein Zimp7 is required for the restriction of the zebrafish organizer and mesoderm development

Rabellino, A.; Melegari, M.; Tompkins, V.S.; Chen, W.; Van Ness, B.G.; Teruya-Feldstein, J.; Conacci-Sorrell, M.; Janz, S.; Scaglioni, P.Paolo., 2016:
PIAS1 Promotes Lymphomagenesis through MYC Upregulation

Ochaba, J.; Monteys, A.Mas.; O'Rourke, J.G.; Reidling, J.C.; Steffan, J.S.; Davidson, B.L.; Thompson, L.M., 2017:
PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In Vivo

Ledsaak, M.; Bengtsen, M.; Molværsmyr, A-Kristin.; Fuglerud, B.Maria.; Matre, V.; Eskeland, R.; Gabrielsen, O.Stokke., 2016:
PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status

Puhr, M.; Hoefer, J.; Neuwirt, H.; Eder, I.E.; Kern, J.; Schäfer, G.; Geley, S.; Heidegger, I.; Klocker, H.; Culig, Z., 2015:
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells

Constanzo, J.D.; Tang, K-Jing.; Rindhe, S.; Melegari, M.; Liu, H.; Tang, X.; Rodriguez-Canales, J.; Wistuba, I.; Scaglioni, P.Paolo., 2016:
PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer

Her, J.; Jeong, Y.Young.; Chung, I.Kwon., 2016:
PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2

Nakagawa, K.; Kohara, T.; Uehata, Y.; Miyakawa, Y.; Sato-Ueshima, M.; Okubo, N.; Asaka, M.; Takeda, H.; Kobayashi, M., 2016:
PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability

Abbas, R.; McColl, K.S.; Kresak, A.; Yang, M.; Chen, Y.; Fu, P.; Wildey, G.; Dowlati, A., 2015:
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival

Zhang, P.; Yang, B.; Yao, Y-Yuan.; Zhong, L-Xia.; Chen, X-Yan.; Kong, Q-You.; Wu, M-Li.; Li, C.; Li, H.; Liu, J., 2016:
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling

Li, J.; Cui, J.; Zhang, J.; Liu, Y.; Han, L.; Jia, C.; Deng, J.; Liang, H., 2015:
PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer

Malik, S.; Molina, H.; Xue, Z., 2016:
PIC Activation through Functional Interplay between Mediator and TFIIH

Koczor, Bálint.; Rohonczy, János., 2015:
PIC microcontroller based external fast analog to digital converter to acquire wide-lined solid NMR spectra by BRUKER DRX and Avance-I spectrometers

Behan, L.; Dimitrov, B.D.; Kuehni, C.E.; Hogg, C.; Carroll, M.; Evans, H.J.; Goutaki, M.; Harris, A.; Packham, S.; Walker, W.T.; Lucas, J.S., 2017:
PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia

Liu, G.; Xu, Y.; Jiang, Y.; Zhang, L.; Feng, R.; Jiang, Q., 2016:
PICALM rs3851179 Variant Confers Susceptibility to Alzheimer's Disease in Chinese Population

Xu, Y.; Jiang, Q.; Liu, G., 2016:
PICALM rs3851179 Variant and Alzheimer's Disease in Asian Population

Ryan, C.W.; Merimsky, O.; Agulnik, M.; Blay, J-Yves.; Schuetze, S.M.; Van Tine, B.A.; Jones, R.L.; Elias, A.D.; Choy, E.; Alcindor, T.; Keedy, V.L.; Reed, D.R.; Taub, R.N.; Italiano, A.; Garcia Del Muro, X.; Judson, I.R.; Buck, J.Y.; Lebel, F.; Lewis, J.J.; Maki, R.G.; Schöffski, P., 2016:
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Moodley, N.; Pease, R.; Channer, L., 2016:
PICC in a community setting

Gabriel, J., 2016 :
PICC in an acute oncology setting

Shawyer, V., 2016:
PICC in an intensive care setting

Masuda, S.; Tanaka, M., 2017:
PICCORO: A technique for manipulating the activity of transcription factors with blue light

Nielsen, C.F.; Hickson, I.D., 2016:
PICH promotes mitotic chromosome segregation: Identification of a novel role in rDNA disjunction

Wang, Z.; Yuan, Y.; Xie, K.; Tang, X.; Zhang, L.; Ao, J.; Li, N.; Zhang, Y.; Guo, S.; Wang, G., 2017:
PICK1 Regulates the Expression and Trafficking of AMPA Receptors in Remifentanil-Induced Hyperalgesia

Xie, J.; Wu, X.; Zhou, Q.; Yang, Y.; Tian, Y.; Huang, C.; Meng, X.; Li, J., 2016:
PICK1 confers anti-inflammatory effects in acute liver injury via suppressing M1 macrophage polarization

Madasu, Y.; Yang, C.; Boczkowska, M.; Bethoney, K.A.; Zwolak, A.; Rebowski, G.; Svitkina, T.; Dominguez, R., 2016:
PICK1 is implicated in organelle motility in an Arp2/3 complex-independent manner

Rocca, D.L.; Hanley, J.G., 2015:
PICK1 links AMPA receptor stimulation to Cdc42

Herbert, L.M.; Nitta, C.H.; Yellowhair, T.R.; Browning, C.; Gonzalez Bosc, L.V.; Resta, T.C.; Jernigan, N.L., 2016:
PICK1/calcineurin suppress ASIC1-mediated Ca2+ entry in rat pulmonary arterial smooth muscle cells

Holt, R.; Murphy, J., 2015:
PICO™ incision closure in oncoplastic breast surgery: a case series

Luo, Y.; Morgan, S.L.; Wang, K.C., 2017:
PICSAR: Long Noncoding RNA in Cutaneous Squamous Cell Carcinoma

Mohl, W.; Gangl, C.; Jusić, A.; Aschacher, T.; D.J.nge, M.; Rattay, F., 2016:
PICSO: from myocardial salvage to tissue regeneration

Chen, H.; Han, L.; Tsai, H.; Wang, Z.; Wu, Y.; Duo, Y.; Cao, W.; Chen, L.; Tan, Z.; Xu, N.; Huang, X.; Zhuang, J.; Huang, L., 2016:
PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway

Chen, H.; Duo, Y.; Hu, B.; Wang, Z.; Zhang, F.; Tsai, H.; Zhang, J.; Zhou, L.; Wang, L.; Wang, X.; Huang, L., 2016:
PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway

Okamura, K.; Takayama, K.; Kawahara, K.; Harada, T.; Nishio, M.; Otsubo, K.; Ijichi, K.; Kohno, M.; Iwama, E.; Fujii, A.; Ota, K.; Koga, T.; Okamoto, T.; Suzuki, A.; Nakanishi, Y., 2015:
PICT1 expression is a poor prognostic factor in non-small cell lung cancer

LaFond, C.M.; Van Hulle Vincent, C.; Corte, C.; Hershberger, P.E.; Johnson, A.; Park, C.G.; Wilkie, D.J., 2015:
PICU Nurses' Pain Assessments and Intervention Choices for Virtual Human and Written Vignettes

Slonim, A.D.; Coppes, M.J., 2016:
PICU Outcomes: Does It Matter Whether the Children's Hospital Is Freestanding?

Pessach, I.; Paret, G., 2016:
PICU Propofol Use, Where Do We Go From Here?

Natale, J.E.; Marcin, J.P., 2016:
PICU Readmissions: Not Just Output but Patient Throughput

Wieczorek, B.; Ascenzi, J.; Kim, Y.; Lenker, H.; Potter, C.; Shata, N.J.; Mitchell, L.; Haut, C.; Berkowitz, I.; Pidcock, F.; Hoch, J.; Malamed, C.; Kravitz, T.; Kudchadkar, S.R., 2016:
PICU Up!: Impact of a Quality Improvement Intervention to Promote Early Mobilization in Critically Ill Children

Markovitz, B.P.; Kukuyeva, I.; Soto-Campos, G.; Khemani, R.G., 2017:
PICU Volume and Outcome: A Severity-Adjusted Analysis

Colleti, Jé.; de Carvalho, W.Brunow., 2016:
PICU-Acquired Weakness: Underestimated and Underreported

McArt, D.G.; Blayney, J.K.; Boyle, D.P.; Irwin, G.W.; Moran, M.; Hutchinson, R.A.; Bankhead, P.; Kieran, D.; Wang, Y.; Dunne, P.D.; Kennedy, R.D.; Mullan, P.B.; Harkin, D.Paul.; Catherwood, M.A.; James, J.A.; Salto-Tellez, M.; Hamilton, P.W., 2016:
PICan: An integromics framework for dynamic cancer biomarker discovery

Frans, G.; Moens, L.; Schrijvers, R.; Wuyts, G.; Bouckaert, B.; Schaballie, H.; Dupont, L.; Bossuyt, X.; Corveleyn, A.; Meyts, I., 2016:
PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome

de Souza Granja Barros, J.; Rossi, L.Antonio.; Sartor, K., 2015:
PID temperature controller in pig nursery: improvements in performance, thermal comfort, and electricity use

Wüthrich, B., 2015:
PID: the slogans of political parties

Achar, T.Kumar.; Maiti, S.; Mal, P., 2016:
PIDA-I2 mediated direct vicinal difunctionalization of olefins: iodoazidation, iodoetherification and iodoacyloxylation

Yang, N.; Gao, X.; Qu, X.; Zhang, R.; Tong, F.; Cai, Q.; Dong, J.; Hu, Y.; Wu, G.; Dong, X., 2016:
PIDD Mediates Radiation-Induced Microglia Activation

Anonymous, 1995:
PIE, Pharoah and persuasion

Wang, Y.; Xu, L.; Thilmony, R.; You, F.M.; Gu, Y.Q.; Coleman-Derr, D., 2016:
PIECE 2.0: an update for the plant gene structure comparison and evolution database

Imashuku, S.; Muramatsu, H.; Sugihara, T.; Okuno, Y.; Wang, X.; Yoshida, K.; Kato, A.; Kato, K.; Tatsumi, Y.; Hattori, A.; Kita, S.; Oe, K.; Sueyoshi, A.; Usui, T.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; Miyano, S.; Ogawa, S.; Kojima, S.; Kanno, H., 2016:
PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus

Barnea, E.R.; Kirk, D.; Todorova, K.; McElhinney, J.; Hayrabedyan, S.; Fernández, N., 2016:
PIF direct immune regulation: Blocks mitogen-activated PBMCs proliferation, promotes TH2/TH1 bias, independent of Ca(2+)

Kim, K.; Jeong, J.; Kim, J.; Lee, N.; Kim, M.Eon.; Lee, S.; Chang Kim, S.; Choi, G., 2016:
PIF1 Regulates Plastid Development by Repressing Photosynthetic Genes in the Endodermis

Kim, J.; Kang, H.; Park, J.; Kim, W.; Yoo, J.; Lee, N.; Kim, J.; Yoon, T-Young.; Choi, G., 2016:
PIF1-Interacting Transcription Factors and Their Binding Sequence Elements Determine the in Vivo Targeting Sites of PIF1

Choi, H.; Oh, E., 2016:
PIF4 Integrates Multiple Environmental and Hormonal Signals for Plant Growth Regulation in Arabidopsis

Press, M.O.; Lanctot, A.; Queitsch, C., 2016:
PIF4 and ELF3 Act Independently in Arabidopsis thaliana Thermoresponsive Flowering

Beltran, R.; Nocquet-Thibault, S.; Blanchard, F.; Dodd, R.H.; Cariou, K., 2016:
PIFA-mediated ethoxyiodination of enamides with potassium iodide

Xu, J.; Cai, J.; Jin, X.; Yang, J.; Shen, Q.; Ding, X.; Liang, Y., 2016:
PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway

Liu, J.; Peng, L.; Niu, T.; Wu, Y.; Li, J.; Wang, F.; Zheng, Y.; Liu, T., 2016:
PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization

de Massougnes, S.; Dirani, A.; Ambresin, A.; Decugis, D.; Marchionno, L.; Mantel, I., 2016:
PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB: Time Course and Drug Effects

Itoh, S.; Hattori, C.; Nakayama, S.; Hanamoto, A., 2016:
PIGRET assay can detect mutagenicity of ethyl methanesulfonate much earlier than RBC Pig-a assay

Park, D.S.; Baran, Y.; Hormozdiari, F.; Eng, C.; Torgerson, D.G.; Burchard, E.G.; Zaitlen, N., 2015:
PIGS: improved estimates of identity-by-descent probabilities by probabilistic IBD graph sampling

Anonymous, 2015:
PII and exemption for intrapartum care extended to end of 2015

Scheffer, I.E., 2016:
PIK-ing the right gene for polymicrogyria

Liu, T.; Zu, C-Hua.; Wang, S-Sen.; Song, H-Li.; Wang, Z-Lu.; Xu, X-Nv.; Liu, H-Sheng.; Wang, Y-Liang.; Shen, Z-Yang., 2016:
PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells

Sabha, N.; Volpatti, J.R.; Gonorazky, H.; Reifler, A.; Davidson, A.E.; Li, X.; Eltayeb, N.M.; Dall'Armi, C.; Di Paolo, G.; Brooks, S.V.; Buj-Bello, A.; Feldman, E.L.; Dowling, J.J., 2017:
PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models

Li, A.; Chen, H.; Lin, M.; Zhang, C.; Tang, E.; Peng, J.; Wei, Q.; Li, H.; Yin, L., 2015:
PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin

Lee, H.; Lee, J-Ho.; Kim, D-Kwang.; Choi, I-Jang.; Hwang, I.; Kang, Y-Na.; Kim, S., 2016:
PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation

Paleari, L.; Puntoni, M.; Clavarezza, M.; DeCensi, M.; Cuzick, J.; DeCensi, A., 2015:
PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies

Nicoś, M.; Krawczyk, Pł.; Powrózek, T.; Szudy, P.; Jarosz, Bżena.; Sawicki, M.; Szumiło, J.; Trojanowski, T.; Milanowski, J., 2016:
PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

Stachler, M.D.; Rinehart, E.M.; Garcia, E.; Lindeman, N.I., 2017:
PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver Mutations

Han, N.; Cheng, Q-Yuan.; Chen, B.; Cai, J-Fen.; Wang, X-Jia.; Lou, C-Jin.; Qin, J.; Ye, W-Wu.; Lei, L.; Lu, H-Yang., 2016:
PIK3CA Mutations in Resected Small Cell Lung Cancer

de la Rochefordiere, A.; Kamal, M.; Floquet, A.; Thomas, L.; Petrow, P.; Petit, T.; Pop, M.; Fabbro, M.; Kerr, C.; Joly, F.; Sevin, E.; Maillard, S.; Curé, Hé.; Weber, Béatrice.; Brunaud, C.; Minsat, M.; Gonzague, L.; Berton-Rigaud, D.; Aumont, M.; Gladieff, L.; Peignaux, K.; Bernard, V.; Leroy, Q.; Bieche, I.; Margogne, A.; Nadan, A.; Fourchotte, V.; Diallo, A.; Asselain, B.; Plancher, C.; Armanet, Sébastien.; Beuzeboc, P.; Scholl, S.M., 2016:
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Phipps, A.I.; Ahnen, D.J.; Cheng, I.; Newcomb, P.A.; Win, A.Ko.; Burnett, T., 2016 :
PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer

Kim, H.Song.; Lee, S.Eun.; Bae, Y.Sung.; Kim, D.Joon.; Lee, C.Geol.; Hur, J.; Chung, H.; Park, J.Chul.; Shin, S.Kwan.; Lee, S.Kil.; Lee, Y.Chan.; Kim, H.Ryun.; Shim, Y.Mog.; Jewell, S.S.; Kim, H.; Choi, Y.La.; Cho, B.Chul., 2017:
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma

Goto, K.; Maeda, D.; Kudo-Asabe, Y.; Hibiya, T.; Hayashi, A.; Fukayama, M.; Ohashi, K.; Goto, A., 2016:
PIK3CA and AKT1 mutations in hidradenoma papilliferum

Wen, F.; He, S.; Sun, C.; Li, T.; Wu, S., 2015:
PIK3CA and PIK3CB expression and relationship with multidrug resistance in colorectal carcinoma

Wu, S.; Wen, F.; Li, Y.; Gao, X.; He, S.; Liu, M.; Zhang, X.; Tian, D., 2016:
PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma

Papageorgiou, S.; Psyrri, A.; Liakata, E.; Scorilas, A.; Rontogianni, D.; Kontos, C.; Argiriou, P.; Pappa, V.; Harhalakis, N.; Pectasides, D.; Economopoulos, T., 2016:
PIK3CA as a molecular target in mantle cell lymphoma

Ross, R.L.; McPherson, H.R.; Kettlewell, L.; Shnyder, S.D.; Hurst, C.D.; Alder, O.; Knowles, M.A., 2016:
PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma

Cescon, D.W.; Bedard, P.L., 2015:
PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancer

Kim, S.Tae.; Lira, M.; Deng, S.; Lee, S.; Park, Y.Suk.; Lim, H.Yeong.; Kang, W.Ki.; Mao, M.; Heo, J.Seok.; Kwon, W.; Jang, K-Taek.; Lee, J.; Park, J.Oh., 2016:
PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA

Majewski, I.J.; Nuciforo, P.; Mittempergher, L.; Bosma, A.J.; Eidtmann, H.; Holmes, E.; Sotiriou, C.; Fumagalli, D.; Jimenez, J.; Aura, C.; Prudkin, L.; Díaz-Delgado, M.Carmen.; de la Peña, L.; Loi, S.; Ellis, C.; Schultz, N.; de Azambuja, E.; Harbeck, N.; Piccart-Gebhart, M.; Bernards, Ré.; Baselga, Jé., 2015:
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer

Loibl, S.; Majewski, I.; Guarneri, V.; Nekljudova, V.; Holmes, E.; Bria, E.; Denkert, C.; Schem, C.; Sotiriou, C.; Loi, S.; Untch, M.; Conte, P.; Bernards, R.; Piccart, M.; von Minckwitz, G.; Baselga, J., 2016:
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab

Goel, S.; Krop, I.E., 2016:
PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum

Castaneda, C.A.; Lopez-Ilasaca, M.; Pinto, J.A.; Chirinos-Arias, M.; Doimi, F.; Neciosup, S.P.; Rojas, K.I.; Vidaurre, T.; Balko, J.M.; Arteaga, C.L.; Gomez, H.L., 2015:
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers

Santarpia, M.; Altavilla, G.; Margeli, M.; Mesiti, M.; Cavallari, V.; Cirauqui, B.; Reguart, N.; Barnadas, A.; Taron, M.; Rosell, R., 2016:
PIK3CA mutations in breast cancer: A potential predictive marker

Zadeh, G.; Karimi, S.; Aldape, K.D., 2016:
PIK3CA mutations in meningioma

Scheffler, M.; Bos, M.; Gardizi, M.; König, K.; Michels, S.; Fassunke, J.; Heydt, C.; Künstlinger, H.; Ihle, M.; Ueckeroth, F.; Albus, K.; Serke, M.; Gerigk, U.; Schulte, W.; Töpelt, K.; Nogova, L.; Zander, T.; Engel-Riedel, W.; Stoelben, E.; Ko, Y-Dschun.; Randerath, W.; Kaminsky, B.; Panse, J.; Becker, C.; Hellmich, M.; Merkelbach-Bruse, S.; Heukamp, L.C.; Büttner, R.; Wolf, Jürgen., 2015:
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies

Oshiro, C.; Kagara, N.; Naoi, Y.; Shimoda, M.; Shimomura, A.; Maruyama, N.; Shimazu, K.; Kim, S.Jin.; Noguchi, S., 2015:
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients

Shenoy, S., 2015:
PIK3CA mutations in small bowel adenocarcinoma

Manceau, G.; Marisa, L.; Boige, Vérie.; Duval, A.; Gaub, M-Pierre.; Milano, Gérard.; Selves, J.; Olschwang, S.; Jooste, Vérie.; le Legrain, Mè.; Lecorre, D.; Guenot, D.; Etienne-Grimaldi, M-Christine.; Kirzin, S.; Martin, L.; Lepage, C.; Bouvier, A-Marie.; Laurent-Puig, P., 2015:
PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

Li, H-Guang.; Liu, F-Feng.; Zhu, H-Qiang.; Zhou, X.; Lu, J.; Chang, H.; Hu, J-Hua., 2016:
PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma

Zheng, S.; Yang, C.; Lu, M.; Liu, Q.; Liu, T.; Dai, F.; Gao, X.; Sheyhidin, I.; Lu, X., 2017:
PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma

Mir, A.; Sadegh, M.Harati.; Ahmadinia, Z.; Kaboli, P.Jabbarzadeh., 2015:
PIK3CA rs7640662 (C/G) single nucleotide polymorphism lacks association with breast cancer cases in Persians

Green, S.; Trejo, C.L.; McMahon, M., 2016:
PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis

Zhai, L.Z.; Huang, Y.; Wang, S.S.; Cao, Y.B.; Xiao, J.; Fu, X.; Ye, S.; Guo, C.C.; Tian, Y.; Lin, T.Y., 2016:
PIK3CA, BCL-6, MLL and FOXP1 in the transformation and prognosis of MALT lymphoma

Keppler-Noreuil, K.M.; Rios, J.J.; Parker, V.E.R.; Semple, R.K.; Lindhurst, M.J.; Sapp, J.C.; Alomari, A.; Ezaki, M.; Dobyns, W.; Biesecker, L.G., 2015:
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation

Cui, W.; Zheng, S.; Li, X.; Ma, Y.; Sang, W.; Liu, M.; Zhang, W.; Zhou, X., 2016:
PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc

Yan, L-Xu.; Liu, Y-Hui.; Xiang, J-Wen.; Wu, Q-Nian.; Xu, L-Bo.; Luo, X-Lan.; Zhu, X-Lan.; Liu, C.; Xu, F-Ping.; Luo, D-Lan.; Mei, P.; Xu, J.; Zhang, K-Ping.; Chen, J., 2016:
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Baretić, D.; Williams, R.L., 2015:
PIKKs--the solenoid nest where partners and kinases meet

Krishna, S.; Palm, W.; Lee, Y.; Yang, W.; Bandyopadhyay, U.; Xu, H.; Florey, O.; Thompson, C.B.; Overholtzer, M., 2017:
PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment

Hessvik, N.Pettersen.; Øverbye, A.; Brech, A.; Torgersen, M.Lyngaas.; Jakobsen, I.Seim.; Sandvig, K.; Llorente, A., 2016:
PIKfyve inhibition increases exosome release and induces secretory autophagy

Tsuruta, F.; Dolmetsch, R.E., 2015:
PIKfyve mediates the motility of late endosomes and lysosomes in neuronal dendrites

Marchiò, C.; D.F.lippo, M.R.; Ng, C.K.Y.; Piscuoglio, S.; Soslow, R.A.; Reis-Filho, J.S.; Weigelt, B., 2015:
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas

Tian, Z.; Li, Z.; Zhou, M.; Jin, Y.; Wu, Z., 2016:
PILA: Sub-Meter Localization Using CSI from Commodity Wi-Fi Devices

Lauw, M.; How, C.How.; Loh, C., 2015:
PILL Series. Deliberate self-harm in adolescents

Kui, S.Leng.; How, C.How.; Koh, J., 2015:
PILL Series. The 'problematic' asthma patient

Gani, L.Utami.; How, C.How., 2016:
PILL Series. Vitamin D deficiency

How, C.How.; Koh, L.Hoe., 2016:
PILL series. Not that way: advance care planning

Misauno, M., 2011:
PILOT EXPERIENCE WITH Laparoscopic Cholecystectomy in Jos, Nigeria - CHALLENGES and prospects

Ophir, Y.; Duev-Cohen, A.; Yamin, R.; Tsukerman, P.; Bauman, Y.; Gamliel, M.; Mandelboim, O., 2016:
PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions

Warfel, N.A.; Sainz, A.G.; Song, J.H.; Kraft, A.S., 2017:
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species

Warfel, N.A.; Kraft, A.S., 2015:
PIM kinase (and Akt) biology and signaling in tumors

Kirschner, A.N.; Wang, J.; van der Meer, R.; Anderson, P.D.; Franco-Coronel, O.E.; Kushner, M.H.; Everett, J.H.; Hameed, O.; Keeton, E.K.; Ahdesmaki, M.; Grosskurth, S.E.; Huszar, D.; Abdulkadir, S.A., 2015:
PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer

Shannan, B.; Watters, A.; Chen, Q.; Mollin, S.; Dörr, M.; Meggers, E.; Xu, X.; Gimotty, P.A.; Perego, M.; Li, L.; Benci, J.; Krepler, C.; Brafford, P.; Zhang, J.; Wei, Z.; Zhang, G.; Liu, Q.; Yin, X.; Nathanson, K.L.; Herlyn, M.; Vultur, A., 2016:
PIM kinases as therapeutic targets against advanced melanoma

Xu, J.; Xiong, G.; Cao, Z.; Huang, H.; Wang, T.; You, L.; Zhou, L.; Zheng, L.; Hu, Y.; Zhang, T.; Zhao, Y., 2017:
PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value

Mitra, T.; Bhavsar, R.S.; Adams, D.J.; Budd, P.M.; Cooper, A.I., 2016:
PIM-1 mixed matrix membranes for gas separations using cost-effective hypercrosslinked nanoparticle fillers

Anonymous, 2016:
PIM1 May Be a Therapeutic Target in Triple-Negative Breast Cancer

Sagar, V.; Caldarola, S.; Aria, V.; Monteleone, V.; Fuoco, C.; Gargioli, C.; Cannata, S.; Loreni, F., 2016:
PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells

Xie, Y.; Bayakhmetov, S., 2016:
PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells

Wu, Y-Bo.; Lu, D.; He, Z-Feng.; Jin, C-Guan., 2016:
PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population

Leung, C.Oi-ning.; Wong, C.Chak-lui.; Fan, D.Ngo-yin.; Kai, A.Ka-lun.; Tung, E.Kwok-kwan.; Xu, I.Ming-jing.; Ng, I.Oi-lin.; Lo, R.Cheuk-lam., 2016:
PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma

Kaleeckal Mathew, O.; Sowdhamini, R., 2016:
PIMA: Protein-Protein interactions in Macromolecular Assembly - a web server for its Analysis and Visualization

Mathew, O.K.; Sowdhamini, R., 2016:
PIMADb: A Database of Protein-Protein Interactions in Huge Macromolecular Assemblies

Blanchard, A.M.; Egan, S.A.; Emes, R.D.; Warry, A.; Leigh, J.A., 2016:
PIMMS (Pragmatic Insertional Mutation Mapping System) Laboratory Methodology a Readily Accessible Tool for Identification of Essential Genes in iStreptococcus

Li, Z.; Yang, J.; Zhao, J.; Han, P.; Chai, Z., 2016:
PIMR: Parallel and Integrated Matching for Raw Data

Pasu, S.; Bunce, C.; Hooper, R.; Thomson, A.; Bainbridge, J., 2016:
PIMS (Positioning In Macular hole Surgery) trial - a multicentre interventional comparative randomised controlled clinical trial comparing face-down positioning, with an inactive face-forward position on the outcome of surgery for large macular holes: study protocol for a randomised controlled trial

Lavenus, J.; Guyomarc'h, S.; Laplaze, L., 2016:
PIN Transcriptional Regulation Shapes Root System Architecture

Waine, W., 1998:
PIN number delays cost time and money

Anonymous, 2000:
PIN number security alert

Bennett, T., 2016:
PIN proteins and the evolution of plant development

Adamowski, M.; Friml, Jří., 2015:
PIN-dependent auxin transport: action, regulation, and evolution

Kim, H.J.; Cho, Y.A.; Lee, Y.M.; Lee, S.Y.; Bae, W.J.; Kim, E.C., 2016:
PIN1 Suppresses the Hepatic Differentiation of Pulp Stem Cells via Wnt3a

Huang, L.; Mo, Z.; Lao, X.; Zhang, X.; Liu, Y.; Sui, J.; Qin, X.; Li, S., 2015:
PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population

Bae, J.Sang.; Noh, S.Jae.; Kim, K.Min.; Jang, K.Yun.; Park, H.Sung.; Chung, M.Ja.; Park, B-Hyun.; Moon, W.Sung., 2016:
PIN1 in hepatocellular carcinoma is associated with TP53 gene status

Cho, Y-A.; Jue, S-S.; Bae, W-J.; Heo, S-H.; Shin, S-I.; Kwon, I-K.; Lee, S-C.; Kim, E-C., 2015:
PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses

Żabka, A.; Polit, J.Teresa.; Winnicki, K.; Paciorek, P.; Juszczak, J.; Nowak, M.; Maszewski, J., 2016:
PIN2-like proteins may contribute to the regulation of morphogenetic processes during spermatogenesis in Chara vulgaris

Simon, S.; Skůpa, P.; Viaene, T.; Zwiewka, M.; Tejos, R.; Klíma, P.; Čarná, Mária.; Rolčík, J.; De Rycke, R.; Moreno, I.; Dobrev, P.I.; Orellana, A.; Zažímalová, E.; Friml, Jří., 2018:
PIN6 auxin transporter at endoplasmic reticulum and plasma membrane mediates auxin homeostasis and organogenesis in Arabidopsis

Świtnicki, Mł.P.; Juul, M.; Madsen, T.; Sørensen, K.D.; Pedersen, J.S., 2017:
PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification

Pai, P.P.; Ranjani, S.S.Shree.; Mondal, S., 2016:
PINGU: PredIction of eNzyme catalytic residues usinG seqUence information

Choi, I.; Woo, J.Hong.; Jou, I.; Joe, E-Hye., 2016:
PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation

Kubli, D.A.; Cortez, M.Q.; Moyzis, A.G.; Najor, R.H.; Lee, Y.; Gustafsson, Åsa.B., 2016:
PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and Activation of Mitophagy in Cardiac Myocytes

Agnihotri, S.; Golbourn, B.; Huang, X.; Remke, M.; Younger, S.; Cairns, R.A.; Chalil, A.; Smith, C.A.; Krumholtz, S-Lynn.; Mackenzie, D.; Rakopoulos, P.; Ramaswamy, V.; Taccone, M.S.; Mischel, P.S.; Fuller, G.N.; Hawkins, C.; Stanford, W.L.; Taylor, M.D.; Zadeh, G.; Rutka, J.T., 2017:
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma

Aerts, L.; D.S.rooper, B.; Morais, V.A., 2016:
PINK1 activation-turning on a promiscuous kinase

Cang, X.; Wang, X.; Liu, P.; Wu, X.; Yan, J.; Chen, J.; Wu, G.; Jin, Y.; Xu, F.; Su, J.; Wan, C.; Wang, X., 2017:
PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways

Degos, B.; Toussaint, Aélie.; Lesage, S.; Brice, A.; Vidailhet, M.; Beldjord, Cérif.; Catala, M., 2016:
PINK1 and FLNA mutations association: A role for atypical parkinsonism?

Chen, Y.; Deng, J.; Wang, P.; Yang, M.; Chen, X.; Zhu, L.; Liu, J.; Lu, B.; Shen, Y.; Fushimi, K.; Xu, Q.; Wu, J.Y., 2016:
PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration

Gehrke, S.; Wu, Z.; Klinkenberg, M.; Sun, Y.; Auburger, G.; Guo, S.; Lu, B., 2015:
PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane

Huang, Y.; Mu, D-Zhi., 2016:
PINK1 and the related diseases

Gómez-Sánchez, Rén.; Yakhine-Diop, S.M.S.; Bravo-San Pedro, Jé.M.; Pizarro-Estrella, E.; Rodríguez-Arribas, M.; Climent, V.; Martin-Cano, F.E.; González-Soltero, Mía.E.; Tandon, A.; Fuentes, Jé.M.; González-Polo, R.A., 2016:
PINK1 deficiency enhances autophagy and mitophagy induction

Bueno, M.; Lai, Y-Chun.; Romero, Y.; Brands, J.; St Croix, C.M.; Kamga, C.; Corey, C.; Herazo-Maya, J.D.; Sembrat, J.; Lee, J.S.; Duncan, S.R.; Rojas, M.; Shiva, S.; Chu, C.T.; Mora, A.L., 2015:
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis

Pryde, K.R.; Smith, H.L.; Chau, K-Yin.; Schapira, A.H.V., 2017:
PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy

Choi, I.; Choi, D-Joo.; Yang, H.; Woo, J.Hong.; Chang, M-Yoon.; Kim, J.Yeon.; Sun, W.; Park, S-Myun.; Jou, I.; Lee, S-Hun.; Lee, S.Hoon.; Joe, E-Hye., 2016:
PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes

Arena, G.; Valente, E.Maria., 2016:
PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease

Liu, Y.; Lin, J.; Zhang, M.; Chen, K.; Yang, S.; Wang, Q.; Yang, H.; Xie, S.; Zhou, Y.; Zhang, X.; Chen, F.; Yang, Y., 2016:
PINK1 is required for timely cell-type specific mitochondrial clearance during Drosophila midgut metamorphosis

Aerts, L.; Craessaerts, K.; D.S.rooper, B.; Morais, V.A., 2015:
PINK1 kinase catalytic activity is regulated by phosphorylation on serines 228 and 402

Min, B.; Kwon, Y-Chang.; Choe, K-Min.; Chung, K.Chul., 2015:
PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation

O'Flanagan, C.H.; O'Neill, C., 2015:
PINK1 signalling in cancer biology

Truban, D.; Hou, X.; Caulfield, T.R.; Fiesel, F.C.; Springer, W., 2016:
PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

O'Flanagan, C.H.; Morais, V.A.; O'Neill, C., 2016:
PINK1, cancer and neurodegeneration

Olszewska, D.A.; Lynch, T., 2016:
PINK1, parkin, and autophagy receptors: A new model of mitophagy

Ashrafi, G.; Schwarz, T.L., 2015:
PINK1- and PARK2-mediated local mitophagy in distal neuronal axons

Stolz, A.; Dikic, I., 2015:
PINK1-PARKIN interplay: down to ubiquitin phosphorylation

Wu, W.; Xu, H.; Wang, Z.; Mao, Y.; Yuan, L.; Luo, W.; Cui, Z.; Cui, T.; Wang, X.Li.; Shen, Y.H., 2016:
PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury

Dai, H.; Deng, Y.; Zhang, J.; Han, H.; Zhao, M.; Li, Y.; Zhang, C.; Tian, J.; Bing, G.; Zhao, L., 2015:
PINK1/Parkin-mediated mitophagy alleviates chlorpyrifos-induced apoptosis in SH-SY5Y cells

Eiyama, A.; Okamoto, K., 2015:
PINK1/Parkin-mediated mitophagy in mammalian cells

Zhang, H-Tao.; Mi, L.; Wang, T.; Yuan, L.; Li, X-Hui.; Dong, L-Sha.; Zhao, P.; Fu, J-Ling.; Yao, B-Yun.; Zhou, Z-Can., 2017:
PINK1/Parkin-mediated mitophagy play a protective role in manganese induced apoptosis in SH-SY5Y cells

Haga, K.; Sakai, T., 2016:
PINOID functions in root phototropism as a negative regulator

Lungu, C.; Stănescu, I.; Cojocaru, S.Ioana.; Ciobanu, C.; Ivănescu, B.; Miron, A., 2015:
PINUS cembra L: histo-anatomical features, antioxidant enzyme activities and heavy metal contents of leaves and long shoots

Jozefkowicz, C.; Sigaut, L.; Scochera, F.; Soto, G.; Ayub, Nás.; Pietrasanta, Lía.Isabel.; Amodeo, G.; González Flecha, F.Luis.; Alleva, K., 2016:
PIP Water Transport and Its pH Dependence Are Regulated by Tetramer Stoichiometry

Moschetta, M.; Telegrafo, M.; Cornacchia, I.; Vincenti, L.; Ranieri, V.; Cirili, A.; Rella, L.; Stabile Ianora, A.A.; Angelelli, G., 2016:
PIP breast implants: rupture rate and correlation with breast cancer

Choi, S.; Thapa, N.; Tan, X.; Hedman, A.C.; Anderson, R.A., 2015:
PIP kinases define PI4,5P₂signaling specificity by association with effectors

Yaneff, Aín.; Vitali, V.; Amodeo, G., 2016:
PIP1 aquaporins: Intrinsic water channels or PIP2 aquaporin modulators?

Bousova, K.; Jirku, M.; Bumba, L.; Bednarova, L.; Sulc, M.; Franek, M.; Vyklicky, L.; Vondrasek, J.; Teisinger, J., 2016:
PIP2 and PIP3 interact with N-terminus region of TRPM4 channel

Orłowski, A.; Kukkurainen, S.; Pöyry, A.; Rissanen, S.; Vattulainen, I.; Hytönen, V.P.; Róg, T., 2016:
PIP2 and Talin Join Forces to Activate Integrin

de la Cruz, L.; Puente, E.I.; Reyes-Vaca, A.; Arenas, I.; Garduño, J.; Bravo-Martínez, J.; Garcia, D.E., 2016:
PIP2 in pancreatic β-cells regulates voltage-gated calcium channels by a voltage-independent pathway

Brown, D.A., 2016:
PIP2Clustering: From model membranes to cells

Ayyadevara, S.; Balasubramaniam, M.; Johnson, J.; Alla, R.; Mackintosh, S.G.; Shmookler Reis, R.J., 2016:
PIP3-binding proteins promote age-dependent protein aggregation and limit survival in C. elegans

Fiume, R.; Stijf-Bultsma, Y.; Shah, Z.H.; Keune, W.Jan.; Jones, D.R.; Jude, J.Georg.; Divecha, N., 2015:
PIP4K and the role of nuclear phosphoinositides in tumour suppression

Fiume, R.; Jones, D.R.; Divecha, N., 2017:
PIP4K2B: Coupling GTP Sensing to PtdIns5P Levels to Regulate Tumorigenesis

Roser, F.; Tatagiba, M.S., 2016:
PIPA, RISA, ATPA & Co.: The Efforts We Spent on Convincing Others to Do the Best for our Patients with Petroclival Meningiomas

Hübner, M.; Teixeira, H.; Boussaha, T.; Cachemaille, M.; Lehmann, K.; Demartines, N., 2015:
PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis

Chang, Y-Chun.; Chu, C-Han.; Su, Y-Chen.; Chen, C.Chin.; Hsu, W-Lian., 2017:
PIPE: a protein-protein interaction passage extraction module for BioCreative challenge

Trusheim, M.R.; Shrier, A.A.; Antonijevic, Z.; Beckman, R.A.; Campbell, R.K.; Chen, C.; Flaherty, K.T.; Loewy, J.; Lacombe, D.; Madhavan, S.; Selker, H.P.; Esserman, L.J., 2016:
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms

Bjertnaes, O.; Iversen, H.Hestad.; Kjollesdal, J., 2016:
PIPEQ-OS--an instrument for on-site measurements of the experiences of inpatients at psychiatric institutions

Yu, F.; Li, N.; Yu, W., 2016:
PIPI: PTM-Invariant Peptide Identification Using Coding Method

Kalkhof, S.; Schildbach, S.; Blumert, C.; Horn, F.; von Bergen, M.; Labudde, D., 2016:
PIPINO: A Software Package to Facilitate the Identification of Protein-Protein Interactions from Affinity Purification Mass Spectrometry Data

Gweon, H.S.; Oliver, A.; Taylor, J.; Booth, T.; Gibbs, M.; Read, D.S.; Griffiths, R.I.; Schonrogge, K., 2016:
PIPITS: an automated pipeline for analyses of fungal internal transcribed spacer sequences from the Illumina sequencing platform

Hanssen, A., 2016:
PIPOM or the need of a new acronym

Toker, A.; Rameh, L., 2015:
PIPPing on AKT1: How Many Phosphatases Does It Take to Turn off PI3K?

Barry, E.; O'Brien, K.; Moriarty, F.; Cooper, J.; Redmond, P.; Hughes, C.M.; Bennett, K.; Fahey, T.; Smith, S.M., 2017:
PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique

Waugh, M.G., 2015:
PIPs in neurological diseases

Turkbey, B.; Choyke, P.L., 2015:
PIRADS 2.0: what is new?

Granja, C.; Póvoa, P., 2016:
PIRO and sepsis stratification: reality or a mirage?

Rathour, S.; Kumar, S.; Hadda, V.; Bhalla, A.; Sharma, N.; Varma, S., 2016:
PIRO concept: staging of sepsis

Wang, K.; Lin, L.; Lu, J.; Li, C.; Shi, K., 2015:
PISA: pixelwise image saliency by aggregating complementary appearance contrast measures with edge-preserving coherence

Kondili, L.A.; Vella, S., 2016 :
PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy

Rusu, V.H.; Baron, R.; Lins, R.D., 2015:
PITOMBA: Parameter Interface for Oligosaccharide Molecules Based on Atoms

Halberg, N.; Sengelaub, C.A.; Navrazhina, K.; Molina, H.; Uryu, K.; Tavazoie, S.F., 2016:
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion

Takenobu, M.; Osaki, M.; Fujiwara, K.; Fukuhara, T.; Kitano, H.; Kugoh, H.; Okada, F., 2016:
PITX1 is a novel predictor of the response to chemotherapy in head and neck squamous cell carcinoma

Mudie, S.; Bandarra, D.; Batie, M.; Biddlestone, J.; Moniz, S.; Ortmann, B.; Shmakova, A.; Rocha, S., 2015:
PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia

Uhl, B.; Gevensleben, H.; Tolkach, Y.; Sailer, V.; Majores, M.; Jung, M.; Meller, S.; Stein, J.; Ellinger, Jörg.; Dietrich, D.; Kristiansen, G., 2016:
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies

Zhao, C-Mei.; Peng, L-Ying.; Li, L.; Liu, X-Yuan.; Wang, J.; Zhang, X-Ling.; Yuan, F.; Li, R-Gu.; Qiu, X-Biao.; Yang, Y-Qing., 2016:
PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome

Syeda, F.; Holmes, A.P.; Yu, T.Y.; Tull, S.; Kuhlmann, S.Michael.; Pavlovic, D.; Betney, D.; Riley, G.; Kucera, J.P.; Jousset, F.; de Groot, J.R.; Rohr, S.; Brown, N.A.; Fabritz, L.; Kirchhof, P., 2016:
PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers

Sailer, V.; Holmes, E.Eva.; Gevensleben, H.; Goltz, D.; Dröge, F.; de Vos, L.; Franzen, A.; Schröck, F.; Bootz, F.; Kristiansen, G.; Schröck, A.; Dietrich, D., 2016:
PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma

Sun, Y-Min.; Wang, J.; Qiu, X-Biao.; Yuan, F.; Xu, Y-Jia.; Li, R-Gu.; Qu, X-Kai.; Huang, R-Tai.; Xue, S.; Yang, Y-Qing., 2016:
PITX2 loss-of-function mutation contributes to tetralogy of Fallot

Li, N.; Dobrev, D.; Wehrens, X.H.T., 2016:
PITX2: a master regulator of cardiac channelopathy in atrial fibrillation?

Rial Boubeta, A.; Gómez Salgado, P.; Isorna Folgar, M.; Araujo Gallego, M.; Varela Mallou, Jús., 2015:
PIUS-a: Problematic Internet Use Scale in adolescents. Development and psychometric validation

Yovich, J.L.; Alsbjerg, B.; Conceicao, J.L.; Hinchliffe, P.M.; Keane, K.N., 2016:
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome

Teruya, M.; Soundar, E.; Hui, S.R.; Eldin, K.; Adcock, D.; Teruya, J., 2016:
PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns

Xu, J-feng.; Liu, X-yu., 2015:
PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transition

Weinberg, A.E.; Brooks, J.D., 2012:
PIVOT and the challenges of localized prostate cancer care

Yang, Z.; Chen, K-Ming.; Pandey, R.Raman.; Homolka, D.; Reuter, M.; Janeiro, B.Kotska.Rodino.; Sachidanandam, R.; Fauvarque, M-Odile.; McCarthy, A.A.; Pillai, R.S., 2016:
PIWI Slicing and EXD1 Drive Biogenesis of Nuclear piRNAs from Cytosolic Targets of the Mouse piRNA Pathway

Homolka, D.; Pandey, R.Raman.; Goriaux, C.; Brasset, E.; Vaury, C.; Sachidanandam, R.; Fauvarque, M-Odile.; Pillai, R.S., 2016:
PIWI Slicing and RNA Elements in Precursors Instruct Directional Primary piRNA Biogenesis

Xiao, Y.; Ke, A., 2016:
PIWI Takes a Giant Step

Mikhaleva, E.A.; Iakushev, E.Iu.; Stoliarenko, A.D.; Klenov, M.S.; Pozovskiĭ, I.M.; Gvozdev, V.A., 2015:
PIWI protein as a nucleolus visitor in Drosophila melanogaster

Ku, H-Yen.; Lin, H., 2014:
PIWI proteins and their interactors in piRNA biogenesis, germline development and gene expression

Iwasaki, Y.W.; Siomi, M.C.; Siomi, H., 2015:
PIWI-Interacting RNA: Its Biogenesis and Functions

Jacobs, D.I.; Qin, Q.; Lerro, M.C.; Fu, A.; Dubrow, R.; Claus, E.B.; DeWan, A.T.; Wang, G.; Lin, H.; Zhu, Y., 2018:
PIWI-Interacting RNAs in Gliomagenesis: Evidence from Post-GWAS and Functional Analyses

Vella, S.; Gallo, A.; L.N.gro, A.; Galvagno, D.; Raffa, G.Maria.; Pilato, M.; Conaldi, P.Giulio., 2016:
PIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells

Fu, A.; Jacobs, D.I.; Hoffman, A.E.; Zheng, T.; Zhu, Y., 2016:
PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome

Stalker, L.; Russell, S.J.; Co, C.; Foster, R.A.; LaMarre, J., 2016:
PIWIL1 Is Expressed in the Canine Testis, Increases with Sexual Maturity, and Binds Small RNAs

Li, C.; Zhou, X.; Chen, J.; Lu, Y.; Sun, Q.; Tao, D.; Hu, W.; Zheng, X.; Bian, S.; Liu, Y.; Ma, Y., 2016:
PIWIL1 destabilizes microtubule by suppressing phosphorylation at Ser16 and RLIM-mediated degradation of Stathmin1

Qu, X.; Liu, J.; Zhong, X.; Li, X.; Zhang, Q., 2016:
PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression

Eisa, M.H.; Shen, H.; Jin, W.; Alaamer, A.S.; Al-Rajhi, M.A.; Idriss, H., 2016:
PIXE study on the effects of parathyroid hormone on elemental content in rat bones

Bengtsson, Göran.; Pallon, J.; Nilsson, C.; Triebskorn, R.; Köhler, H-R., 2016:
PIXE-electrophoresis shows starving collembolan reallocates protein-bound metals

Balasse, L.; Maerk, J.; Pain, Fédéric.; Genoux, A.; Fieux, S.; Lefebvre, Fçoise.; Morel, C.; Gisquet-Verrier, P.; Lanièce, P.; Zimmer, L., 2016:
PIXSIC: A Wireless Intracerebral Radiosensitive Probe in Freely Moving Rats

Kamenicky, J.; Bartos, M.; Flusser, J.; Mahdian, B.; Kotera, J.; Novozamsky, A.; Saic, S.; Sroubek, F.; Sorel, M.; Zita, A.; Zitova, B.; Sima, Z.; Svarc, P.; Horinek, J., 2016:
PIZZARO: Forensic analysis and restoration of image and video data

Visser, N.C.M.; Bulten, J.; van der Wurff, A.A.M.; Boss, E.A.; Bronkhorst, C.M.; Feijen, H.W.H.; Haartsen, J.E.; van Herk, H.A.D.M.; de Kievit, I.M.; Klinkhamer, P.J.J.M.; Pijlman, B.M.; Snijders, M.P.M.L.; Vandenput, I.; Vos, M.Caroline.; de Wit, P.E.J.; van de Poll-Franse, L.V.; Massuger, L.F.A.G.; Pijnenborg, J.M.A., 2016:
PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study

Sax, P.E., 2018:
PIs may lead to premature delivery

Motta, C.; D'Angeli, F.; Scalia, M.; Satriano, C.; Barbagallo, D.; Naletova, I.; Anfuso, C.Daniela.; Lupo, G.; Spina-Purrello, V., 2016:
PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells

Koch, K.M.; Roman, J.R.; Jaworski, D.; Godillot, P.; Robertson, M.J.; Kirkwood, J.M.; Lucas, S.; Bell, B.; Dar, M.M., 2016:
PK and PD of recombinant human IL-18 (rhIL-18) administered IV in repeated cycles to patients with solid tumors

Wang, Q.; Liang, Y.; Rao, T.; Xie, L.; Ye, W.; Fu, H.; Zhou, L.; Xing, R.; Shao, Y.; Xiao, J.; Kang, D.; Wang, G., 2016:
PK study of octreotide based on LC-MS/MS combining protein precipitation and impurity extraction technique

Schindler, E.; Amantea, M.A.; Karlsson, M.O.; Friberg, L.E., 2016:
PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor

Golikova, M.V.; Strukova, E.N.; Portnoy, Y.A.; Firsov, A.A., 2016:
PK/PD Modeling as a Tool for Predicting Bacterial Resistance to Antibiotics: Alternative Analyses of Experimental Data

Marostica, E.; Van Ammel, K.; Teisman, A.; Gallacher, D.; Van Bocxlaer, J.; D.R.dder, F.; Boussery, K.; Vermeulen, A., 2016:
PK/PD Modelling of the QT Interval: a Step Towards Defining the Translational Relationship Between In Vitro, Awake Beagle Dogs, and Humans

Haraya, K.; Tachibana, T.; Iwayanagi, Y.; Maeda, A.; Ozeki, K.; Nezu, J.; Ishigai, M.; Igawa, T., 2016:
PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model

Akashita, G.; Hosaka, Y.; Noda, T.; Isoda, K.; Shimada, T.; Sawamoto, K.; Miyamoto, K-Ichi.; Taniguchi, T.; Sai, Y., 2016:
PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

Tu, L.N.; Zhao, A.H.; Stocco, D.M.; Selvaraj, V., 2015:
PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO)

Kim, Y-Kyoung.; Zhang, M.; Lu, J-Jian.; Xu, F.; Chen, B-An.; Xing, L.; Jiang, H-Lin., 2015:
PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier

Chen, B.; Zhang, H.; Liu, L.; Wang, J.; Ye, Z., 2016:
PK2/PKR1 Signaling Regulates Bladder Function and Sensation in Rats with Cyclophosphamide-Induced Cystitis

Kaihara, K.A.; Dickson, L.M.; Ellenbroek, J.H.; Orr, C.M.D.; Layden, B.T.; Wicksteed, B., 2015:
PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control

Groß, C.J.; Groß, O., 2016:
PKA Has the Gall to Oppose NLRP3

Song, J.; Cheon, S.Yeong.; Lee, W.Taek.; Park, K.Ah.; Lee, J.Eun., 2016:
PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury

García-Bermúdez, J.; Sánchez-Aragó, Mía.; Soldevilla, B.; Del Arco, A.; Nuevo-Tapioles, C.; Cuezva, Jé.M., 2016:
PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase

Kostic, M.; Ludtmann, M.H.R.; Bading, H.; Hershfinkel, M.; Steer, E.; Chu, C.T.; Abramov, A.Y.; Sekler, I., 2016:
PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic Neurons

Akabane, S.; Uno, M.; Tani, N.; Shimazaki, S.; Ebara, N.; Kato, H.; Kosako, H.; Oka, T., 2017:
PKA Regulates PINK1 Stability and Parkin Recruitment to Damaged Mitochondria through Phosphorylation of MIC60

Krishnan, H.; Retzbach, E.P.; Ramirez, M.I.; Liu, T.; Li, H.; Miller, W.Todd.; Goldberg, G.S., 2015:
PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility

Sinha, C.; Ren, A.; Arora, K.; Moon, C.Suk.; Yarlagadda, S.; Woodrooffe, K.; Lin, S.; Schuetz, J.D.; Ziady, A.G.; Naren, A.P., 2016:
PKA and actin play critical roles as downstream effectors in MRP4-mediated regulation of fibroblast migration

Pavot, P.; Carbognin, E.; Martin, J-René., 2015:
PKA and cAMP/CNG Channels Independently Regulate the Cholinergic Ca(2+)-Response of Drosophila Mushroom Body Neurons

Xu, J.; Yu, L.; Minobe, E.; Lu, L.; Lei, M.; Kameyama, M., 2016:
PKA and phosphatases attached to the Ca(V)1.2 channel regulate channel activity in cell-free patches

Zhou, X-L.; Wang, Y.; Zhang, C-J.; Yu, L-N.; Cao, J-L.; Yan, M., 2016:
PKA is required for the modulation of spinal nociceptive information related to ephrinB-EphB signaling in mice

Kim, S.Sook.; Lee, E.Hye.; Lee, K.; Jo, S-Hyun.; Seo, S.Ryeon., 2015:
PKA regulates calcineurin function through the phosphorylation of RCAN1: identification of a novel phosphorylation site

Kong, D.; Shen, Y.; Liu, G.; Zuo, S.; Ji, Y.; Lu, A.; Nakamura, M.; Lazarus, M.; Stratakis, C.A.; Breyer, R.M.; Yu, Y., 2017:
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation

Bram, Z.; Louiset, E.; Ragazzon, B.; Renouf, S.; Wils, J.; Duparc, Céline.; Boutelet, I.; Rizk-Rabin, M.; Libé, R.; Young, J.; Carson, D.; Vantyghem, M-Christine.; Szarek, E.; Martinez, A.; Stratakis, C.A.; Bertherat, Jérôme.; Lefebvre, Hé., 2018:
PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease

Yi, D-Gwan.; Huh, W-Ki., 2015:
PKA, PHO and stress response pathways regulate the expression of UDP-glucose pyrophosphorylase through Msn2/4 in budding yeast

Georg, B.; Falktoft, B.; Fahrenkrug, J., 2016:
PKA, novel PKC isoforms, and ERK is mediating PACAP auto-regulation via PAC 1 R in human neuroblastoma NB-1 cells

Liu, H.; Jin, X.; Yin, X.; Jin, N.; Liu, F.; Qian, W., 2016:
PKA-CREB Signaling Suppresses Tau Transcription

Diering, G.H.; Gustina, A.S.; Huganir, R.L., 2015:
PKA-GluA1 coupling via AKAP5 controls AMPA receptor phosphorylation and cell-surface targeting during bidirectional homeostatic plasticity

Baccarini, L.; Martínez-Montañés, F.; Rossi, S.; Proft, M.; Portela, P., 2015:
PKA-chromatin association at stress responsive target genes from Saccharomyces cerevisiae

Romarowski, A.; Battistone, Mía.A.; L.S.ina, F.A.; Puga Molina, L.del.C.; Luque, G.M.; Vitale, A.M.; Cuasnicu, P.S.; Visconti, P.E.; Krapf, Dío.; Buffone, M.G., 2015:
PKA-dependent phosphorylation of LIMK1 and Cofilin is essential for mouse sperm acrosomal exocytosis

Biever, A.; Puighermanal, E.; Nishi, A.; David, A.; Panciatici, C.; Longueville, S.; Xirodimas, D.; Gangarossa, G.; Meyuhas, O.; Hervé, D.; Girault, J-Antoine.; Valjent, E., 2015:
PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons

Chen, Y.; Mathias, L.; Falero-Perez, J.M.; Kim, S.F., 2016:
PKA-mediated phosphorylation of Dexras1 suppresses iron trafficking by inhibiting S-nitrosylation

Wang, Y.; Ho, T.G.; Franz, E.; Hermann, J.S.; Smith, F.Donelson.; Hehnly, H.; Esseltine, J.L.; Hanold, L.E.; Murph, M.M.; Bertinetti, D.; Scott, J.D.; Herberg, F.W.; Kennedy, E.J., 2016:
PKA-type I selective constrained peptide disruptors of AKAP complexes

Xiong, J.; Zhou, X.; Gong, Z.; Wang, T.; Zhang, C.; Xu, X.; Liu, J.; Li, W., 2015:
PKA/CREB regulates the constitutive promoter activity of the USP22 gene

Quan, C.; Xie, B.; Wang, H.Yu.; Chen, S., 2016 :
PKB-Mediated Thr649 Phosphorylation of AS160/TBC1D4 Regulates the R-Wave Amplitude in the Heart

Marchesi, N.; Amadio, M.; Colombrita, C.; Govoni, S.; Ratti, A.; Pascale, A., 2018:
PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells

Lopes-Pires, M.Elisa.; Naime, A.C.Antunes.; Almeida Cardelli, Nádia.J.; Anjos, Débora.J.; Antunes, E.; Marcondes, S., 2016:
PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis

Andersen, M.Nybo.; Skibsbye, L.; Tang, C.; Petersen, F.; MacAulay, N.; Rasmussen, H.Borger.; Jespersen, T., 2016:
PKC and AMPK regulation of Kv1.5 potassium channels

Groten, C.J.; Magoski, N.S., 2015:
PKC enhances the capacity for secretion by rapidly recruiting covert voltage-gated Ca2+ channels to the membrane

Colomb, J.; Brembs, Börn., 2016:
PKC in motorneurons underlies self-learning, a form of motor learning in Drosophila

Li, S-Jie.; Cui, S-Ying.; Zhang, X-Qiong.; Yu, B.; Sheng, Z-Fu.; Huang, Y-Li.; Cao, Q.; Xu, Y-Ping.; Lin, Z-Ge.; Yang, G.; Cui, X-Yu.; Zhang, Y-He., 2016:
PKC in rat dorsal raphe nucleus plays a key role in sleep-wake regulation

Ni, S.; Chen, L.; Li, M.; Zhao, W.; Shan, X.; Wu, M.; Cheng, J.; Liang, L.; Wang, Y.; Jiang, W.; Zhang, J.; Ni, R., 2016:
PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma

Wang, Q.; Bubula, N.; Brown, J.; Wang, Y.; Kondev, V.; Vezina, P., 2017:
PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux

Gonnella, R.; Granato, M.; Farina, A.; Santarelli, R.; Faggioni, A.; Cirone, M., 2015:
PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction

Chichger, H.; Vang, A.; O'Connell, K.A.; Zhang, P.; Mende, U.; Harrington, E.O.; Choudhary, G., 2016:
PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension

Yu, Y-Hsiang.; Liao, P-Ru.; Guo, C-Jung.; Chen, C-Hong.; Mochly-Rosen, D.; Chuang, L-Ming., 2017:
PKC-ALDH2 Pathway Plays a Novel Role in Adipocyte Differentiation

Barrera, S.P.; Castrejon-Tellez, V.; Trinidad, M.; Robles-Escajeda, E.; Vargas-Medrano, J.; Varela-Ramirez, A.; Miranda, M., 2016:
PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination

Galeotti, N.; Ghelardini, C., 2013:
PKC-Dependent Signaling Pathways within PAG and Thalamus Contribute to the Nitric Oxide-Induced Nociceptive Behavior

Brezar, V.; Tu, W.Juan.; Seddiki, N., 2015:
PKC-Theta in Regulatory and Effector T-cell Functions

Zeki, J.; Taylor, J.S.; Yavuz, B.; Coburn, J.; Ikegaki, N.; Kaplan, D.L.; Chiu, B., 2018:
Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth

Arrighetti, N.; Cossa, G.; D.C.cco, L.; Stucchi, S.; Carenini, N.; Corna, E.; Gandellini, P.; Zaffaroni, N.; Perego, P.; Gatti, L., 2016:
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells

El-Yazbi, A.F.; Abd-Elrahman, K.S.; Moreno-Dominguez, A., 2015:
PKC-mediated cerebral vasoconstriction: Role of myosin light chain phosphorylation versus actin cytoskeleton reorganization

Willems, P.H.G.M.; Pahle, Jürgen.; Stalpers, X.L.; Mugahid, D.; Nikolaew, A.; Koopman, W.J.H.; Kummer, U., 2015:
PKC-mediated inhibitory feedback of the cholecystokinin 1 receptor controls the shape of oscillatory Ca²⁺ signals

Gonzalez, A.A.; Liu, L.; Lara, L.S.; Bourgeois, C.R.T.; Ibaceta-Gonzalez, C.; Salinas-Parra, N.; Gogulamudi, V.R.; Seth, D.M.; Prieto, M.C., 2016:
PKC-α-dependent augmentation of cAMP and CREB phosphorylation mediates the angiotensin II stimulation of renin in the collecting duct

Durpès, M-Claude.; Morin, C.; Paquin-Veillet, J.; Beland, Rël.; Paré, M.; Guimond, M-Odile.; Rekhter, M.; King, G.L.; Geraldes, P., 2016:
PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis

Li, X.; Cullere, X.; Nishi, H.; Saggu, G.; Durand, E.; Mansour, M.K.; Tam, J.M.; Song, X-Yu.; Lin, X.; Vyas, J.M.; Mayadas, T., 2017:
PKC-δ activation in neutrophils promotes fungal clearance

Muscella, A.; Vetrugno, C.; Antonaci, G.; Cossa, L.Giulio.; Marsigliante, S., 2016:
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin

Lee-Rivera, I.; López, E.; Carranza-Pérez, M.Gabriela.; López-Colomé, A.María., 2016:
PKC-ζ Regulates Thrombin-Induced Proliferation of Human Müller Glial Cells

Michalczyk, I.; Toporkiewicz, M.; Dubielecka, P.M.; Chorzalska, A.; Sikorski, A.F., 2016:
PKC-θ is a negative regulator of TRAIL-induced and FADD-mediated apoptotic spectrin aggregation

Tsubaki, M.; Takeda, T.; Tani, T.; Shimaoka, H.; Suzuyama, N.; Sakamoto, K.; Fujita, A.; Ogawa, N.; Itoh, T.; Imano, M.; Funakami, Y.; Ichida, S.; Satou, T.; Nishida, S., 2015:
PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects

Shio, M.Tiemi.; Christian, J.Gregor.; Jung, J.Yong.; Chang, K-Poo.; Olivier, M., 2016:
PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection

Kwan, R.; Chen, L.; Looi, K.; Tao, G-Zhong.; Weerasinghe, S.V.; Snider, N.T.; Conti, M.Anne.; Adelstein, R.S.; Xie, Q.; Omary, M.Bishr., 2016:
PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding

Siska, P.J.; Rathmell, J.C., 2015:
PKCs Sweeten Cell Metabolism by Phosphorylation of Glut1

Zaid, Y.; Senhaji, N.; Naya, A.; Fadainia, C.; Kojok, K., 2016:
PKCs in thrombus formation

Li, L.; Zhao, L.; Wang, Y.; Ma, K-Tao.; Shi, W-Yan.; Wang, Y-Zi.; Si, J-Qiang., 2015:
PKCɛ mediates substance P inhibition of GABAA receptors-mediated current in rat dorsal root ganglion

Pandya, K.; Wyatt, D.; Gallagher, B.; Shah, D.; Baker, A.; Bloodworth, J.; Zlobin, A.; Pannuti, A.; Green, A.; Ellis, I.O.; Filipovic, A.; Sagert, J.; Rana, A.; Albain, K.S.; Miele, L.; Denning, M.F.; Osipo, C., 2016:
PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance

Tabeling, C.; Noe, E.; Naujoks, J.; Doehn, J-Moritz.; Hippenstiel, S.; Opitz, B.; Suttorp, N.; Klopfleisch, R.; Witzenrath, M., 2016:
PKCα Deficiency in Mice Is Associated with Pulmonary Vascular Hyperresponsiveness to Thromboxane A2 and Increased Thromboxane Receptor Expression

Andersson, A.; Bluwstein, A.; Kumar, N.; Teloni, F.; Traenkle, J.; Baudis, M.; Altmeyer, M.; Hottiger, M.O., 2017:
PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation

González-Arenas, A.; Peña-Ortiz, M.Ángel.; Hansberg-Pastor, V.; Marquina-Sánchez, B.; Baranda-Ávila, N.; Nava-Castro, K.; Cabrera-Wrooman, A.; González-Jorge, Jús.; Camacho-Arroyo, I., 2015:
PKCα and PKCδ activation regulates transcriptional activity and degradation of progesterone receptor in human astrocytoma cells

Wang, J.; Shao, M.; Liu, M.; Peng, P.; Li, L.; Wu, W.; Wang, L.; Duan, F.; Zhang, M.; Song, S.; Jia, D.; Ruan, Y.; Gu, J., 2015:
PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma

Vaškovičová, Kína.; Szabadosová, E.; Čermák, Vír.; Gandalovičová, A.; Kasalová, L.; Rösel, D.; Brábek, J., 2016:
PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness

Dutta, A.K.; Khimji, A-Karim.; Liu, S.; Karamysheva, Z.; Fujita, A.; Kresge, C.; Rockey, D.C.; Feranchak, A.P., 2016:
PKCα regulates TMEM16A-mediated Cl⁻ secretion in human biliary cells

Gao, X.; Xu, F.; Zhang, H-Tian.; Chen, M.; Huang, W.; Zhang, Q.; Zeng, Q.; Liu, L., 2017:
PKCα-GSK3β-NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis

Park, C.; Kalinec, F., 2016:
PKCα-Mediated Signals Regulate the Motile Responses of Cochlear Outer Hair Cells

Zestos, A.G.; Mikelman, S.R.; Kennedy, R.T.; Gnegy, M.E., 2016:
PKCβ Inhibitors Attenuate Amphetamine-Stimulated Dopamine Efflux

Zheng, M.; Zhang, X.; Guo, S.; Zhang, X.; Choi, H.Jin.; Lee, M-Yeol.; Kim, K-Man., 2016:
PKCβII inhibits the ubiquitination of β-arrestin2 in an autophosphorylation-dependent manner

Bellini, G.; Torella, M.; Manzo, I.; Tortora, C.; Luongo, L.; Punzo, F.; Colacurci, N.; Nobili, B.; Maione, S.; Rossi, F., 2016:
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity

Dieb, W.; Alvarez, P.; Hafidi, A., 2015 :
PKCγ-positive neurons gate light tactile inputs to pain pathway through pERK1/2 neuronal network in trigeminal neuropathic pain model

Berardi, Dán.E.; Flumian, C.; Rodriguez, C.E.; Bessone, Mía.I.Díaz.; Cirigliano, S.M.; Joffé, E.D.Bal.de.Kier.; Fiszman, G.L.; Urtreger, A.J.; Todaro, L.B., 2015:
PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy

Hwang, E.; Yoo, K-Chun.; Kang, S-Gu.; Kim, R-Kwon.; Cui, Y-Hong.; Lee, H-June.; Kim, M-Jung.; Lee, J-Seong.; Kim, I-Gyu.; Suh, Y.; Lee, S-Jae., 2016:
PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling

Khamaisi, M.; Katagiri, S.; Keenan, H.; Park, K.; Maeda, Y.; Li, Q.; Qi, W.; Thomou, T.; Eschuk, D.; Tellechea, A.; Veves, A.; Huang, C.; Orgill, D.Paul.; Wagers, A.; King, G.L., 2016:
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts

Shin, E-Joo.; Dang, D-Khanh.; Tran, H-Quyen.; Nam, Y.; Jeong, J.Hoon.; Lee, Y.Hun.; Park, K.Tae.; Lee, Y.Sup.; Jang, C-Gon.; Hong, J-Shyong.; Nabeshima, T.; Kim, H-Chun., 2016:
PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice

Kc, R.; Li, X.; Kroin, J.S.; Liu, Z.; Chen, D.; Xiao, G.; Levine, B.; Li, J.; Hamilton, J.L.; van Wijnen, A.J.; Piel, M.; Shelly, D.A.; Brass, D.; Kolb, E.; Im, H-Jeong., 2016:
PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth

Symonds, J.M.; Ohm, A.M.; Tan, A-Choon.; Reyland, M.E., 2017:
PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells

Li, D.; Li, C.; Wu, M.; Chen, Q.; Wang, Q.; Ren, J.; Zhang, Y., 2016:
PKCδ stabilizes TAp63 to promote cell apoptosis